var title_f31_57_32656="Aortic root aneurysm parasternal long axis echocardiogram";
var content_f31_57_32656=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1040px;\">",
"  <div class=\"videoplayer\" h264=\"./images/CARD/79876/aorrtane_conv.mp4?title=Aortic+root+aneurysm+parasternal+long+axis+echocardiogram\" style=\"width:320px;height:256px\">",
"  </div>",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Aortic root aneurysm long axis view from a 2",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 324px; height: 242px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCADyAUQDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD5UooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAp21tm/aducZxxmlijeaRY41LO3QCuigtZH0w2LXtwtoJRMYskx+Zjbv29OnGcZ7c0Ac1SkEYyCAeR710jaVbeR5cU0T4OdxyM9e4H+c1Je6RvtEiMsjSwoFhySVVSWYqAegyxOB6k/UA5ainyxtFIyP95Tg175c+I/Cen3ctzpGvWU+m3dsFOkDTFRbdio/5aONxwQeOnvgVzYjEOja0b7/AIfJ7m1Kkqm7seAUUppK6TEKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAoortPg5Z2epfEnQdO1PTYNSsr25S3mhm34CsQCwKMCCOx6eoNAHF0V7g3gHwxqWqapqGrC+0i0PilfDttZaXEGVcodkhMrEjO3cTzyeAAeJtY+F3h6LRdB0u1kvI9dufEd1okupMuYW8u4WLc6lsKMHKgYJJwT0NAHhNFe8Xnwc8NDVmtrbXtRRLaG9a8jaFZJYzAm8MMbV+YA/ITkY6nrWJ4e+Gvh/wAQ+G5/Emm6tqK6Hpz3Y1E3EMaTRLHEHhIUEjLk7cZPPSgDyKivZ9T+E2i6f4NtLybXLj+2bjTrfUo0CAwyrKQSigAn5VP3ycEgjArbg+EvhC28T/Y/t+sXq6X4istK1CKeJI0uFnbChCjbgMjBOQcZIAOKAPn2ivXvFngTwppuleJtb+1a3Z2llrkmkWtoLdHYv5TuuSzghNykbsk7QOCTxqeLPhvpFnrXizUNTe9lsNKfT7dbTRbWNJGee3R95XlUUcjODuY9qAPDaK9lPweiee0khm1VbCbQ7vVWlmtdpikhZwIn7KflXIzkE1tX3w30XWPEcbTW09hpFroely3EtiY41WadMbmBDFmYg8KpyepFAHgFFet+O/hpofg3RNVu7/V9SmuYdUudMtI4bZCsjJGjo0hLgqPnwcBvYV5JQAUUUUAFSQQyTyCOFGdz0CjNSWMC3N3HE7MiMfmZV3FR64yM/nW9bwLpUcc0aM77iHbOD9PYc8//AKqAL1pp0UFsjQRoLhcKXRWO/wByCSevoAPYVesQdwmktUGCRu3NwcHORj/9f0rPbVGe1/1UagHcAijfx33dQOvaotM10iUJGjqNwJ2uM9P5cUAdnYadJJD5zWweNi2/OMZK4LDarEenPqPXNUX0xs7RKp3d9u4tnrhjinweIo4wnmtLktlsNnP14Hr/AJxWZd38cirvDLyTtVifMPvnrjjoaAKWpaJamC6PmAzhP3a7SWUg98EKoOO+evFcbLG8TlJFKsOxrp59UjiMiyoDjkc5yecZzzj2FZdzdwagyfaVdJd2GeMbyAB2GQDz7igDJooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigArT8O3usWOqxSeG7nULbUnzHG1hI6TNnqoKcnPpWZXYfCrxRB4Q8XxardSXMcSwyxE28CTE71xgo7KCOecMp96AI7mfxzqGpy2t1L4ludRSZL6SGRp3lWVFCpMVPIZVwoc8gYANVxdeLr3Tb1BPr1xp88r3t0oeZ4pJFYF5pOxYNjLHnOMmvXrX4z+HLfUtZWz0/VdPtLo2ksF3GonlEkIbOYnm+VCWyFEh2kZ5zWo3xT0HTNG8M6+1/f3V6l5rNz/ZVsYlWZpnG37Wgf92p3EjCtn5sepAPJNck+I1vaaVc6tfeI3gvrNns2a8kl3W7AhgMMdoKqcqcZA5GK5uwbXo9PuLHTzqiWN+gkmt4DII7lUPDMo4cKe5zg16xofxa0eBfBb6odfl/snT5tMvbaMo0bI6SoJoyz8yAOowyjgYzSW/xS8O6Ra2dtoK69GLLw5f6Rb3EixpKs8zlo5Mq/AB5JHI7A9aAPOJ7zxlpmhy6fcXPiGz0eKURSWzvNHAkhAYKUOFDdDgjPeoLu/8AExW5nuNQ1SVLqVLieUXLyLLIv3HdgSCw7E8ivSPGHxctPEHhXxBpUj6zM1/pel2sAuSGRJ7d1aaQ/OcbsHBAJPfFeOQTy2774JXif+8jFT+YpO/Q0pun9tP5f1r96NDVfEet6vHJHq2s6lfRyyrO63N08oeRV2K5DE5YL8oPUDjpUtt4r8RW2qTanba9q0OozKqS3Ud5IsrqoAAZwckAAAAnoBVY6rLJ/wAfkNvdD1ljwx/4EuG/WjOmT9VubR/VSJV/I4I/M0uZrdGnsYS+Ca+ej/VfiWovFniOGyazi8QavHaN5mYFvZAh353/AC7sfNk59cnNJa+K/EVpctcWuvatDO0C2zSx3kisYVGFjJBzsHZegqt/Zhk5s7q2uP8AZD7G/wC+Wxn8M1VubW4tW23MEsTdg6kZoUk9CZ0KkFzNad+n37FvUtd1bVI2j1PVL+8jaY3BW4uHkBlIAL4Yn5iAAT14FZtFFUYhUsdvNJE0qRO0SsqM4U7QzAkAnoCQrY+h9KbHG0jhUXLHtWjBbLDwwR2Pfpg/jQBf0OCKNmVuX4JZTjcO4FbOqQq1m726l1RAGKjnn16dMeneswWcxVZgykocMyk5xjr65qa1ddRuniFwLZl45yA/scdO/agDlJeGKqzFc559aSN2jYMjFSOcg1NqEXkXkse4NtY8gYqtQBs21+3A8ttpU4wccClub0qSHVnwozkfdPT1rJErDB4JAwCR0prMzfeJP1NACyuZZGdvvMcmnQRSTShIlJY8cVLp9jPf3Cw265Y9zwB+Nez+Dbbwt4I02aXWYY9U1yTY0abw0ajk4K457fp0oA8xk8NTRWCPMSsrqXXIPC+/1rDubW4tTGLmGSLzF3pvUjcuSMj1GQRn1Br0nxN4xnmmmX7MkcTsSmFCkjsDj0/zzzXIazcrqCfNCFKr+6IGCPb6e3+JoA56inMpRsMCD6Gm0Ael/CT4Yf8ACfWmpzzaoum+Uy2tjvj3C7u2R3EWcjHyxkk+4rL8PfDPxBrumRXdqtpE9xJNFZ2txOI57x4RmVYkPUr3zjnjrUvhn4peJvDOiaXpPh6WCxt7O7e8byoyWu5GK/63JIIAUKNoXgnOa3Jvip4ms2lvZdP0O2vPtNxeWJaF/OsJLgYlaBd52hvvfOGGeR2pNpblxpymm4rRblPwf8IdU16+8Ope6ppWm2utqslu0l1G07IdwysG4M3Kn296hh+GGoXtjFFpATUNQl1t9Kjmt7qNrd9sAlJ9RgEktnAAI6isq3+IesW+qeE9Qgis0uPDUKwWf7tiHUOzfvAW5J3EcY49DzWhZfFXWtN8kaPZaVpyQ6q+rokETlRI8AhePDu2Y2QHIPOWPPTDIOa17w9JpGoWtqmo6XqP2gApLYXPmoDuK7ScAg5HcdCCODXUXXwj8QWWoX1rf3mh2wsEL3sz6jGyWg3Ki+btyULFgFBGTzxxXMa74gXVNRtLq20bSdKFsBthsInVHO4tubc7MTzjrwAAMVvH4m6tJ4i8RareWGl3cWv7ft+nzxObaTawZSAHDgqwBB3UAS2vwm8SyalqFld/2fp8lndx2G+7uQiTXEi7o442GdxZcMO2CMkVH4j+HF1oPgOz8Q3upWiXUt3PZzaazKJYnicIQPmO5gScgAbRg5OatW/xe8QDU9QvdQtdK1M3d7FqKw3duxjt7iJdkbxhWXG1AFAORgDINY2r+PNU1nwxLo2rQWV5vvpdQW9kjYXEcsrBpNpDBcMRzlT1OMUAclRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFW7bUbu2XZDcSLH3QnKn6qeKqUUmk9y4VJU3eDs/I0ft8E3/AB92EDnu8J8lv0+X/wAdpVttPuCBb3UkDn+G4jyP++lz/wCgiq+mQQXWo20F3c/ZbeSQLJP5Zk8tSeW2jk49Kc8Ihl2oRKrHAfGDx39qXJ2NfrDl8cVL1X6qz+9l9tJvDGpjhSaOFcF7RgzMNxOSBznnHIHAFbWnWEt5M1siiY7N+ZBt2+h/pVXSkktoRNK2dwKqRwRnvx/I1r6N4jWxlkhvxcTSNjyyvzcc55J47VnUdSMW46s68DTwdevGNduEeut/+G/ElvNG1DTtPhuWRDbg4UqxOAeo9se9YMqRm53RyPK5JxJ5eCD6EV1M/ie2niMRimjycYc4BP05B/Gqemf2cuoSS3UaxocfuED4f6ddtVTlKSvJWZjjsPRoVeWhUU499V9//AOU1yAyIt0ImWQ8SgDgEf5//XWJXq11DbXDGbypIYAuwSON/mccBhnpz1GfpXG6t4ckgluJI5oPLX5vLDjcBn0NaHEc3SgZOB1pWUqxDDBFWtKhSa7XzQSi/McUAdHYNBo2ltcXMUzXcqgRJu2oM9TgZz9OKyftzSM73HzTue+ckYo16/8AttwrMJPLT5VB7DGPpmsuXJk2Kp+XgDOTQBqXF6ssTvMzMw4VRhcVAjCRiqkFm6APzn0FU4HKfw5UEE8V6D4V0OCyYajqhSO4PMSSMBsHqR6/5+mVWqqUbs9DLcuqY+r7OGi6vol/WxzZ0+OW3lg3BrpmBUKmXUrkbfoc8j2FUDpsdof+JpOImH/LCLDyfj2X8Tn2rsPFk1ut0v2KeMNOP3vksq7iO7MOce3TisRrOy1G9t4Z7oWsAKo86RbxGvc46tj0zmiEpVIqWw8XQpYKtKivfa69Pwev3r0ZkHU/IG3TYRajp5gO6U/8D7f8BxWezFiSxJJ6k0Ou12XOcEim1oopbHFUrTqfE9F93yWwUUUUzMKKKKACiiigAooooAKKKKACiiigDX8IaQuv+LNE0Z5jAuo3sFoZQu4oJJFTdjvjOcV0EXw71LUPH3iHw3orxzLo09ys13OfLRYopCnmNjJ5OPlGTk8ZrmPD2qz6Dr+mavaJE9zp91FdxLKCUZ43DAMAQcZAzgiu7f4waqviG41my0Pw/Y3N4k6X6W0EoS+ErKzebmUnIZcgoVIyeeaANXSvg99i07xbdeMNQitG0WOAxRwXMaiczAlH3uMBCBwMZY5HBBrkvih4HPgTxWdGOrWmoDZG/mxkKV3IrfOgLbfvcc8jB74pdV+Ieo6hpmvaf9h063tdZFqJ1iEpMf2dmZNjPIx5LnO4t2xis/xz4uu/GepxajqdnYwXywpDLNaoym42KEVnBYjdtUD5QBx0oA3JvhJ4siv2svskDXP9ox6WiLOv72Z4hKNp6FfLIYt0AIqzP8GvE8N0kfmaW1s1lNfi8N2Eg8qF0SXLOBgqZEzkdDkZqC8+Lvii5k8KSiW1hm8NqBayRRHMp2qm6XJIc7EC544zT7z4q6pdm9WPTNGs1vrC402by1nYBJ2jZ3G6ViCPKXAHygZ+WgC9D8G9RSDxA2o6zpNq2mWNvqEDidXhu4pmwrrJkbV6/Ng5OBjkGq2l/CrU11Cyh1ZrRvtlk15FbWuoQ/aNnkNMrshyVXA5JAz0FTR+PdeMbRCy0DU7R9Gt9De3JYrJDCQY3K+Yr78jORge1Z0vxA8QWXim11y40+0ivbfTBpKRyQyKhiEJiyQWzu2nOc4z27VKknszadCrBXlF279PvJvDXwwvL2+8NDWb/T7GHWJrVktDdKt49tNMsYlRCCO5IBOcDOMCrMHwb8Q6pd6mdESB7SG9urSyW4lCy3hgYhggAxnAHXaCeBWfYfFDUraPRHn0jQ73UNGFvHZ6hc27meOOGRXjjyrhSBt2527tpIyKs2Hxe122tbi2uLLS72B7ya+iSdZR9nklbc4TZIpKk87X3CqMTzipEid45JFXKJjcfTPAqOnI209AR7igB8ZwDiPev8WR0/GrkYZCJIQCpH3WqtDIN552AnI/Gp4g0DfvQJEHA55H0oA0I5GiCglxvyMZIArTktbqK3jneJzFL0kABT8wKwYJCm4iR8A7hu6dOtaNh4gvNOUQ2837t2+aHIKn14PFADLhLjzFi8sohwwZ+Tn610nhuzE9xHCb8QbTgLcZCH2yDn8hmiO20++gWW1aVmbrbSrzu9VI4x7HFRQi5so0SW38kM2V81SoI9if6UAdDb6FfJqQiMEMxGWxHdbSBnkgMRjj2putWUTXE8JjeKM5eCOcn96D0wdgH0qoIpL6yeSZWmhRgPMD8Jnt6n8M1u6VfJAMAW1y6DcYpoHOUHQ7iMDtzkUAcsujRqitNo/mKrBXMbkMD1Ge1dhoWjvfWBjsNEs7KJQ5EnlLJI5x0Z+CPXr+FQ6h4hjv7iKG6iksbV3y62ZO1vf5mOR+NdNY6/p1npo02SFpLUg4vS/lkkngNjIP6igDwzV7aSOSSKZg7qeY9u3bg9elZISJIw4jYNnjI6V2virT0hu5poiksEzHYY84AHY//XIrmvKdC5kQbiActgnAoAzhb5G+U5xnPpVi32rMixoWy2BtH6//AK6tQwqLYyMrOmegOAD/AFNNgike4T90MEEc8AfX/E0AROhaXG07ieh5pt1PHFLsVxgfKSnI/E1LPGXm2rIp2nkg8fQd6JoVyd5AX0I5P4elAFCZElz1VyeC3c1WngkgZRMu0socc9Qa0ruVVJlkUB+iL3FUvKeYL8oVQOCTkmgCrXpfwk+GH/CfWmpzzaoum+Uy2tjvj3C7u2R3EWcjHyxkk+4rzUgg4NejeEviD4y0DQdL03w1EtnZ2V0948kcJ/0qRiv+uZjggBQoxt4znPWk2luXCnOo7QV35Gf4e+GfiDXdMiu7VbSJ7iSaKztbicRz3jwjMqxIepXvnHPHWtXwf8IdU16+8Ope6ppWm2utqslu0l1G07IdwysG4M3Kn296fJ8YPENrfTyjT9ES8S6ubuzmSJmOny3A/fGA7yPmPOG3YPTFYNv8Q9Yt9U8J6hBFZpceGoVgs/3bEOodm/eAtyTuI4xx6HmmS007M1YfhhqF7YxRaQE1DUJdbfSo5re6ja3fbAJSfUYBJLZwACOorldd8PNpGo2toNU0m+W4AKz2VyJIl+YqQxwCuCM8jpgjIrpbL4q61pvkjR7LStOSHVX1dEgicqJHgELx4d2zGyA5B5yx56Y5fxLrcet3MMsOj6VpKRJs8nTonRWO4ks29mYnnHXAAAAFAjo7r4WeIbG7MGpGxsiNSbS988+0GURCUkYBJXaVwQOSwA5Na8vwkvdHj8Qr4jlEctlov9r2b2rZSYGVY8NuUMOrZGAeKryfGfxRLq/hzUZU055tDtntolMLbZw8Yjd5fmyXKqo3KV6DGKg1j4s6zqdtc27afpVvBNpX9j7IUl+SDzfNyC0hO/PGSTx2zzQBDc/CfxVBdSW32W3klF5b2MYSdSJ5Z4/MTyz0YbOSegHWs7x14B1nwXDYz6obWa1vTIkM9rIXQvGQHU5AIIyO2DngmtG7+K/ieey8J26S20B8NsHtJYozvkZVVVMuSQ5CqFHA4yDms3xx42u/F/kfa9O0+zMTvITaeb87NjJPmSPgccBcD2oA5OiiigAooooAKKKKACiiigAq3baheWw229zNGv8AdVztP1HSqlFJpPcqE5Qd4OzNhbmeaxkvLiytLi3jkWJnMWw7mBI5TB/hNQB9NmOGt7m3b1jkDr+TAH/x6rMXiHUpNHOjT3LSac5TKGNXZNpyCpPPA4xnGOKoCKI8Qs55Ox2GM/UZODS5F0NvrM38dn6pN/fv+JaktrWfAtr63XChds0TRscd8jIz+NA0O9PMSCXAzmFhJj/vnNZqYLHcR+Pf8amExjIRt20cqejLRaS2Ye0pS+KFvR/53JUiuZL1LYRFbh3AVcY5OKs31nd2cxt720KMv5EeqmtLQNaa21S2OoXUrwJn5T84PynBGenOOldDqfijSru3MMllPOp7MFUj3BzWM6lSM0lG6PUw2BwNbDSqSr8k76J+nld/P8Dg3DLKDvYKASCeR9Pel/eK3yqGVjuzjPP+RU0nkzbjb+YsROVDNll+pp9s0fkOFTzZM/N0U5roPEas7Eml3l3pskc9tI6Tq29SuQQ3t/8AWrr5viFqF3pgs76OOeFG37HQHcfUHt07VySZtbY+YSu48BRnHPpUCOJZWdQXOcEYI/SgR1CeIbDzzLPYSMD97bMEOPQHacVNBq2mhVzbXcZYfIROBxx0BUg1zEReBc7FCk9XGSPx60p3sSwRGRTjgcUAdNfa6GkVfKupC4IQzskoHuF2Dmqc2t3OyTbJLujGAoyn6Zxn3rGsmaPDxkmU5A6YB7imCRmZ2ZSSwz8oxjmgDUtNcvYLjepZV6N5i7+3bI4roYZ9O1q4tYpbO20piDulhGd3+9uJOfxFcVCTKwaV1VlxjJrq/D2kvfQq9usTzZLO0mcAfX0oA6NtD8M6cYzcyXd9xnLMkak+wGSevUEVy+s2TLHNeWtqY7ReVBfOBmpDfxwXc5v4nuhGfX5Rj2I5rTl8RWctkwxLC8kZ8sOoPOODgE1z1alSLShG57WX4HB1qcp4muouzsut/O+nyX3o4W1s7uWVnghldz/djJz+n86stp915hacWkIHJ86UA5+gyalvtQkuN0Sz3EhHXc4wP6Cq1tEZAhkkIXluu4n0+lbe8zzb0I7Jv52/DX8xGs7aGUiW8kldiD+6h4PtliMD8KleSxtv3dvaGV/4pLmQn9Fx/n1pyFIVdypLKSFC+p4/Os9wTcFpAD0GB0Ht+dHL3YfWLfBFL5X/ADuWZLy7MObZILY54khjCuT0xnr+tYd5LcyTH7XJK8g6+YxY/rXS29obmY7AGCjA52qnuT2rtfC/wuufGkXk2TxwtGhb7UyYRep57kdh37+1CilsiJ16lRWlJtHjtFXdZ0y70bU7iw1CIxXMDFHXOR9QRwQexHWqVUZBRRRQAUUUUAFFFFABRRRQB6P8DvB2jeNPEGsWfiK6ntLO10qW7WeJgPLkEkSBmyDlRvJI9q9B/wCFKaZpzeB7GZxd67qF7NaanFLOwt0kWEy7AUAb5QVBIJ5BrwrRNd1HRF1FdLuPIGoWj2Nz8it5kLlSyfMDjJVeRg8da19H+IHifRotLj07VDEmmXMl3aZhjcxyyKVdsspLZBPDZFAHaaZ8KdM1vRfh6dK14x6x4m+0CSOeJjGvlM4JXCjAXbtOSck5HFVfBXwmg8WXM8eneJYHgWaO2ivEsZRbyTMgbZvk2HIJxgAseuMYrmNE+IvijQ7LSbTTNSWKHSpnnsd1rDI0DPu3bWZC207iSucZ5xnFM8KeP/EvhOyNpoOorb232kXapJbRTBJgMeYvmK21sAAkYyODmgDT+I/haz8OeHfB8sEWy/vba4a9YSFleSO4ePIz0GF7Yq9f/Ce9s9HXVG1KGSwuEsGsnjhdmu2uiwCIoydybH3Drxx1rjNe8S6tr8NlFq139ojslkWAeWibA7l2+6BnLMTzn8q0bfx54gj0vRNMkv3l07RZ/tNhCfl8iXduDhlwxIJOMkgZ4FA4q7s3Y9Q0r4KWmn6zYPql8NT025hv0eLYbeWGeG3aQBgGOOcHBIPYiuPT4T6hN4bj1y31C2l0+bT4LuGQKR5k0spiFtz/ABhlbJ6YFOuPjB4mvZ42lljV0eZ1FvBBEN0yFJGwI8EspOSe/PXmqieI7uXwnbeGftl+NEguTdR2/mRsI5eed2wNjJPGcZOcZqeZ9jf2MelRfj/kavjv4US+CdKF5Pq9nfTRXS2t1bRqUeN9pbdHk/OgIIJwDntiuHdFWNjGQwyMsP6jsfeuw8ReLNR8RWQttc1KeVNyM0jWMAkdgCFMkq4d+D1YnrWHBa2rxtGb1ldful4iPw4J4o50H1aXRr/wJf5mE1i5UyeUDjJO3kEf0qusQdyMq8Y7HqPb1rq7TSGnY/ZtQjZ0AJVSwI/Ajke9OvNFlmiWM/ZobnGUlDqqyj6Hv9PWjnQfVar2V/Sz/I5iMxxEljuHrn5uv+NS7g8ZC5CPz16e4rXh8O38DvFe2pKn+IEEgnvjNRXOlXVuQsNvcFM8HyiPxBxRzx7ieFrLeD+5mXBBJBuKhWj/ALwGcexqW1TyXZ0G3JyBuAH61amt5in76PYwySduD+P+NMV2tx80fOdwZWI5/lVGLTWjCa2dzhkTy2HBHT8xUADxn5HOMDcR6/UcVo2UbX8gjhKrNkMqBsMx9unNdMvh2aONAViWX+OJkcOPfJXFDdtWEYuTUYq7ZxoLR4HmRsh6oMc++asuVVWWNcqvUE9f8K14vDpt7h4y4iaQ4XK7ifpjk1eufBmuW9s0qWDTRhgRLuOCPcHGKSd9UOUZQbjJWaOajRUGfIAZ+D3wKhKmJiD+7yOAM5b09K6+08DeKdQBNrpjbHUYCPjPTvW5pvwm8STRtbM+lpIf+WU9+gZOOh7A+1Mk8qYuH2pjG7oVz+Vd1oWoXVtp032ZpC0mBIVB+VQPuj/9VdJD8HNTj1JY5dW0OAAYYrc+Zz34VDXog+FUo0KKRr23vEQ5CRwmMHsTl15HvQB8+Mr3V0waJwrEkgHgnuQOp/KoWsZJZlCRPKinJzkKPc16DqWifZ76SKOyHlhyTh+oHqEOfzNYepzRXRMDNIkUYK4SLagIHYZ5P1oA51oDHE3kpEiM2C2RgfQetRSn/SIzHuMY4G0/xd+3Xp1rQnCOyRybmjj48wuAfoOuf1pyupzi2TavCdSAPX1JoApEJM2yCMb1PIDZxxSvZiS4RVdWkA4VeQM9+OteieCPhZqniGaICaNLeVgzRRnkD/aI719E+Ffg/o+kzw3E8aPIg4AQAZ9f/rnNAHh/wz+Gd7rJga7tJI7LdvdpuA3vjv8Aj0/PPrviqPTvCXh2XTtJkSS5uBtYKdq4/wBo9SMfwj8c16dqVvcSWhh01VWMfKFX5V/z9K8s8b2Vn4d23U032vUweccpAT/M+goA8F8feErzXbFrl4Gi1GN9sJkG0zA/wnP3R6D1PPWvGtU0680q+ks9Stpba6jxvilXDDIyK+m5tXf+10uL2dVaJC20DLR5Hr2Y8/QZx1rhPiDp8XiO1N1cAQ3UYItyOSB/dPrk8n+7yc9iAeKUVNd201pcPBcRtHKvVWGKhoAKKKKACiiigAooooAKKKKACiiigApQCxAHU06NGkkVEGWY4Aq/ewRWssixJI0e448zAcDPHT29KAJDeyXKWsEyxIbWMxJsiVSy7i3JAyxyep/xpVLDPHy9j6VEkbSxeYgWVV6hvvD6063jkUlotzRnhkJzg0AaD3BWyzksn+1yVP8AhVezkw3zM8fPDcHHt7ir8aReV5kSliOGQ9auQ6eLyImwxOR1i25cH6d6AKtpFLBOrhyDuyjKeM+o7j+ddjbqbyEOWEJbk5XMZPqf7p/z1rm7HT725ISO1fZjO5uE/A1t20t7oc0apcIS3JRl3KPbnr+INR7SPNy31Ol4OuqXt3BqHd6fd3+Roarot5c6cZUlUSQ8MpHGP9lh0+h49D2ribi0vEdRMjKrcrLEdwP45/8A1V6rY3T6rZi6j2208Yw0cIDRyD+8vofbn6CsjVYlu4mZBby+XyzRnZKh91POPwIHtVnOnbVHDSS6hBGdtxM6DkNG7KffI4q1ZXEs0SvdTybMH5iocg+hGM1uW979mRYbpo4sE/vJYyyMPfB6e9U9Ze1dgqQW4VuRLCxK/Uf/AF6nkj2Nliay0U397KD3iCdDJbxMueJBCv8A8Tn9a7Wz160OkiA3MikgDacleD26/wBK8/byZZ1gRNwJ529Rx9alkMkT/ZwXVBx8qknH41MqcZJo1o4+vRqRq3u4tPXXY7ZtTijIMbcn7rBgAf1rJvNevbiWIyOYh0EiOwJ9uvP4VhsFXahhjd24DPhSfz4P60+FWkl2hGjkHGCmR19etKlRjSVomuYZpXzCSlXtp2SX47/iaR1TUGt3jkvbrynP3VuW/lT7C4ubW1VlnY7yVUFmY/kTj8azZ0li2mUyTbTyW+UD6VG9xIWCw3P3gDguePYDpWp5x1NnftbQmVjOssfXZIRx/wABY/zFdXonjyS5s3gvrcG1cBWuYy5kA9C3PH0xXksssyDZ50CMfXqT9DV+2vXa3ZP3Kso7sCW+nX/PegD1nU9MttZsQdBuBGzcsiMxZvbjc2PyrkdT8KazEd8dt5q26niMb9g9DnjPsPyrm/D89x9rZzLLGA3yqgOM/qe1d5Ya1qcEgSTULdI8HcdpB59AOSfpj3oA5a08LavfTeZL5qlmywkjPyj6df5Cu/8AB3wvnu7ozXEe20QYy8e6SQ/yUe/arGneLbW0AS1uHeX+NkJZ3P45AP0zSHxVq02qSokksSHBCyvuKDHUgdD+VAHvWnxad4T0S2gt47OzO1V3MPmOeu1R8xP1xVvT/GFle3DwRK/nKcCNsAgf3nPRB7da8KN+vlt9tuBcXjjKqeqj/cXJ/M/lXL/2lOLySGyEkUY5eRzt3eoUDP8AP8qAPpzxF4y03SdOe4Mnm8fKIz94/U9B714Z4gvz4gc315OwhH+qihGdpPp7n16n16CuYeSfUwZrq4cW8TYWMHjg8sSe3v8AzrT091W2Wae4ZIWJWJQCZJj7D+FfyoAqahYWsdsbeOFo2B82VUbLAY4y3brXF38ryEgbYoI+Mk549/8AOSa6DxNevPHtRGhtYmyxb+Nu3Hf2GDXKnT7jVtscUborEfezub3P9B+VAGT4pvX1ixks7WGIx7kZJGjUyNt3ADdjIBLHjI/LNeeSI0UjJIpV1OCpHINfReheCYdPCTXyDMXIgLAPI2Dwx7epHQAc57cf470m01L7RdXBSMxIRHLEm1S2DtUDuuccnnjIoA8hoqW4glt5THPG0bjBww9aioAKKKKACiiigAooooAKs2VlcXzulrEZGRdzAdhkDP5kVWrrvDIitbdbi3cvLnMmB8ygenqvqOvegC1Z6DbQWewnz5JAN/HzAjun0/X9Kq3Fg72zMqs7w/eK85X1/wARXaW0FlrKCS2c22oLzsBysnuPf8a6DTdGsvERaMuNN1uEDnOEm9D/AJ/GgDxy2hZcNADgcke3r9P5VO8UkOJ1xLDgk7eqj/P/ANauz1jw8+mzyi7tjbSLk74x8uR/EPT6jp3FZB8hELPmOQD5s/zI6Ee4oAwmmaRTtUbhwrrxuHoferdmJZZUa3y1wCOn3l57n+tXDpTzXKyW0UcQyCSjELj26/kPwq0zRND5UBZC3DOQVYn0YYyoz26VLfRbnRTpK3tKmkfxfp/nsvN6HSR6vDJGHlkUvgZdBlWPcjFZeNu+SdRdwyNuaSNgHjP0PUVkT28lmSZFZMgfMBw35cH/ADzTDHK7rNDsPbcCVz6g9qzp0Y022up1Y7Na+NpwpVPhht/we+mh1VtbSxAXljdI0Dd+hU+jLyPxqndzWs6tMsbRXA7oxKN/P8qSysJVsGlhulhfkbGG5c+me34j86XSdJtJrr/TGnhlY4zA3J+gxyPpWx5pgrqKPmK+VUG7JyvGefT/AOvTR9mbd9nuWjccfuycMB2xwP0rrdb8E3EFqb/SzdalbqdsypBuaH64zx+AriHFv9pGHdc8GMtgg/Q0ARyJIZPkdSSejrnn8sircysY1WQxKwGSzNnirVmd8uRO6nHPynj8P8KVI9l0skh8xOgkhbj9elABBDLPGyJJJMmOzHn8Pwqu0CrLv+07WHbf8348+1WpSLhiixSMR/z0yQfxGKT7JdKB55dscCMgMoGPXk0AVGdIvMJuGOf7+T+RzVeOYSkeSybVOWZ15Oe3XNWpIVL8u0bEfdTGCPy5qCS2YPlYYgAc/MDnP5ZoAkgnUsGMI2j72EB/QipomRZWcQGVecMpCkfqe3bFUk3sfLMsWeMhTx+uKesAju08iQM7dRuwv1460AbUd7ex2wVXaKJ+QmcHHtgf4U9rottfeJG5xGgPJ9yM1hqRFK7bYlZeNzEE/gMYq+r3DRD7uCMsxfcT+H+FAGidWa0t0aGPyXbIBiXbt55O7rn8qnGqSfZv3LrHjnLEjn1IH9f/AK1Zuy6usSDIijG1VRyuPr/nNT2awwwFJH3buST8x4oA39L1CYsseWkG3Lso2qT/ALTcflWlNdtJHt01AWk5kuGHAXvgenuayrBJLpElMBaIYw0+FQemBn9B+tbOoXttaaUTLfG4kPSK1jWNB6Avg/oD9aANPT9Lub2wkaa6KwphvLbCoi/3mJ4GffPsKoveW8LMkNz5hKhXuWGPl/upnoPfqfasS21e5ks/IwqW+7cITnaD6nnLN9f0ro/DnhiPUrsPczTSXb8pbwAM6j1OfljHuefQUAZt2r3cUUFqrSEDLZyAAfXvjp6Z6etd/wCF/CupLYK9vGRdzdJWGGRe+3+6P9r8ga6TQPCOn2kUckyrHEhztifc0rDqWkPJA9VA9BnmuxudWhgsX+wWpnk4WOAfKpA7sT0H1/IUAcFf+G49I0eW4v7n92qEz3Eg+8o5wq/wpn8WPr28h8T3AuG+0x2+1Fz5ML8nH/PRx6nsO38vU/HbahqGnCa/uE8hTuWGAfK7jp15fHHPQYrgdO8OTape+QqkENvlLP8AKg9Xb1/2QKAOCuvCV1r8TzXDlbo5EJwWLN2GB1B/Tt6HzW+tZ7G8ntLuMx3EDmORD1VgcEV9d29hBo8DSadAb28xt85ztSNcdBjpn0HJ9QK8V+I2nWesXJnUomoAYMi9JPdvb0PU59ABQB5PRUk8LwStHKu11OCKjoAKKKKACiinPt3tsztzxnrigB/nyeSkJbMSszBcdyAD/wCgj8quaXcvAcxNgg9uv1rOp8bmNgynmgDvND1RIpBI4ITI8xV4x/tD0/Cu4tbtJ40E0oVkwYLqIc89jj/P514/ZXqowZSMngqa6bRNThiuBiYxBhgq3Kn6/nQB6hPfTXUC22o7WYj5Jv4X9sjv+v4VgyaRbzEQyJG/PDEDofUjqPfjrVvS9Zi8qO01Xy4o5CoWUjftH94e3sf5cV1MWlPaTo9t5V9p0uOQAWQ46g+/oai7lojqVONFc1VXfRfq+y8t35LU4HUtFmsEijtigixn7MQMkdypzh/p1HpXN3uZnG8+W/3UmU5z7H3+tevajp9nfo9pPEkDH5l6hWP+6cEH3H5muOvvCt5G7skTzQLyxDZZBng54yKpJLRGFSpKpLmkzmBPcJYqJPKuLfHKk9Poex9vzFJZxSWq+bGjm3YclGz19R0P5VblsTaSncCnBDH7p+pB4P8AniqFzFNBLiKZSoxgKdpH5/59qZBL9ujgkZUYqG6bGAVh9Og/SrEd7JJGCcuAcDcu3HPqPlP4VDZWCzB3mthIQfmOfLcD69PzrotL8PXcNt9stpLmKHuJE3Lj03LlW/H9KAJvDXiO70ScStd6hZs3+qlLkqfZWB6fQ1s6x8Qo9QK/2/oWlauy8ebd2a+Zj2kUhvTrWDcQWYDM81sxb70ZQru+oUYBrm7vTZppmFiVWDOWiLZH5ZJFAHa7vAHiKzd00+90DUlG1fIufMgJ6c7+R+dc1eeGb63kIDSXVu5/dzKA/wBDkd6zZ9J1C0jR30qZNw4mjiJB98kD+tX9D8VDRmCsm5hwHliAK/g2f6UALfaHq8Vuu+K4SNcEStCyKfx7VnpFGwUusgZSCp25X88/zr1jwz8VvtsP2PWmgubY/wARjJJ9sZArH8X+HNEdJZ9Ha5WFvn8vcowfb5sUAeeuyyzKojgdgPvCTb/I021tVZ5HIhf0Xdu/L1/GppRJaZRBsTOAZoV/njFQFz5bKZoASc7sj+QBoAgubIRuNqxRFuQoGMikdZYQNiCPP8RYfN+dSOkUhVvNYv0G5NoP0phiw2wXci5PzDdtz+tAD4kiYZ4EncjkDv1PFM855pDExEi9s/Kv5DrULnaxEaRkZ/vZH15NWIUM5EJLMW42ow/Q9B+dAG9oXl6haPDd267oTtVx/Evt9Ki1CzhsZw/nybW6jaOPQcDn6UWccOmfvAsglxgg4A/H2/Gr/m2gVN7/AGqcnPTISuZU5wqOSfu9j3p47DYrBxoVIJVlpzeS2u/w1uuvmoLi9ldE85pDEMALkZA985xTI7mFZCXZpGC52oDhR9SM4/T69akkW4lkUM4BbgTYyq/7oHX+fvWzpPhK5um/dI7KDyZyBuP+6K6E76o8OcJQbjJWaI/D0D311HKVSC0XoScH3JJ/z7Gve/Afg67u7PeqtYWMoBLbcPL788n9Bz0Nc14B8MWsdyu+Jr++j+ZYoRxH7kkbUHv1+hr0nXvEsmi6eIIp4Wv5OqxniMeuTkt9eTTJLur2Wi+G9NjtlL/aLg7Uyd80hxyR/j27VhXr2NjCJbhPNcdI2bKL/wDFN+grhJ/Ezf2gJJrlLi9PUux+UehJ7ew69/Sl1HUbq7g3Tlri4bhIU+REH+0e/wBBxj1oAm8V6ityDI0vm3H3REnCxf8A1/8APGKyfDlzZtbH7XOPsiAsyRNgSHvj+906nj+VcXrOqwx+ZbQyLdXLnY3ljcq+oz0AHp1PoB1yRePcBIppNkH3nKn/AFnsPX+Q96AOx8aeLJ9TtZINKC2unR53SA4U/wCyp7+5/AV5DfTu0jgsVAJLOf4f/r1ta9r4crHCVjhThAfuxj19z9K5m42u6m4bbg5SJeWPoSPXvk0AUNTR9SWO3hUgREmMYxtzjJY++BxXOSIY5GRsZU4OOa7FioTylXBbkovLMP6CsXWBZhm35WZVwiRYIHpuP+TzQBi0UUUAFFd38E/Cun+M/iBaaNq4uDaSwzyEW8gRyUjZgASDjkDtXV+JvhXpEd2s9nqMmj2VtpCalq1vdSLey2DtJsWIGMLuLEg4OCByeoFAHjNFev6X8EL281vWtPfWbYtp/kNGLWBp5riOZN6SLFkMF2nnqQcjB61JefCGyuh4IsdB1tpNZ15JWniuoXjSMRmTzHHyAqEEZBU5YnpxQB5CgZHG0K+7gDGQfat2Mw6YB9pUSX3Vbc/MsX+96n/Z7d/SvRx8KBpi3M1r4l0+OGOwe/kv5on3QRrIsbKYk3srfMCDzkdMVQj+Gsd9b6Lc2t9Z2+n/ANl3eq3eoqJWLwQzGPzPLbnccrhRjrz3qGnL0OmMoUUpLWX4L/N/gvN7cxpGoPqJZRKZLhQSUY8v7j3rqvD3iK50m5+zeZJJauCWhkONp9j/AF7Uk/wm+zrqOpXHiWxsdLs7exvUvXt5m82G73eWwRFZw3yEFcde+Oa46PVJpI0a6UOyt98HDH8fX/PNWc7bk7s9ls/EMV4TDeyPbuD8rTAEEe7DhgfpXTabfW9n5bTwhN3ABYrG/vHIOB/unBrw+11R5Iw6uxC9Qw/yPy4rqtJ8Sy6dEqyRNNaPwQpzg9+D1+n6UCO/8SaPp2pRubcvazOM7ZU+Vvy4H14ryPVtINhdi3vInVWzswcjGf4T3H0r2bRLnS9ftYks7xtPuk5VdxaGT6Hqv0P5itbXvBN/qWkq1raW083UJwN57Y7Z/wB3B96APn+FEtI1MIljXs6nII9P5duKgg1fUrCf/RrqUIxwWhPb3A4/MV3t9oZhd4pbCfTNVXhonB8uTHfBJ7eua5e50uOWYpLCsNwvG6In9VyT+VADbLU3muRLcxGaYHO9IcE/UZwffitqS/sndJJbKfj7zQA8fVT938DWKNBulQvJazyRfdzBNn9MZ/MVLbW8ls4f/SJQDwC+1l/76FAHQWOuWFtIDpzXULgZHBIz25Q5H4jFF7r2sakSLyVTFngzRxfoxyfzrOiaUXHm7GLqfl8yNd49s5BrtdD0+/u4Ung0u6ukbhjJbk49wwRh+dAHAtuklEc0kMaEj58FF+pbGDXsfhbw7aSaVDmTTlJXO6OZOeOfuk5q9YaLZWEfnal9jhVufs4yn6hh/Kti2hS/Int7OJII85jM0koI+mf8aAPPPG/w/MsZurKS4mx1WOF3HfOCQAK8X1HTHs71oWSVXHVDByv6gfpX1cl48l1stbuzt/70SK8b/mynJrivFfgm98Ta5H9mjYq3Blm2BT9SvPp2oA+epVYMY45FaRuMspJx6AdqsxfabKMFYBk9mAGfqeTX0kvwAMkKrLdxx4x8sb7R/wCgHPbvWfqvwWs9H2vJrqKCdphjRNx/4Ex/pQB897ZrqY4LopOWKqTj6cf41aSJbaLbblfMOfmbr+nTivYbjwH4XaYLJqpEi9lYyEfXaMfrVt7PwxpFqqeeZJT8vneWmV7cDqP/AK1AHkUCXFzGoSJSqchiSwAH04H5U+yd7uUW0Fsuc9EQsW49AOa9Lk0Twy915k2qhvM65RpJD9FHA/GtjTtB8KaWBNKb+aInIjJCb/qS36bTQBhaP4dkleAWzLPqXVUP76TOOm1ciMcfhW9a+E9U1TUvs5vLmO4tzie2ZsNGfQgAKFPY5wa6PSPiBbJL/ZnhvRYYQvylYs5J9DtHJ/4EPpS6pb6jqDRzl1F7EMIsEQjjRc5KsByw9uvfNQ007o6YVI1IqnV+T7eT8vxXTs+906Ox8MeHAlw8TBRuZIW+8fdurH6V5R4o1u/1KSWWw0uGwso2O+eU4/8A1H9a6Oyv5LqFrfUIwt7Av/Huys24dnUAfMnHsB3z0rzjx7qt1aypJPMJnB+RTjag9ERflXp9fpVJpq6MalOVOXLIzjLEso8hGNw/LXEwxgf7IPIzke57Ad6ev3D7PstxcSKn3WgRjvl9mP8A7KPxrPhvLuENqOoKYfMXEW772PVR/CP1PrWPd64kmRaIhfp5rDIX1+v0GB6k0yBZJI7O0kkYIJSpRAoARR6D19yOPrXManqW1DHGzOSBv4yzY9fQe1XLrzZ9zgsTj55n6/QY6fQVz1zCI5CgQbfvHcfXuT/SgCWFJp2M0vCryob1pySRJKdpDOSd0hyxPsPX/OaqTXAZQi52AYOOM+w9BWZPfPlhCduRjI4/KgDT1HUltkaK2/1zj52OCfxP9Olc+zFmLMSSepNJRQAUUUUAa3hnxDqnhjVk1PQ7r7LfIjxrJ5avhXUqwwwI5BI6Vf8ADV94k8M2MviHRVmg0+Zzp0tw8Cy28rFQ5hdXBRjgBtpB6Zrmq9Y8L3/hjVPglJ4V1nxNBomor4hOpr51nPOGi+zCMcxoRncT3/h+lAFOy8RfEq28ThIVu5dd1nZqEQm0+KaaUbDsli3oSoCKcFMYC8dK59fiF4qS30yAaxLnTLhrq0m2IZopGLFj5u3eQS7ZUsVOelejaN8SNCg+FME11cSjx5pVhcaJp6+WxzbzMmJd+MAxoZFUZB9uc1zHwY1/wzpkms2PjUBdMuEgu4nEJkYz28yyLGMAlRIu9CemDzQBg3/xE8TX0V5FNe26R3du1rOkFjbwiSNmVmBCIOSVU7uvHWrXhvxH40kt0n0S5d4PD2nyoQIoikNq7/OrqwxIpZ+QwbrXpc/jrwLca14Ult7k6bFcTy6trMlvZkfZbxrdY1iUlCTGHDnKA4D5GCMh/jHx94RvYdbay1G1e8vfC39nyPb2s6rNdC5DAZdAx+Qffb0HOeKAPMPGXiHxpZ3uuaN4nupI7i/Fqb63eOLlY1DwBdowgCuCAmBzyK4+CeSM4VjtPVc8Guy+NWu6d4k+JOp6rotx9psJorVY5djJkpbRI3DAHhlYdO1cSgBbBzz0xQB0ulXCxttk+4/3WGR+RFbdtMbecgSl4nxw45/A9+vqDXERTSQnbvVl/uNnH/1jWlDdTbVG9mQ8hTzQB39rqNrbzRmWeRB1WRR0/Ef1Fel+HPH97YxxrDPNInADJIRn2PO0/Q18/wAF9JG2Y2SVT1Qj/Irc0vWLNmCkz2M/C5RiAfYg8Y/KgD698OeN01uLydW06yvXUcFigb8VYcfkBWhJH4SvpPJvLMWEsmQqSxjyz/ukZX8iDXyZDrn2eeNTd3G8YKyLgg/1/Jq6WHxbqDbVuW85P73mbCf1BH45oA+iB4BsbeEsmoQC2kOEWb5kPsAxJ9ehrnr/AOHq+cQsLy2jHBezIkQf8B3AiuE0XxiIpIRZ3F/BcZw0Urbkbnt0H5g17jo1/dz6Ut6be3d9oOWthz/wJTx/3zQB56fCGjWNxH597cQR5wVltyVz7MC2PyrTsfDFil2Qmr3USN/qhG45/wDHQf0rq4tbs7uJzqNhaSy8gcMFPt8y5/ShvFulafCUuNJmhj6ERqkifocUAc7caLqtjOPs0Wo3aNwTtZ8j6swxXU2XgvTpYkkuVulm6uRMQc+nBNY9x49jmZv7JvNMgth1EzAMPw3DFYmteOLiBS1xeQxBgBuilUZ/4EWGR+BoA9IttF0c7YhaQTlOMTpkj8CKzNd1LTrd3shc3NmyjI8p1jRQR2APNePxa081w8tgbi43/e2SI2fxGfSmalfySWzR3ENyrD+F2VG492NAGl4w8SWNvC0MeqzPO3yrJNAGP/fTYx9a4aPVHiikkvb5maTorShi3pwCdv5Vj6rPp+TtnkjIJys0iH9ADn/69ZH2q0Ib7CqqRgNI4bn6AnH6UAdRcaylnAJLe1tQG/jcl2/8eP8AIVkXd6by4WcQIVxl5JXCbfoByPwH41j/AG0LaSGCN3Lj55XjwB+ZxWWNSaRTBtVYzwzNuI/754B+nSgDu9M1/wAP2TEfYTeTAgMUJ2f+zMf0rprDxjakqtrosMJPQQ2waQ/9tJMkfn+FcP4cv7R1MYS6kCfxqojQfj269Aa6KzvPLRngjYsejPkgfT1+oxQB2o8SapLGsWn2XkRY+ds/KOOnufyqGGXV73c0N2LWAH5pRH50n/AQcqv+eKw49USxtBJrs8SR5JS3cZLfWJTlv+BMaavxJt/NXPyQR4CqwBb6BV+Vfzz9aALWs22r3Uisss0VrBki4mYvMxPUA5AXPpXG30F3p7NcXQkSVVDKZ8mR/cEg+n4Vv6n4+muXDW0Cwtj5HlG6T/gKjhR7kj15rgNb1S9mka4nkL9cqz5HXox/p1FS1rdHRTqpx9nV26Pqv+B5HP63rUk9w73BXd/CG+bH+P61hW1wftBdFaQjqX6fXB/z7VoTWIv5WuLaRRbr99GxmM/jwR6H8OtJFbW9mrTTNK8an5pCdi5/Hkn9aadzOrSlTdn8n0fp/XrqWZTcyQlQxGO4PT/P+fSuf1UR2ZZJZjJcddgOcfWptY8RmWPyLBBHGBt3jIOPYdvqf0rmycnJ60zMfLK0h5JC9hmo6KKACiiigAooooAKKKKACiiigAooooAKcjFGDKcEU2igCV5FkbLjB7lakjnaLPzAg/iCfp/Wq1FAF5JwyNn34Iz/AJH4VNbXqDCzFiAeMnOPoay6KAOrhvwsKqZFeM8gMucflV2wvopDypz/AHTnH0//AFVy9gCyctuGcYzjH41prLFE2SVz2GAD+Y//AF0AdppN5E13E003lRggDK5/UH9TXsNhq95b6YHt7iZkwCDHmQf+OHP6V88addEXCtBMqOOT5qn+YNb9x4iljiCbkzg/NF1+vr+tAHfHxhew3skgluZJF6gXDp+e5AfTqauHxte3oCvFErgcGa6mGfxDAflXjq6uJpFF1LJP3yGORx7jmtJdWjt4iJE3IehdDnHvxQB30+taioaSSFCzc7jh1/76YdPxqOTxEstuBcyw7gOGX5gDnsQOK8um1aFpmMJZSTyEG3GfoRQk8o+aK5uIGHTABz/49QB6H/b0kyPD5+UYYG1iT/KqF1ql1ZwSBZt0eP8AloFBP48GuJXWr2NwDdiQd9xYfyp11qklxtUxLcN1O0u2OPXNAFy68Qb3O5UJ9ck1QbVVk3E5Uk55JJra0LTBqXyCG6Ld0jUgfjmk8QeGJ7GMSi2khXudock/WgDJbVbhogryKir0Urn8sin2+oXT5MjPHGQQWkfAI+mMms+PSb26kH2Sxu5n7sIic/kKvjQby3jD3qzRBeiSLg/lnP6UAXbTWbyFl8ieSZV6KsZCfnx6d60/+EuubQDy4o5Jz1OWbb75yAPwrGI2R+Wd7MflUBcN/WoGtJUTdIPLH+3x+Xc0ARXniW5lmLSx72Y87QMfyx+dPtNSc/Pcq8YGACW5+noOKiljI6K6r3dvlH5msq8vYYy0cQV+xYc5/H/9dAHVf8JAipttLcu3TO0msq9unklWbVJSi/wxl+3oFHaui+DOmweIm8aW95am5az8M3t7Zom7ctwhTy2G05JG44Hv0rQ+H/ws07WfDL6z4t1O903fqB08IsY3QN5auHkDDJzvGEGCRzntQBwC+IzatnT7dUYdHkOTj0x2qHUpH1pDdwuzSRr+8tSSfLHdkH931HUfrXvvgzwh4Jn0/wCG+h6jpbXc+uXF6bucxbXmMDSIR5gYOihlGAuMjrzXjng3w7FrnxIg0rSk1UWu93GTHDcpGiFiW3HavTnrx0BPBlx6rc3pVUlyVNY/l5r+tfua4qivor/hWHhC11jWJLxtQ1Cyn8LSa3ai3Xa8LrKEZlxsDnoVBAU7jkcCsbwr8O/D8HjLwFp7X17NqWvWceoGC6sYpbaON0myGy2WbMYwNuO+e1UjGSSbSPDqK9b0v4SpfWWk3guL77JeeHrjWJJ1hykcsW/EW7pg7R781o/8Kv8ACdp4Y/tHUtW137RBothrlylvbxFfLuCFMaZYEsCepwAOxoEeJ0V1PxP8MR+DfHus6BBcPcw2UwVJXADMpUMM47gNj8K5agAooooAKKKKACiiigAooooAKKKKACiiigDa8HabBq/ibT7G8Li1lk/fFCAwQAs2CfYGjxppcWi+LNW0633eRbXLxx5OTsz8vPfjFW/h+/leIXuNobyLC9mAJ7raykfril+JP/I86v8A9dR/6CKr7Jjd+1t0t+pzasy/dYj6GkJLHJJJ9TVmCwvJ4xJBaXEqE4DJGSCfqBUMsMsX+tidOSPmUjkdRUmxZ027FtLlxuHbk8flWncaskyFRt9PmGf6ZrAIwcHrSUAagvMyB5GTI7g8/wAqlbUwQVMm5OwYHj8qxqKALv2mLduCnPc4Ga7L4ZadY+JPEiWWowubVIiz7DsJJZUXn/ecH8K4Cu/+ELyW+pX91EcNH9jXv3v7Y4/8dqo7mVZv2bs7HLS7YZXjdgGUlTk45BqSC5AdUEpXHTa2Kq67k67qAHX7TJ/6EaYNM1AWwuRY3f2fO3zfJbbn0zjGamxondJnZaV4gazjEaM4B7LKf8BXSWviqzityz2kDTAAF5IFPP14ryOWK4R0WVJVc4KhgQTnpioScnJ60DPV5/HcbPseOymjUnCSIoGfwNVr/wAZxXkBQrpVou3jy42J/QGvMKKAOpk8S+UzCB5pB/snygfy5qjJ4jvM5gEcJ/vAbmP1J6/jWJRQB23hLRYNe0DxFfalJNJPaw/6Kdxwr+VNMTjvxDtx/t57VxNenfDhP+KM1hR964e4UE9MLYXH/wAWK8zVSzAKCSegFU1ojGEm6kl2sXtE1vVdBunutD1O+025dDG0tnO8LshIJUspBxkA49hV+Hxn4ogv7q+h8Sa1He3YUXFwl9KJJgAAN7bstgAAZ7CsqTT7yJEaS0uEVxlS0bAMPUcc0ye1uLdImngljWZN8ZdCodckZGeoyCM+1Sa3RbXXdXVrFl1W/DWDM9oRcPm3Zm3MY+fkJbkkYyeaRdb1VdZ/thdTvhq28yfbRcP5+48bvMzuz75rOooGbx8Y+JjqcWpHxFrJ1GKMxR3RvpfNRCclQ+7IBJJxnvVVPEOtJfWV6mr6it7ZRiG1uBcuJIEGcKjZyq/M3AwOT61l0UAbNp4o8QWemjTrTXNVg08B1FtFdyLEA4IYbAcYIJzxzmoZNf1iWB4JdW1B4Xt0tGja5cq0KHKREZwUU9F6DtWZRQBa1K/vNUvpb3U7u4vLyUgyT3Ehkkc4xyzEk8ACqtFFABRRRQBvaZr1vZWUcMmg6TeTplRPcLIW2k5wQrgEgk8kE4wOgqx/wmV9H/x52GjWbj7skGnRB1PYhipII7EGuZop3ZDpxe6OmHjfW0A8iSytyPuvBp9vG6n1DBNwPfIOaX/hOddDbo5rKKQDCyRafbo6f7rBMrjtjGOtcxRT5n3F7Gn/ACr7jd1bxLd6taPFf29hJcSMC94LZVnbHQbh0AHHAHGAegpNJ8RSWFmLSfTtM1CBWLIt5BuKZ6gMpDYPHftxjJzh0Uru9yuSNrJHUr4vELBrTw94ft3BBDfZDLj1GJGYc/n6EU6Tx5rDHKR6XEclgyadACCepB255y3/AH234cpRRzMn2MOqOn/4TnXhkJcWsaEcpHZQohPYlQmCQOASMgfU0f8ACca3kDzbXyj9+H7HD5cnuy7cE44z1xx0rmKKOZ9w9lD+VHWQ+NJoobuKPR9FiWe2ltw0NmqOgkQoSHHzdCeCfrmtzxZbQWOsX3iK+gjuVEsNvbWrgmOSX7PG7M/qqgr8vcsOwOfN66Xxj4obxINPUWgtI7WBUZRIX8yQKqtJ2AyEUYx26mnzaWIdK0k4r1IpfGXiWSUyf29qcZ6ARXLxqPoqkAfgKlg8deKYW3J4g1InG357hnH5En865qilzMv2UP5V9x1LeM7u5CHV9P0zVZVG0z3kBMrj/adSGPHGSc4A9Kani6S3IbTtG0OzcdHSz81gO4zKX6jA/DjGTnmKKOZh7KHY6h/HGrmQyJHpUUrHLSR6Zbhm+p2fhSDxxrvU3Fs7fxM9nCxfuA2U+YA5bnuc9a5iijmfcPY0/wCVfcdQvjfV2bbdDT7q1PDW01jD5RX+6AqgqP8AdIOcnOea0tH8aXM9xZae1jp8EDX1tIDbQCIoqyBiuB1yQpycnj8uFqa0nNtdQzqMtE6uB7g5o5mHsYdjuNYUeFNXudX8qOTVbi9nksFdQyQIkzKZSvdtykKCCBgnrtrnT4t8RG5Nx/bup+eV2GQXTg7c5xnPSn+NvEJ8T+IJtRW1WziYBY7dW3CMdTzgZyxY9B1rApuXRE06a5U5rU6OPxv4ojVwviDVCGBB3XLt19Mnj8KkHi+SZhJqei6LqNx/z3ntijn/AHvKZAx9yCfeuYoo5mV7KHY6geMrqMYttL0K3XuE02Jiw/uksCSOPX60g8b60oKxnTUQjG1dLtQMen+rrmKKXM+4eyh2R1kHxA8QwXEc8U9kkyHKumnW6sPoRGDUZ8bapK5+2w6ZeRHJEU9hEUU+owoIx9f0rl6KOZ9w9jT/AJUemeGPFR1iWDTP7NsLLybfUpi9pEIlk3WkgUFQOqgH5iSSMZ6ZOJLeP4Kiih0iV01y6tUkubxSVa3SRQwhjHY4I3MeecDAzuxfC2sDQtbhv2txcoqSxvEW27lkjaNsHBwcMex+hqLxHqja3r+oam8flm7neby927YGOQucDOBgdB0qubQzVJKVkvdLkfjDxJEWMfiDVhubccXcmCfXrU8fjnxPHGyJrl9hmLMTJksTjqTyRx06dfU1zVFTzM1dKD3SLWpXkmoXsl1MkSSSY3CKMIpIAGcDgE4yfcmqtFFIvYKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAP/9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    D echocardiogram shows marked aneurysmal dilatation of the aortic root. Aortic valve motion is normal and the left ventricle is of normal size, although there is concentric hypertrophy of the septum and posterior wall.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Thomas Binder, MD. University of Vienna.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_57_32656=[""].join("\n");
var outline_f31_57_32656=null;
var title_f31_57_32657="Condylomata lata";
var content_f31_57_32657=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F77221&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F77221&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Condylomata lata, penis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 337px; height: 244px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced from: Centers for Disease Control and Prevention. STD Picture Cards. Available at:",
"     <a href=\"file://www.cdc.gov/std/training/picturecards.htm\">",
"      file://www.cdc.gov/std/training/picturecards.htm",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_57_32657=[""].join("\n");
var outline_f31_57_32657=null;
var title_f31_57_32658="Radical hysterectomy PI";
var content_f31_57_32658=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F78941&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F78941&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 559px\">",
"   <div class=\"ttl\">",
"    Radical hysterectomy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 539px; height: 476px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    During a radical hysterectomy, the surgeon removes the uterus and cervix, some of the tissue around the uterus and cervix, and a part of the vagina. It is not always necessary to remove the ovaries. The surgery is usually done through an opening in the belly. But it can also be done \"laparoscopically\". To do a laparoscopic hysterectomy, the surgeon inserts a tiny camera and tools through small openings in the belly. Then he or she removes the uterus and other tissues through the vagina.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_57_32658=[""].join("\n");
var outline_f31_57_32658=null;
var title_f31_57_32659="Signs and symptoms of hypophosphatemia";
var content_f31_57_32659=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Signs and symptoms of hypophosphatemia",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?31/57/32659/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?31/57/32659/contributors\">",
"     Zalman S Agus, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?31/57/32659/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?31/57/32659/contributors\">",
"     Stanley Goldfarb, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?31/57/32659/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?31/57/32659/contributors\">",
"     John P Forman, MD, MSc",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?31/57/32659/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Dec 3, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hypophosphatemia when combined with phosphate depletion (that is, when not due solely to phosphate movement into the cells) can cause a variety of signs and symptoms [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32659/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. The manifestations depend in large part upon the severity and chronicity of the phosphate depletion, with the plasma phosphate concentration usually being below 1.0",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (0.32",
"    <span class=\"nowrap\">",
"     mmol/L)",
"    </span>",
"    in symptomatic patients.",
"   </p>",
"   <p>",
"    The major conditions associated with symptomatic hypophosphatemia are chronic alcoholism, intravenous hyperalimentation without phosphate, and the chronic ingestion of antacids. The alcoholic patient is prone to severe hypophosphatemia, particularly when admitted to the hospital. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/25/15767?source=see_link\">",
"     \"Causes of hypophosphatemia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/42/28324?source=see_link\">",
"     \"Hypophosphatemia in the alcoholic patient\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Severe hypophosphatemia can also be seen during treatment of diabetic ketoacidosis and with prolonged hyperventilation; however, symptoms are unusual in these settings since the hypophosphatemia is acute and there is no preexisting chronic phosphate depletion [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32659/abstract/3\">",
"     3",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/48/15114?source=see_link&amp;anchor=H19#H19\">",
"     \"Treatment of diabetic ketoacidosis and hyperosmolar hyperglycemic state in adults\", section on 'Phosphate depletion'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Except for the effects on mineral metabolism, the clinical manifestations of hypophosphatemia are primarily due to the consequences of intracellular phosphate depletion which can affect many organ systems. The signs and symptoms of hypophosphatemia will be reviewed here. The diagnostic approach to and treatment of hypophosphatemia are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?2/7/2167?source=see_link\">",
"     \"Diagnosis and treatment of hypophosphatemia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     MINERAL METABOLISM",
"    </span>",
"    &nbsp;&mdash;&nbsp;Prolonged hypophosphatemia produces a number of effects on both the kidney and bone. Distal tubular reabsorption of calcium and magnesium are inhibited and striking hypercalciuria ensues. This response to phosphate depletion is dramatic, but the mechanism is unknown. A number of patients with idiopathic hypercalciuria have mild hypophosphatemia and it has been suggested that impaired phosphate balance may be the primary abnormality, with enhanced calcium excretion representing a secondary effect.",
"   </p>",
"   <p>",
"    The initial response of bone to hypophosphatemia is increased resorption; the associated release of bone calcium contributes to the hypercalciuria. This effect may be mediated in part by the phosphate depletion-induced rise in the synthesis of calcitriol (1,25-dihydroxyvitamin D). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?9/15/9462?source=see_link\">",
"     \"Metabolism of vitamin D\"",
"    </a>",
"    .) More prolonged hypophosphatemia leads to rickets and osteomalacia due to decreased bone mineralization.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16063123\">",
"    <span class=\"h1\">",
"     CONSEQUENCES OF INTRACELLULAR PHOSPHATE DEPLETION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most of the symptoms of hypophosphatemia are due to two consequences of intracellular phosphate depletion which impact virtually all organ systems. These include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Red cell 2,3-DPG (diphosphoglycerate) levels fall, thereby increasing the affinity of hemoglobin for oxygen and reducing oxygen release at the tissue level [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/57/32659/abstract/4\">",
"       4",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Intracellular ATP levels fall with severe hypophosphatemia, and those cell functions dependent upon energy-rich phosphate compounds begin to fail.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Central nervous system",
"    </span>",
"    &nbsp;&mdash;&nbsp;Severe hypophosphatemia can lead to a metabolic encephalopathy that is due to ATP depletion. Typical presenting symptoms include irritability and paresthesias, which can progress to confusion, seizures, delirium, and coma [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32659/abstract/2,5,6\">",
"     2,5,6",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Cardiopulmonary system",
"    </span>",
"    &nbsp;&mdash;&nbsp;Myocardial contractility may be impaired with ATP depletion [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32659/abstract/7\">",
"     7",
"    </a>",
"    ] and respiratory failure due to weakness of the diaphragm has been described [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32659/abstract/8,9\">",
"     8,9",
"    </a>",
"    ]. The reduction in cardiac output may become clinically significant, leading to heart failure, when the plasma phosphate concentration falls to 1.0",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (0.32",
"    <span class=\"nowrap\">",
"     mmol/L).",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Skeletal and smooth muscle",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hypophosphatemia-induced",
"    manifestations of muscle dysfunction include a proximal myopathy (affecting skeletal muscle) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32659/abstract/10\">",
"     10",
"    </a>",
"    ] and dysphagia and ileus (affecting smooth muscle). In addition, acute hypophosphatemia superimposed upon preexisting severe phosphate depletion can lead to rhabdomyolysis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32659/abstract/11,12\">",
"     11,12",
"    </a>",
"    ]. Although CPK elevations are fairly common in hypophosphatemia, clinically significant rhabdomyolysis has been described almost exclusively in alcoholics and in patients receiving hyperalimentation without phosphate supplementation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32659/abstract/12\">",
"     12",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/42/28324?source=see_link\">",
"     \"Hypophosphatemia in the alcoholic patient\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The development of rhabdomyolysis with the associated release of phosphate from the damaged muscle cells has two clinical consequences: it may",
"    <strong>",
"     mask",
"    </strong>",
"    the underlying hypophosphatemia and may therefore protect against the development of other hypophosphatemic symptoms [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32659/abstract/11,12\">",
"     11,12",
"    </a>",
"    ]. The demonstration of a low plasma phosphate concentration before or after the peak muscle breakdown may be the only clue to the underlying phosphate depletion.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Hematologic dysfunction",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hypophosphatemia can also affect each of the components of the hematopoietic system.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Red blood cells",
"    </span>",
"    &nbsp;&mdash;&nbsp;A reduction in intracellular ATP levels increases erythrocyte rigidity, predisposing to hemolysis which can be seen when the plasma phosphate concentration falls below 0.5",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (0.16",
"    <span class=\"nowrap\">",
"     mmol/L)",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32659/abstract/13,14\">",
"     13,14",
"    </a>",
"    ]. However, clinically evident hemolysis due solely to hypophosphatemia is rare.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     White blood cells",
"    </span>",
"    &nbsp;&mdash;&nbsp;Diminished intracellular ATP levels reduces both phagocytosis and granulocyte chemotaxis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32659/abstract/15\">",
"     15",
"    </a>",
"    ]. This complication is also rare and only seen with severe hypophosphatemia.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Platelets",
"    </span>",
"    &nbsp;&mdash;&nbsp;Defective clot retraction and thrombocytopenia can occur which can aggravate mucosal hemorrhage",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16061297\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The manifestations of hypophosphatemia depend upon the severity and chronicity of the phosphate depletion. Most symptomatic patients have a plasma phosphate concentration below 1.0",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      (0.32",
"      <span class=\"nowrap\">",
"       mmol/L).",
"      </span>",
"      (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The effects of hypophosphatemia may be categorized into those that arise from changes in mineral metabolism and those due to ATP depletion. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H16063123\">",
"       'Consequences of intracellular phosphate depletion'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Hypophosphatemia-induced changes in mineral metabolism include a decrease in distal tubular reabsorption of calcium and magnesium and increased bone resorption, both resulting in hypercalciuria. Increased bone resorption is likely mediated by the phosphate depletion-induced rise in the synthesis of calcitriol (1,25-dihydroxyvitamin D). Prolonged hypophosphatemia may lead to rickets and osteomalacia. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Mineral metabolism'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Decreased intracellular ATP levels may cause metabolic encephalopathy, impaired myocardial contractility, respiratory failure due to weakness of the diaphragm, a proximal myopathy, dysphagia and ileus. (See",
"      <a class=\"local\" href=\"#H16063123\">",
"       'Consequences of intracellular phosphate depletion'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Acute hypophosphatemia superimposed upon preexisting severe phosphate depletion may cause rhabdomyolysis. Rhabdomyolysis may mask the underlying hypophosphatemia and therefore protect against the development of other hypophosphatemic symptoms. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Skeletal and smooth muscle'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The hematologic effects of a hypophosphatemia-induced decrease in intracellular ATP levels include an increased predisposition to hemolysis, a decrease in both phagocytosis and granulocyte chemotaxis, and defective clot retraction and thrombocytopenia. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Hematologic dysfunction'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32659/abstract/1\">",
"      Knochel JP. The pathophysiology and clinical characteristics of severe hypophosphatemia. Arch Intern Med 1977; 137:203.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32659/abstract/2\">",
"      Weisinger JR, Bellor&iacute;n-Font E. Magnesium and phosphorus. Lancet 1998; 352:391.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32659/abstract/3\">",
"      Liu PY, Jeng CY. Severe hypophosphatemia in a patient with diabetic ketoacidosis and acute respiratory failure. J Chin Med Assoc 2004; 67:355.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32659/abstract/4\">",
"      Travis SF, Sugerman HJ, Ruberg RL, et al. Alterations of red-cell glycolytic intermediates and oxygen transport as a consequence of hypophosphatemia in patients receiving intravenous hyperalimentation. N Engl J Med 1971; 285:763.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32659/abstract/5\">",
"      Silvis SE, DiBartolomeo AG, Aaker HM. Hypophosphatemia and neurological changes secondary to oral caloric intake: a variant of hyperalimentation syndrome. Am J Gastroenterol 1980; 73:215.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32659/abstract/6\">",
"      Subramanian R, Khardori R. Severe hypophosphatemia. Pathophysiologic implications, clinical presentations, and treatment. Medicine (Baltimore) 2000; 79:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32659/abstract/7\">",
"      O'Connor LR, Wheeler WS, Bethune JE. Effect of hypophosphatemia on myocardial performance in man. N Engl J Med 1977; 297:901.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32659/abstract/8\">",
"      Planas RF, McBrayer RH, Koen PA. Effects of hypophosphatemia on pulmonary muscle performance. Adv Exp Med Biol 1982; 151:283.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32659/abstract/9\">",
"      Newman JH, Neff TA, Ziporin P. Acute respiratory failure associated with hypophosphatemia. N Engl J Med 1977; 296:1101.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32659/abstract/10\">",
"      Ravid M, Robson M. Proximal myopathy caused by latrogenic phosphate depletion. JAMA 1976; 236:1380.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32659/abstract/11\">",
"      Knochel JP. Hypophosphatemia and rhabdomyolysis. Am J Med 1992; 92:455.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32659/abstract/12\">",
"      Singhal PC, Kumar A, Desroches L, et al. Prevalence and predictors of rhabdomyolysis in patients with hypophosphatemia. Am J Med 1992; 92:458.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32659/abstract/13\">",
"      Jacob HS, Amsden T. Acute hemolytic anemia with rigid red cells in hypophosphatemia. N Engl J Med 1971; 285:1446.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32659/abstract/14\">",
"      Klock JC, Williams HE, Mentzer WC. Hemolytic anemia and somatic cell dysfunction in severe hypophosphatemia. Arch Intern Med 1974; 134:360.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32659/abstract/15\">",
"      Craddock PR, Yawata Y, VanSanten L, et al. Acquired phagocyte dysfunction. A complication of the hypophosphatemia of parenteral hyperalimentation. N Engl J Med 1974; 290:1403.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 847 Version 8.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-118.195.65.248-EA571C30FB-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_57_32659=[""].join("\n");
var outline_f31_57_32659=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H16061297\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      MINERAL METABOLISM",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16063123\">",
"      CONSEQUENCES OF INTRACELLULAR PHOSPHATE DEPLETION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Central nervous system",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Cardiopulmonary system",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Skeletal and smooth muscle",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Hematologic dysfunction",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Red blood cells",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - White blood cells",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Platelets",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16061297\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?15/25/15767?source=related_link\">",
"      Causes of hypophosphatemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?2/7/2167?source=related_link\">",
"      Diagnosis and treatment of hypophosphatemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/42/28324?source=related_link\">",
"      Hypophosphatemia in the alcoholic patient",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?9/15/9462?source=related_link\">",
"      Metabolism of vitamin D",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?14/48/15114?source=related_link\">",
"      Treatment of diabetic ketoacidosis and hyperosmolar hyperglycemic state in adults",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f31_57_32660="Right aortic arch LL";
var content_f31_57_32660=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F61348&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F61348&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 581px\">",
"   <div class=\"ttl\">",
"    Right aortic arch LL",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 561px; height: 372px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A) Right aortic arch with aberrant left subclavian artery and left ligamentum arteriosum. Kommerell's diverticulum is the bulbous vascular structure giving rise to the left subclavian artery and ligamentum. The proximity of Kommerell's diverticulum to the trachea and esophagus is apparent. B) A computer reconstructed image of a CT angiogram viewed from posterior. DK-Diverticulum of Kommerell., RAA-right aortic arch, Dao-descending aorta. The star represents the location of the trachea and esophagus (not shown in this projection). The Diverticulum of Kommerell demonstrates a change in caliber as it continues as the aberrant left subclavian artery.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Figure A) Reproduced with permission from: Fyler, D, Nadas, AS. Nadas' Pediatric Cardiology, 1st ed, Hanley and Belfus, Philadelphia 1992. Copyright &copy;1992 Elsevier.",
"     <br>",
"      Figure B) Courtesy of Laureen M. Sena, MD.",
"     </br>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_57_32660=[""].join("\n");
var outline_f31_57_32660=null;
var title_f31_57_32661="Continuous wave Doppler MV area";
var content_f31_57_32661=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F65636%7ECARD%2F64364&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F65636%7ECARD%2F64364&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Calculation of mitral valve area from continuous wave Doppler",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 395px; height: 261px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The mitral valve area can be obtained from the continuous wave Doppler by calculating the time required for the opening pressure to reach one half of its value (P 1/2); this is called P 1/2 time and is calculated as shown. By regression analysis, a critically stenotic valve measuring 1 cm2 has a pressure half time of 220 ms; the valve area can be calculated as shown above.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Mitral valve area from continuous wave Doppler",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 385px; height: 263px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A computer system, incorporated into current echocardiographic equipment, can automatically measure the P 1/2 time on the continuous wave Doppler tracing and compute the mitral valve area (MVA). In this case the P 1/2 time is 255 msec and the MVA is 220/255 or 0.86 cm",
"    <sup>",
"     2",
"    </sup>",
"    .",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_57_32661=[""].join("\n");
var outline_f31_57_32661=null;
var title_f31_57_32662="MRI amebic encephalitis due to Balamuthia Mandrillaris";
var content_f31_57_32662=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RADIOL%2F85823&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RADIOL%2F85823&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 573px\">",
"   <div class=\"ttl\">",
"    MRI amebic encephalitis due to Balamuthia Mandrillaris",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 553px; height: 462px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The MRI is from a two-year-old boy who presented with fevers, obtundation, and seizures. The T2 weighted images (A and B) show bilateral hemispheric lesions (arrows) in the right posterior parietal lobe (A) and in the left caudate nucleus (B). The pre gadolinium T1 weighted sequence in the sagittal plane (C) shows subtle findings that become more apparent as enhancing lesions (arrows) in the post gadolinium sequence (D). The ependymal enhancement (arrowhead) confirms the presence of ependymitis. The diagnosis of amebic meningoencephalitis due to Balamuthia Mandrillaris was confirmed by surgical biopsy.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Images courtesy of Steven Goldstein, MD, University of Kentucky. Reproduced with permission from: James Smirniotopoulos, MD (Editor, MedPix, USUHS).",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_57_32662=[""].join("\n");
var outline_f31_57_32662=null;
var title_f31_57_32663="Lichen sclerosus follicular plugging";
var content_f31_57_32663=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F79659&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F79659&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Extragenital lichen sclerosus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 379px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Follicular plugging is evident in this lesion of lichen sclerosus.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_57_32663=[""].join("\n");
var outline_f31_57_32663=null;
var title_f31_57_32664="Lemon sign";
var content_f31_57_32664=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F81929%7EOBGYN%2F64380&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F81929%7EOBGYN%2F64380&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    The \"lemon\" sign",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 410px; height: 266px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The frontal bossing (arrows) typically termed the lemon sign is present in cases of open spina bifida.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Ana Monteagudo, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    The \"banana\" sign",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 389px; height: 288px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The cerebellum as it herniates through the foramen magnum takes up the shape of a banana (arrows). When both the lemon and banana signs are seen together, an open spinal defect is present.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Ana Monteagudo, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_57_32664=[""].join("\n");
var outline_f31_57_32664=null;
var title_f31_57_32665="Specific learning disabilities in children: Clinical features";
var content_f31_57_32665=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Specific learning disabilities in children: Clinical features",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?31/57/32665/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?31/57/32665/contributors\">",
"     L. Erik von Hahn, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?31/57/32665/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?31/57/32665/contributors\">",
"     Carolyn Bridgemohan, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?31/57/32665/contributors\">",
"     Marc C Patterson, MD, FRACP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?31/57/32665/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?31/57/32665/contributors\">",
"     Mary M Torchia, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?31/57/32665/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 2, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Learning disabilities (LDs) are a heterogeneous group of disorders characterized by the unexpected failure of an individual to acquire, retrieve, and use information competently. They are the most severe, pervasive, and chronic form of learning difficulty in children with average or above-average intellectual abilities [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32665/abstract/1,2\">",
"     1,2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    LDs have a multifactorial etiology [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32665/abstract/3\">",
"     3",
"    </a>",
"    ]. They typically manifest as a failure to acquire reading, writing, or math skills at grade- and age-expected levels. Learning problems that are outside of these traditional core domains, such as memory problems, attention problems, and difficulty managing social interactions, are not typically considered to be LDs. However, they can also be important contributors to academic failure and may require intervention.",
"   </p>",
"   <p>",
"    The clinical features of LDs will be presented here. The evaluation, management, and prognosis of LDs and the role of the primary care provider are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/6/35944?source=see_link\">",
"     \"Specific learning disabilities in children: Evaluation\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/27/37306?source=see_link\">",
"     \"Specific learning disabilities in children: Educational management\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/18/44329?source=see_link\">",
"     \"Specific learning disabilities in children: Role of the primary care provider\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Educational definitions for LD and a review of special education law, which describes how students can access special education services in school settings, also are provided separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/38/37480?source=see_link\">",
"     \"Definitions of specific learning disability and laws pertaining to learning disabilities\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     TERMINOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;In this topic review, the term \"learning disability\" (or \"specific learning disability\") refers to a heterogeneous group of disorders characterized by the unexpected failure of an individual to acquire, retrieve, and use information competently.",
"   </p>",
"   <p>",
"    However, in some countries, the term \"learning disability\" is used to refer to intellectual disability (formerly \"mental retardation\"). Intellectual disability is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/10/26793?source=see_link\">",
"     \"Intellectual disability (mental retardation) in children: Definition; causes; and diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?5/8/5257?source=see_link\">",
"     \"Intellectual disability (mental retardation) in children: Evaluation\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/59/40887?source=see_link\">",
"     \"Intellectual disability (mental retardation) in children: Management; outcomes; and prevention\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     DEFINITION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The core feature of specific learning disabilities (LD) is an intrinsic cognitive difficulty that results in academic achievement at a level less than expected for the individual's intellectual potential [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32665/abstract/4,5\">",
"     4,5",
"    </a>",
"    ]. Several definitions of learning disability agree with this core concept (",
"    <a class=\"graphic graphic_table graphicRef53010 \" href=\"mobipreview.htm?30/34/31276\">",
"     table 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32665/abstract/6-8\">",
"     6-8",
"    </a>",
"    ]. Despite conceptual agreement, the current definitions of LD are not specific enough for consistent case definition. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/38/37480?source=see_link&amp;anchor=H3#H3\">",
"     \"Definitions of specific learning disability and laws pertaining to learning disabilities\", section on 'Educational definitions'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/6/35944?source=see_link\">",
"     \"Specific learning disabilities in children: Evaluation\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Learning disabilities (LDs) are twice as common in children with chronic health conditions as in children without chronic health conditions. Children who receive special education services have greater rates of healthcare utilization than children who do not receive special education services [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32665/abstract/9,10\">",
"     9,10",
"    </a>",
"    ]. These correlations persist into adolescence and adulthood [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32665/abstract/11\">",
"     11",
"    </a>",
"    ]. As such, pediatricians are especially likely to encounter children with LD. However, they may not recognize those children unless they ask about learning problems specifically.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Prevalence",
"    </span>",
"    &nbsp;&mdash;&nbsp;The prevalence of LD is difficult to determine because different criteria are used to define LD in different settings. Data from the National Survey of Children's Health indicate that the lifetime prevalence of LD in children in the United States is 10 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32665/abstract/12\">",
"     12",
"    </a>",
"    ]. Data from the United States Department of Education indicate that, between 2000 and 2007, 5 to 6 percent of the total student population received services for a specific learning disability and that LDs account for the largest proportion of children served under special education law (&gt;40 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32665/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Disorders of reading and written expression are the most common forms of learning disability. In a population-based study, the prevalence of reading disability among school-age children was estimated to be between 5 and 12 percent, depending upon the criteria used for definition (intelligence-achievement discrepancy versus low achievement, respectively) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32665/abstract/14\">",
"     14",
"    </a>",
"    ]. In the same population, the prevalence of disorders of written expression was estimated to be between 7 and 15 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32665/abstract/15\">",
"     15",
"    </a>",
"    ]. In separate studies, the prevalence of dyscalculia (math disability) was estimated to be between 3 and 6 percent of the school-age population [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32665/abstract/16-18\">",
"     16-18",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Risk factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;The prevalence of LD is increased among children:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      With family history of LD [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/57/32665/abstract/19-21\">",
"       19-21",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Who live in poverty and understimulating environments [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/57/32665/abstract/22-24\">",
"       22-24",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Who were born prematurely (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?34/6/34922?source=see_link&amp;anchor=H29#H29\">",
"       \"Long-term neurodevelopmental outcome of premature infants\", section on 'Learning and language delays'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      With other developmental and mental health conditions, such as attention deficit hyperactivity disorder, disruptive behavior disorders, autism, anxiety disorders, and depression. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?26/18/26922?source=see_link&amp;anchor=H22#H22\">",
"       \"Attention deficit hyperactivity disorder in children and adolescents: Clinical features and evaluation\", section on 'Coexisting disorders'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?0/41/664?source=see_link&amp;anchor=H16#H16\">",
"       \"Clinical features of autism spectrum disorders\", section on 'Cognitive skills'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?5/10/5289?source=see_link&amp;anchor=H4#H4\">",
"       \"Depression in adolescents: Epidemiology, clinical manifestations, and diagnosis\", section on 'Comorbidity'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      With neurologic conditions (eg, seizure disorders, neurofibromatosis, tuberous sclerosis complex, Tourette syndrome). (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?33/38/34410?source=see_link&amp;anchor=H27#H27\">",
"       \"Tuberous sclerosis complex: Genetics, clinical features, and diagnosis\", section on 'Cognitive deficits'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?22/8/22664?source=see_link&amp;anchor=H5#H5\">",
"       \"Tourette syndrome\", section on 'Comorbidity'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?35/50/36650?source=see_link\">",
"       \"Neurofibromatosis type 1 (von Recklinghausen's disease)\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      With chromosomal disorders (eg, fragile X syndrome, Turner syndrome, Klinefelter syndrome). (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?32/42/33449?source=see_link&amp;anchor=H22#H22\">",
"       \"Clinical manifestations and diagnosis of Turner syndrome (gonadal dysgenesis)\", section on 'Psychologic and educational issues'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?34/4/34889?source=see_link&amp;anchor=H9#H9\">",
"       \"Clinical features and diagnosis of fragile X syndrome in children and adolescents\", section on 'Cognitive function'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      With certain chronic medical conditions (eg, type 1 diabetes mellitus, HIV infection). (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?39/29/40410?source=see_link&amp;anchor=H12#H12\">",
"       \"Complications and screening in children and adolescents with type 1 diabetes mellitus\", section on 'Neurologic sequelae'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?3/3/3130?source=see_link&amp;anchor=H18840547#H18840547\">",
"       \"Natural history and classification of pediatric HIV infection\", section on 'HIV encephalopathy'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      With a history of central nervous system infection or irradiation or traumatic brain injury. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?30/58/31656?source=see_link&amp;anchor=H16#H16\">",
"       \"Neurologic complications of bacterial meningitis in children\", section on 'Other sequelae'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?36/22/37226?source=see_link&amp;anchor=H25#H25\">",
"       \"Complications of cranial irradiation\", section on 'Neurocognitive effects in children'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     ETIOLOGY AND PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Learning disabilities (LDs) are caused by inborn or acquired abnormalities in brain structure and function, and have a multifactorial etiology [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32665/abstract/3\">",
"     3",
"    </a>",
"    ]. LDs may be present at birth or acquired after birth as a result of illness, exposure to toxins, poor nutrition, medical treatment, sociocultural deprivation, or injury [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32665/abstract/25-28\">",
"     25-28",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    LDs are not caused by eye problems [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32665/abstract/29,30\">",
"     29,30",
"    </a>",
"    ]. Although the eyes are essential to the receipt of visual input, it is the brain that processes visual stimuli and interprets visual images (eg, reverses letters, words, or numbers) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32665/abstract/3\">",
"     3",
"    </a>",
"    ]. Neither LDs nor the processing of visual input is affected by the correction of subtle visual defects [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32665/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The pathogenesis of LDs is not known. Genetic and neuropathologic causes may be at the core of LD, particularly in the case of reading disability. However, the full expression of LD occurs as a result of these neuropathologic differences in conjunction with other intrinsic and environmental factors that affect learning. Other intrinsic factors include brain functions, such as language skills, executive functions, and social cognition. Environmental factors include school factors (eg, student-teacher interactions; appropriately paced instruction; the student's past exposure to learning opportunities at school; level of stimulation provided by the learning materials; physical layout of the classroom setting); and home factors, such as past exposure to learning at home, degree of support provided in the home for reading and homework completion, etc. [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32665/abstract/32-36\">",
"     32-36",
"    </a>",
"    ]. Neuropathologic causes for learning failure can be mitigated with appropriate instruction and a supportive learning environment, and can be aggravated when the learning environment is not supportive. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?6/16/6409?source=see_link&amp;anchor=H14#H14\">",
"     \"Normal reading development and etiology of reading difficulty in children\", section on 'Etiology and pathogenesis of reading disability'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     CLINICAL FEATURES",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     LD syndromes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Learning disabilities (LDs) are a heterogeneous group of disorders that require individualized evaluation and intervention. Nonetheless, patterns of learning problems often cluster together [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32665/abstract/37\">",
"     37",
"    </a>",
"    ]. The following LD syndromes are commonly recognized:",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Reading disability",
"    </span>",
"    &nbsp;&mdash;&nbsp;Specific reading disability (dyslexia) is estimated to occur in approximately 5 to 12 percent of school-age children, depending upon the criteria used for definition [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32665/abstract/14\">",
"     14",
"    </a>",
"    ]. Dyslexia is a specific type of reading disorder caused by deficits in phonologic processing. The phonologic deficits are unexpected in relation to the student's overall intelligence and persist even after receiving appropriate (general education) instruction.",
"   </p>",
"   <p>",
"    Reading disability presents initially with problems in letter-sound relationships (ie, in decoding words and reading fluency in kindergarten or grade one). Problems with reading comprehension usually present in the latter part of the primary school years, when the focus is on reading to learn rather than learning to read. Children with reading disability may have attention problems and may avoid reading. They can be identified by low overall reading achievement, or by low reading ability in relation to their overall intelligence.",
"   </p>",
"   <p>",
"    Reading disability is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?6/16/6409?source=see_link\">",
"     \"Normal reading development and etiology of reading difficulty in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?1/21/1370?source=see_link\">",
"     \"Clinical features and evaluation of reading difficulty in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/11/17592?source=see_link\">",
"     \"Interventions for children with reading difficulty\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Writing disability",
"    </span>",
"    &nbsp;&mdash;&nbsp;Disabilities in written expression are estimated to occur in approximately 7 to 15 percent of school-age children, depending upon the criteria used for definition [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32665/abstract/15\">",
"     15",
"    </a>",
"    ]. Writing disabilities are caused by a range of neurodevelopmental weaknesses or disabilities, including problems with [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32665/abstract/38-40\">",
"     38-40",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Handwriting (fine motor or graphomotor), weaknesses or problems with visual-spatial perception",
"     </li>",
"     <li>",
"      Spelling (also called \"encoding,\" which is the ability to use sound-letter relationships effectively); problems with spelling alone, in the absence of a problem expressing ideas in writing, is more indicative of a phonologic processing deficit (ie, dyslexia) than a disorder of written expression",
"     </li>",
"     <li>",
"      Grammar and syntax",
"     </li>",
"     <li>",
"      Formulating, expressing, and organizing ideas in writing",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    LDs in written expression affect all areas of academics. Children with LDs in written expression may present with difficulty copying efficiently from the chalkboard; may show excessive errors in grammar and punctuation; may produce overly simple written text;",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    may produce disorganized text that is difficult to follow.",
"   </p>",
"   <p>",
"    The differential diagnosis of disorders of written expression includes developmental coordination disorder (particularly for children with handwriting problems), reading disability (especially for children who have encoding weaknesses), language disorder (particularly for children whose text contains too many grammatical errors or is otherwise impoverished",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    disorganized), and attention deficit hyperactivity disorder (for children who have difficulty organizing their ideas in writing) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32665/abstract/41-43\">",
"     41-43",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/46/26343?source=see_link\">",
"     \"Evaluation and treatment of speech and language disorders in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/18/26922?source=see_link&amp;anchor=H830607547#H830607547\">",
"     \"Attention deficit hyperactivity disorder in children and adolescents: Clinical features and evaluation\", section on 'Clinical features'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/18/26922?source=see_link&amp;anchor=H2#H2\">",
"     \"Attention deficit hyperactivity disorder in children and adolescents: Clinical features and evaluation\", section on 'Core symptoms'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/28/13770?source=see_link&amp;anchor=H5#H5\">",
"     \"Overview of developmental coordination disorder\", section on 'Clinical features'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Math LDs",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mathematics LDs, which encompass weaknesses in calculation and reasoning, are estimated to occur in 3 to 6 percent of children [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32665/abstract/16,17,44\">",
"     16,17,44",
"    </a>",
"    ], or 6 to 13.8 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32665/abstract/45\">",
"     45",
"    </a>",
"    ], depending on the age of the student and the formula used to defined math LD.",
"   </p>",
"   <p>",
"    Two important components of math LD include problems with number sense and problems retrieving math facts (arithmetic combinations or calculations) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32665/abstract/46\">",
"     46",
"    </a>",
"    ]. In addition to these two basic components, students with math LD can have difficulty with the language of math (correctly reading and understanding numbers and symbols), word problems in math (correctly reading and understanding the text of word problems), and with the visual-spatial and organizational demands of math. Success in math is thus dependent on a broad range of neurodevelopmental functions, including:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Number sense.",
"      </strong>",
"      Number sense refers to having a mental representation of quantity. It is an early-emerging skill that fails to develop in students with math LD and may manifest as [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/57/32665/abstract/46-48\">",
"       46-48",
"      </a>",
"      ]:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Difficulty in estimating and judging magnitude",
"     </li>",
"     <li>",
"      Difficulty understanding the principle of commutativity (order irrelevance) in math problems",
"     </li>",
"     <li>",
"      Inability to represent the same number in more than one manner",
"     </li>",
"     <li>",
"      Inability to recognize benchmark numbers and number patterns",
"     </li>",
"     <li>",
"      Inability to recognize unreasonable results when doing math calculations",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Retrieval of math facts.",
"      </strong>",
"      Math facts refer to the basic calculations taught in primary school that are typically used from memory in later grades and in higher-order math problems. Retrieval of math facts can be a specific focus for intervention and instruction. Difficulty retrieving math facts can be related to problems with number sense. The student with poor math fact skills may not know how to complete math calculations and may over-rely on tangible aids, such as pictures or tables. They do not have automatic retrieval of math facts and thus have much greater difficulty with higher-order math problems.",
"     </li>",
"     <li>",
"      <strong>",
"       Language of math",
"      </strong>",
"      . Students with math LD may fail to correctly read and understand numbers and math symbols. They may reverse numbers or make errors when reading numbers aloud.",
"     </li>",
"     <li>",
"      <strong>",
"       Ability to understand word problems",
"      </strong>",
"      . Math LDs usually are seen in conjunction with disabilities in reading or written expression. Math functions depend upon language and the ability of the student to understand the words associated with math functions and word problems [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/57/32665/abstract/43\">",
"       43",
"      </a>",
"      ]. Reading difficulties can aggravate difficulty acquiring math skills. Students with reading disability have difficulty with word problems, because they do not understand the meaning of the sentence in math word problems and may not be able to identify extraneous or irrelevant material.",
"     </li>",
"     <li>",
"      <strong>",
"       Visual-spatial and organizational skills",
"      </strong>",
"      . Math LD can be caused by difficulties in handwriting, visual-spatial orientation, temporal sequencing, memory, and attention [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/57/32665/abstract/33\">",
"       33",
"      </a>",
"      ]. Students with math LD may have difficulty organizing math problems on the page. They may copy numbers incorrectly, write numbers illegibly, misalign numbers, have left-right disorientation of numbers, misplace digits in multidigit numbers, skip rows or columns during calculations, fail to carry numbers (eg, regrouping when appropriate), reverse number problems, start a calculation in the wrong place, or not recognize operator signs. Students with math LD also have difficulty planning and organizing their approach to math problems. They have difficulty with multistep problems; they may fail to verify answers and may settle for the first answer they reach for a given problem.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The differential diagnosis of calculation and math LDs includes reading disability, disorder of written expression, language disorder, and attention deficit hyperactivity disorder.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Nonverbal LD",
"    </span>",
"    &nbsp;&mdash;&nbsp;The nonverbal LD syndrome (nonlanguage-based LD, NLD, also known as right hemisphere developmental LD, etc) is characterized by a particular pattern of neuropsychologic abilities and disabilities. NLD is not recognized in the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Diagnostic criteria vary by author and clinician.",
"   </p>",
"   <p>",
"    Common features of the NLD syndrome include [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32665/abstract/36,49-53\">",
"     36,49-53",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Well-developed basic language skills",
"     </li>",
"     <li>",
"      Strong rote skills, such as phoneme awareness, reading decoding, single-word reading, and single-word-spelling skills (which often account for the success of students with NLD in the primary school years)",
"     </li>",
"     <li>",
"      Weakness in visual-spatial organization",
"     </li>",
"     <li>",
"      Weakness in nonverbal problem solving, including social reasoning",
"     </li>",
"     <li>",
"      Weakness in higher-order reading comprehension and written expression (usually not manifest until after the primary school years)",
"     </li>",
"     <li>",
"      Weaknesses in attention and executive function",
"     </li>",
"     <li>",
"      Math disability is common (usually after grade three)",
"     </li>",
"     <li>",
"      Anxiety",
"     </li>",
"     <li>",
"      Depression",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    NLD shares clinical features with Asperger disorder (eg, deficits and social interactions and a similar profile of learning strengths and weaknesses). The overlap between these two conditions is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/20/15689?source=see_link&amp;anchor=H12#H12\">",
"     \"Asperger disorder: Clinical features and diagnosis in children and adolescents\", section on 'Associated conditions'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Language-based LD",
"    </span>",
"    &nbsp;&mdash;&nbsp;Language-based LD reflect the learning impairments experienced by children with language disorders. A language-based LD affects reading and writing. Children with language-based learning problems also will struggle with word problems in math. Language-based LD may or may not include problems with reading decoding (phonologic weaknesses). Children with language-based learning disabilities have relative strengths in the ability to perceive visual information accurately, solve problems using visual information, and learn and socialize effectively using visual cues. They have difficulty understanding and using one or several of the components of language, including:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Content (vocabulary)",
"     </li>",
"     <li>",
"      Phonology (discriminating the sounds in words)",
"     </li>",
"     <li>",
"      Form (grammar, syntax (word order), and morphemes)",
"     </li>",
"     <li>",
"      Pragmatics (narrative, discourse, and conversations)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Children with language-based LD have difficulty understanding and sharing information in a variety of contexts, spoken or written. There is a strong association between language disorders and reading and writing disability [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32665/abstract/54-58\">",
"     54-58",
"    </a>",
"    ]. Children with language disorders typically have weaknesses in reading comprehension, whether or not they have a concomitant phonologic processing disorder (ie, a specific reading",
"    <span class=\"nowrap\">",
"     disability/dyslexia)",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32665/abstract/4\">",
"     4",
"    </a>",
"    ]. The weaknesses in reading comprehension may not be apparent during the primary-school years.",
"   </p>",
"   <p>",
"    Language disorders are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/46/26343?source=see_link\">",
"     \"Evaluation and treatment of speech and language disorders in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/57/21399?source=see_link&amp;anchor=H12#H12\">",
"     \"Etiology of speech and language disorders in children\", section on 'Language disorders'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Clinical expression",
"    </span>",
"    &nbsp;&mdash;&nbsp;Personal (intrinsic) and environmental factors affect the clinical expression of LD, which varies from one student to the next. The clinical expression of LD is not simply a reflection of impairment in a given skill, but results from the interaction of many factors, including co-occurrence with psychiatric conditions or internalizing and externalizing symptoms [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32665/abstract/59,60\">",
"     59,60",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H18\">",
"     'Comorbidities'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    The environment has an important impact on the clinical expression of LD. Classrooms that are organized and instruction that is systematic and predictable can help to mitigate the degree to which intrinsic learning weaknesses affect the child's learning. Teachers who are skilled at determining a student's capacity to understand, remember, and follow oral instructions and who can adjust the language load by simplifying instructions, providing repetition,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    providing visual supports can reduce the impact of language delays on the child's learning and thereby improve the child's overall performance when he or she is expected to learn to read or count. Teachers who understand the impact of executive dysfunctions, which occur in children with attention deficit hyperactivity and other disorders, can mitigate the impact of executive dysfunctions by providing extra monitoring, supervision, and organizational supports. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/61/32730?source=see_link&amp;anchor=H13#H13\">",
"     \"Attention deficit hyperactivity disorder in children and adolescents: Overview of treatment and prognosis\", section on 'School-based interventions'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/61/32730?source=see_link&amp;anchor=H966764713#H966764713\">",
"     \"Attention deficit hyperactivity disorder in children and adolescents: Overview of treatment and prognosis\", section on 'Behavioral interventions'",
"    </a>",
"    .) All of these classroom strategies help to reduce the effort that the student has to make when addressing learning tasks related to his or her areas of weakness, regardless of LD type. However, the consistency with which such teaching strategies are practiced is highly variable.",
"   </p>",
"   <p>",
"    Similarly, the home environment can affect the expression of learning problems. Home environments in which reading is practiced, or that provide structure, predictability, and routine, can moderate the effects of language weaknesses",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    executive dysfunctions. These factors are not always considered to be a specific focus of educational intervention, but when they are addressed successfully, they help prepare the student to learn in the classroom. Language and executive dysfunction are particularly important areas to target for any student with an LD, regardless of the LD type [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32665/abstract/33,61,62\">",
"     33,61,62",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Clinical presentation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pediatric healthcare providers should consider the possibility of LD in children who have risk factors and children who have problems at school (whether the problems are related to academic achievement, behavior, attention, or social interaction). (See",
"    <a class=\"local\" href=\"#H6\">",
"     'Risk factors'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    LDs interfere with all aspects of life, not just academics [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32665/abstract/63\">",
"     63",
"    </a>",
"    ]. Deficits in one area usually lead to, or are associated with, difficulties in another [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32665/abstract/33\">",
"     33",
"    </a>",
"    ]. Poor performance at school can result in a negative self-concept and reluctance to participate in learning, even for those areas that may be a personal strength for the child.",
"   </p>",
"   <p>",
"    Children with LD may show overt hostility or resistance to parent or teacher demands, or get discouraged quickly [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32665/abstract/64-69\">",
"     64-69",
"    </a>",
"    ]. They may have difficulty making friends because they fail to remember the names of peers, have difficulty using language to participate in conversations, have coordination problems that interfere with playing games, or have",
"    <span class=\"nowrap\">",
"     language/cognitive",
"    </span>",
"    problems that prevent them from understanding games with complex rules [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32665/abstract/65,66\">",
"     65,66",
"    </a>",
"    ]. Children with LD also may fail to fully understand social nuances or may not understand the social intentions of others. All of these factors can interfere with their social success.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Clinical course",
"    </span>",
"    &nbsp;&mdash;&nbsp;Limited information is available about the persistence of learning disabilities over time. For example, reading disability is estimated to have a diagnostic stability rate of 28 to 78 percent, depending upon the study [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32665/abstract/70,71\">",
"     70,71",
"    </a>",
"    ]. These estimates are too wide to be clinically meaningful and are explained, in part, by the criteria used to define reading disability, the age at which the original diagnosis was made, and by treatment effects.",
"   </p>",
"   <p>",
"    Diagnostic stability is lower among younger children, suggesting that reading difficulty in younger children may have a variety of causes, some of which are more amenable to treatment than others. Among older children, reading disability tends to persist over time. Even though reading skills may improve, phonologic processing skills continue to measure below normal. Variation in the clinical expression of reading disability over time makes consistent measurement and identification more problematic [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32665/abstract/72-74\">",
"     72-74",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?1/21/1370?source=see_link&amp;anchor=H11#H11\">",
"     \"Clinical features and evaluation of reading difficulty in children\", section on 'Clinical course'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Less information is available about the diagnostic stability of other types of LD. In one study, 65 to 70 percent of children who had difficulty with math throughout kindergarten had persistent math difficulty in grade five [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32665/abstract/75\">",
"     75",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Comorbidities",
"    </span>",
"    &nbsp;&mdash;&nbsp;LD usually do not exist in isolation. They co-occur with internalizing and externalizing symptoms, and with many psychiatric conditions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32665/abstract/59,60\">",
"     59,60",
"    </a>",
"    ]. It is not certain whether LD and comorbid psychiatric conditions share a common neurodevelopmental basis or are causally related [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32665/abstract/76\">",
"     76",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The lack of consistent LD case identification makes it difficult to accurately determine the frequency of co-occurrence of LD with psychiatric conditions. However, the general trend for overlap is striking, with most studies suggesting LD in 20 to 70 percent of children with behavioral or psychiatric conditions (eg, attention deficit hyperactivity disorder, anxiety, depression) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32665/abstract/42,60,77,78\">",
"     42,60,77,78",
"    </a>",
"    ]. This is a much higher incidence than would be expected for the population as a whole.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The differential diagnosis of learning disabilities (LD) includes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32665/abstract/6,26,79\">",
"     6,26,79",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Mild intellectual disability (mental retardation) (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?26/10/26793?source=see_link\">",
"       \"Intellectual disability (mental retardation) in children: Definition; causes; and diagnosis\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Hearing or vision impairment",
"     </li>",
"     <li>",
"      Psychiatric conditions, such as attention deficit hyperactivity disorder or emotional disturbance (eg, depression or anxiety). (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?5/10/5289?source=see_link\">",
"       \"Depression in adolescents: Epidemiology, clinical manifestations, and diagnosis\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?26/18/26922?source=see_link&amp;anchor=H2#H2\">",
"       \"Attention deficit hyperactivity disorder in children and adolescents: Clinical features and evaluation\", section on 'Core symptoms'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?26/18/26922?source=see_link&amp;anchor=H830607547#H830607547\">",
"       \"Attention deficit hyperactivity disorder in children and adolescents: Clinical features and evaluation\", section on 'Clinical features'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <span class=\"nowrap\">",
"       Parent/school",
"      </span>",
"      expectations that are discordant with the student's abilities and interests",
"     </li>",
"     <li>",
"      Environmental factors (eg, lack of opportunity, frequent school absences, poor teaching, and cultural factors, such as English as a second language)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Other causes for learning failure include neurologic conditions (seizures, static or progressive neurologic disorders), genetic causes, lead poisoning, medication side effects, substance abuse, or sleep problems, among others. These conditions can be identified by history, examination, laboratory tests (eg, blood lead level), and ancillary evaluation (eg, audiology, vision screening). Other conditions may require more specialized testing",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    referral. Qualitative observations",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    the student's report card often can identify LD, but psychometric testing is used to make a formal diagnosis. The presence of LD along with the conditions listed above is common.",
"   </p>",
"   <p>",
"    The comprehensive evaluation for a child with learning difficulty is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/6/35944?source=see_link\">",
"     \"Specific learning disabilities in children: Evaluation\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?37/47/38641?source=see_link\">",
"       \"Patient information: Learning disabilities (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The core feature of specific learning disability (LD) is an intrinsic cognitive difficulty that results in academic achievement at a level less than expected for the individual's intellectual potential (",
"      <a class=\"graphic graphic_table graphicRef53010 \" href=\"mobipreview.htm?30/34/31276\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Definition'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Risk factors for LD include family history of LD, poverty, prematurity, developmental and mental health conditions (eg, attention deficit hyperactivity disorder, depression), neurologic conditions (eg, seizure disorder, neurofibromatosis), chromosomal disorders (eg, fragile X syndrome, Turner syndrome), certain chronic medical conditions (eg, type 1 diabetes mellitus), and history of central nervous system infection or irradiation. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Risk factors'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      LD are caused by inborn or acquired abnormalities in brain structure and function, and have a multifactorial etiology. They are not caused by eye problems. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Etiology and pathogenesis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      LD are a heterogeneous group of disorders. However, patterns of learning problems often cluster, resulting in commonly recognized LD syndromes, including reading disability (dyslexia), disorders of written expression (dysgraphia), mathematical disorders, nonverbal LD (nonlanguage-based LD, right hemisphere dysfunction), and language-based LD. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'LD syndromes'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The clinical expression of LD is influenced by concomitant internalizing and externalizing symptoms and psychiatric conditions, the classroom environment (eg, amount of structure, skill of teacher), and the home environment (eg, amount of structure, predictability, routine). (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Clinical expression'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Pediatric healthcare providers should consider the possibility of LD in children who have risk factors and children who have problems at school (whether the problems are related to academic achievement, behavior, attention, or social interaction). (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Clinical presentation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      LD frequently occur with other psychiatric conditions (eg, behavior disorders, attention deficit hyperactivity disorder, autism). (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Comorbidities'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32665/abstract/1\">",
"      Adelman HS. Toward solving the problems of misidentification and limited intervention efficacy. J Learn Disabil 1989; 22:608.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32665/abstract/2\">",
"      Adelman HS. LD: the next 25 years. J Learn Disabil 1992; 25:17.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32665/abstract/3\">",
"      American Academy of Pediatrics, Section on Ophthalmology, Council on Children with Disabilities, American Academy of Ophthalmology, American Association for Pediatric Ophthalmology and Strabismus, American Association of Certified Orthoptists. Joint statement--Learning disabilities, dyslexia, and vision. Pediatrics 2009; 124:837.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32665/abstract/4\">",
"      Lyon GR. Learning disabilities. Future Child 1996; 6:54.",
"     </a>",
"    </li>",
"    <li>",
"     Keogh BK. A matrix of decision points in the measurement of learning disabilities. In: rames of Reference for the Assessment of Learning Disabilities, Lyon GR (Ed), Paul H. Brooks Publishing Co, Baltimore 1994. p.15.",
"    </li>",
"    <li>",
"     Learning Disorders. In: Diagnostic and Statistical Manual - Text Revision (DSM-IV-TR&trade;, 2000), 4th ed, First ME (Ed), American Psychiatric Association, Washington, DC 2000.",
"    </li>",
"    <li>",
"     United States Office of Education. Definition and criteria for defining students as learning disabled. Federal Register, 42:250, US Government Printing Office, Washington, DC, 1977. p.65083.",
"    </li>",
"    <li>",
"     National Joint Committee on Learning Disabilities (NJCLD). Operationalizing the NJCLD definition of learning disabilities for ongoing assessment in schools. American Speech-Language Hearing Association 1997. Available at: www.asha.org/docs/html/RP1998-00130.html (Accessed on February 17, 2010).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32665/abstract/9\">",
"      Boulet SL, Boyle CA, Schieve LA. Health care use and health and functional impact of developmental disabilities among US children, 1997-2005. Arch Pediatr Adolesc Med 2009; 163:19.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32665/abstract/10\">",
"      Petersen, MC, Kube, DA, Palmer, FB. High prevalence of developmental disabilities in children admitted to a general pediatric inpatient unit. J Dev Phys Disabil 2006; 18:307.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32665/abstract/11\">",
"      McDougall J, King G, de Wit DJ, et al. Chronic physical health conditions and disability among Canadian school-aged children: a national profile. Disabil Rehabil 2004; 26:35.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32665/abstract/12\">",
"      Altarac M, Saroha E. Lifetime prevalence of learning disability among US children. Pediatrics 2007; 119 Suppl 1:S77.",
"     </a>",
"    </li>",
"    <li>",
"     Children and Youth with Disabilities. US Dept of Education, National Center for Education Statistics. Available at: nces.ed.gov/programs/coe/2009/section1/indicator09.asp. (Accessed on February 17, 2010).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32665/abstract/14\">",
"      Katusic SK, Colligan RC, Barbaresi WJ, et al. Incidence of reading disability in a population-based birth cohort, 1976-1982, Rochester, Minn. Mayo Clin Proc 2001; 76:1081.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32665/abstract/15\">",
"      Katusic SK, Colligan RC, Weaver AL, Barbaresi WJ. The forgotten learning disability: epidemiology of written-language disorder in a population-based birth cohort (1976-1982), Rochester, Minnesota. Pediatrics 2009; 123:1306.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32665/abstract/16\">",
"      Shalev RS, Auerbach J, Manor O, Gross-Tsur V. Developmental dyscalculia: prevalence and prognosis. Eur Child Adolesc Psychiatry 2000; 9 Suppl 2:II58.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32665/abstract/17\">",
"      Hein J, Bzufka MW, Neum&auml;rker KJ. The specific disorder of arithmetic skills. Prevalence studies in a rural and an urban population sample and their clinico-neuropsychological validation. Eur Child Adolesc Psychiatry 2000; 9 Suppl 2:II87.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32665/abstract/18\">",
"      Dickerson Mayes, S, Calhoun, SL. Challenging the assumptions about the frequency and coexistence of learning disability types. Sch Psychol Int 2007; 28:437.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32665/abstract/19\">",
"      Snowling MJ, Gallagher A, Frith U. Family risk of dyslexia is continuous: individual differences in the precursors of reading skill. Child Dev 2003; 74:358.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32665/abstract/20\">",
"      Snowling MJ, Muter V, Carroll J. Children at family risk of dyslexia: a follow-up in early adolescence. J Child Psychol Psychiatry 2007; 48:609.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32665/abstract/21\">",
"      Vogler GP, DeFries JC, Decker SN. Family history as an indicator of risk for reading disability. J Learn Disabil 1985; 18:419.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32665/abstract/22\">",
"      Learning disabilities and young children: Identification and intervention. A Report from the National Joint Committee on Leaming Disabilities October, 2006. Learn Disabil Q 2007; 30:.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32665/abstract/23\">",
"      Margai F, Henry N. A community-based assessment of learning disabilities using environmental and contextual risk factors. Soc Sci Med 2003; 56:1073.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32665/abstract/24\">",
"      Fujiura, GT, Yamaki, K. Trends in demography of childhood poverty and disability. Except Child 2000; 66:187.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32665/abstract/25\">",
"      Vohr BR, Coll CG, Lobato D, et al. Neurodevelopmental and medical status of low-birthweight survivors of bronchopulmonary dysplasia at 10 to 12 years of age. Dev Med Child Neurol 1991; 33:690.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32665/abstract/26\">",
"      McInerny TK. Children who have difficulty in school: a primary pediatrician's approach. Pediatr Rev 1995; 16:325.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32665/abstract/27\">",
"      Galler JR, Ramsey F, Solimano G. The influence of early malnutrition on subsequent behavioral development III. Learning disabilities as a sequel to malnutrition. Pediatr Res 1984; 18:309.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32665/abstract/28\">",
"      Leiva Plaza B, Inzunza Brito N, P&eacute;rez Torrej&oacute;n H, et al. [The impact of malnutrition on brain development, intelligence and school work performance]. Arch Latinoam Nutr 2001; 51:64.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32665/abstract/29\">",
"      Helveston EM, Weber JC, Miller K, et al. Visual function and academic performance. Am J Ophthalmol 1985; 99:346.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32665/abstract/30\">",
"      Levine MD. Reading disability: do the eyes have it? Pediatrics 1984; 73:869.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32665/abstract/31\">",
"      Romanchuk KG. Scepticism about Irlen filters to treat learning disabilities. CMAJ 1995; 153:397.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32665/abstract/32\">",
"      Orton, ST. \"Word-blindness\" in school children. Arch Neurol Psychiatr 1925; 14:581.",
"     </a>",
"    </li>",
"    <li>",
"     Levine, MD, Hooper, S, Montgomery J, et al. Learning disabilities: An interactive developmental paradigm. In: Better Understanding Learning Disabilities: New Views from Research and Their Implications for Education and Public Policies, Lyon, GR, Gray, DB, Krasnegor, NA, Kavanagh, JF (Eds), Paul H. Brookes Publishing Co., Baltimore 1993.",
"    </li>",
"    <li>",
"     Johnson, D, Myklebust, HR. Learning Disabilities: Educational Principles and Practices. Grune &amp; Stratton, New York 1967.",
"    </li>",
"    <li>",
"     Swanson, HL. Learning disabilities from the perspective of cognitive psychology. In: Better Understanding Learning Disabilities: New Views from Research and Their Implications for Education and Public Policies, Lyon, GR, Gray, DB, Krasnegor, NA, Kavanagh, JF (Eds), Paul H. Brookes, Baltimore 1993.",
"    </li>",
"    <li>",
"     Rourke, BP. Nonverbal learning disabilities: The syndrome and the model. Guilford Press, New York 1989.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32665/abstract/37\">",
"      Johnson DJ. An overview of learning disabilities: psychoeducational perspectives. J Child Neurol 1995; 10 Suppl 1:S2.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32665/abstract/38\">",
"      Stevenson CS, Larson CS, Carter LS, et al. The juvenile court: analysis and recommendations. Future Child 1996; 6:4.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32665/abstract/39\">",
"      Wakely MB, Hooper SR, de Kruif RE, Swartz C. Subtypes of written expression in elementary school children: a linguistic-based model. Dev Neuropsychol 2006; 29:125.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32665/abstract/40\">",
"      Sandler AD, Watson TE, Footo M, et al. Neurodevelopmental study of writing disorders in middle childhood. J Dev Behav Pediatr 1992; 13:17.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32665/abstract/41\">",
"      Botting, N, Simkin, Z, Conti-Ramsden, G. Associated reading skills in children with a history of Specific Language Impairment (SLI). Read Writ 2006; 19:77.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32665/abstract/42\">",
"      Mayes SD, Calhoun SL, Crowell EW. Learning disabilities and ADHD: overlapping spectrumn disorders. J Learn Disabil 2000; 33:417.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32665/abstract/43\">",
"      Kronenberger WG, Dunn DW. Learning disorders. Neurol Clin 2003; 21:941.",
"     </a>",
"    </li>",
"    <li>",
"     Every Child a Chance Trust Impact Report 2009-10: www.everychildachancetrust.org/downloads. (Accessed on April 28, 2011.)",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32665/abstract/45\">",
"      Barbaresi WJ, Katusic SK, Colligan RC, et al. Math learning disorder: incidence in a population-based birth cohort, 1976-82, Rochester, Minn. Ambul Pediatr 2005; 5:281.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32665/abstract/46\">",
"      Geary DC. Consequences, characteristics, and causes of mathematical learning disabilities and persistent low achievement in mathematics. J Dev Behav Pediatr 2011; 32:250.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32665/abstract/47\">",
"      Bryant, B, Bryant, D, Kathley, C, et al. Preventing mathematics difficulties in the primary grades: The critical features of instruction in textbooks as part of the equation. Learning Disability Quarterly 2008; 31:21.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32665/abstract/48\">",
"      Bryant, B, Bryant, D.. Introduction to the special series. Mathematics learning disabilities. Learning Disability Quarterly 2008; 31:3.",
"     </a>",
"    </li>",
"    <li>",
"     Fletcher, JM, Francis, DJ, Rourke, BP, et al. Classification of learning disabilities: Relationships with other childhood disorders. In: Better Understanding Learning Disabilities: New Views from Research and Their Implications for Education and Public Policies, Lyon, GR, Gray, DB, Krasnegor, NA, Kavanagh, JF (Eds), Paul H. Brookes, Baltimore 1993. p.27.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32665/abstract/50\">",
"      Harnadek MC, Rourke BP. Principal identifying features of the syndrome of nonverbal learning disabilities in children. J Learn Disabil 1994; 27:144.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32665/abstract/51\">",
"      Johnson DJ. Nonverbal learning disabilities. Pediatr Ann 1987; 16:133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32665/abstract/52\">",
"      Voeller KK. Clinical neurologic aspects of the right-hemisphere deficit syndrome. J Child Neurol 1995; 10 Suppl 1:S16.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32665/abstract/53\">",
"      Rourke BP. Arithmetic disabilities, specific and otherwise: a neuropsychological perspective. J Learn Disabil 1993; 26:214.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32665/abstract/54\">",
"      Dockrell, JE, Lindsay, G, Connelly, V. The Impact of Specific Language Impairment on Adolescents' Written Text. Except Child 2009; 75:427.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32665/abstract/55\">",
"      Bishop DV, Clarkson B. Written language as a window into residual language deficits: a study of children with persistent and residual speech and language impairments. Cortex 2003; 39:215.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32665/abstract/56\">",
"      McArthur GM, Hogben JH, Edwards VT, et al. On the \"specifics\" of specific reading disability and specific language impairment. J Child Psychol Psychiatry 2000; 41:869.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32665/abstract/57\">",
"      Eisenmajer N, Ross N, Pratt C. Specificity and characteristics of learning disabilities. J Child Psychol Psychiatry 2005; 46:1108.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32665/abstract/58\">",
"      Stoeckel RE, Colligan RC, Barbaresi WJ, et al. Early speech-language impairment and risk for written language disorder: a population-based study. J Dev Behav Pediatr 2013; 34:38.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32665/abstract/59\">",
"      Arnold EM, Goldston DB, Walsh AK, et al. Severity of emotional and behavioral problems among poor and typical readers. J Abnorm Child Psychol 2005; 33:205.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32665/abstract/60\">",
"      Mayes SD, Calhoun SL. Frequency of reading, math, and writing disabilities in children with clinical disorders. Learn Individ Differ 2006; 16:145.",
"     </a>",
"    </li>",
"    <li>",
"     Levine MD. Differences in learning and neurodevelopmental function in school-age children. In: Developmental-Behavioral Pediatrics, 4th ed, Carey WB, Crocker AC, Coleman WL, et al (Eds), Saunders Elsevier, Philadelphia 2009. p.535.",
"    </li>",
"    <li>",
"     Lerner, J. Learning Disabilities: Theories, Diagnosis, and Teaching Strategies, 8th ed, Houghton Mifflin Co, Boston 2000.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32665/abstract/63\">",
"      Silver LB. Psychological and family problems associated with learning disabilities: assessment and intervention. J Am Acad Child Adolesc Psychiatry 1989; 28:319.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32665/abstract/64\">",
"      Lerner JW. Educational interventions in learning disabilities. J Am Acad Child Adolesc Psychiatry 1989; 28:326.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32665/abstract/65\">",
"      Silver LB. Learning disabilities. J Am Acad Child Adolesc Psychiatry 1989; 28:309.",
"     </a>",
"    </li>",
"    <li>",
"     Silver, LB. The misunderstood child: Understanding and coping with your child's learning disabilities. Times Books, New York 1998.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32665/abstract/67\">",
"      Bender WN. Secondary personality and behavioral problems in adolescents with learning disabilities. J Learn Disabil 1987; 20:280.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32665/abstract/68\">",
"      Weinberg WA, Rutman J, Sullivan L, et al. Depression in children referred to an educational diagnostic center: diagnosis and treatment. Preliminary report. J Pediatr 1973; 83:1065.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32665/abstract/69\">",
"      Weinberg WA, McLean A, Snider RL, et al. Depression, learning disability, and school behavior problems. Psychol Rep 1989; 64:275.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32665/abstract/70\">",
"      Shaywitz SE, Escobar MD, Shaywitz BA, et al. Evidence that dyslexia may represent the lower tail of a normal distribution of reading ability. N Engl J Med 1992; 326:145.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32665/abstract/71\">",
"      Smart D, Prior M, Sanson A, Oberklaid F. Children with reading difficulties: A six-year follow-up from early primary school to secondary school. Aust J Learn Disabil 2005; 10:63.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32665/abstract/72\">",
"      Shaywitz SE, Fletcher JM, Holahan JM, et al. Persistence of dyslexia: the Connecticut Longitudinal Study at adolescence. Pediatrics 1999; 104:1351.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32665/abstract/73\">",
"      Wilson AM, Lesaux NK. Persistence of phonological processing deficits in college students with dyslexia who have age-appropriate reading skills. J Learn Disabil 2001; 34:394.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32665/abstract/74\">",
"      Bruck M. Persistence of phonological awareness deficits. Dev Psychol 1992; 28:874.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32665/abstract/75\">",
"      Morgan PL, Farkas G. Five-year growth trajectories of kindergarten children with learning difficulties in mathematics. J Learn Disabil 2009; 42:306.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32665/abstract/76\">",
"      Morgan PL, Farkas G, Tufis PA, Sperling RA. Are reading and behavior problems risk factors for each other? J Learn Disabil 2008; 41:417.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32665/abstract/77\">",
"      Prior M, Smart D, Sanson A, Oberklaid F. Relationships between learning difficulties and psychological problems in preadolescent children from a longitudinal sample. J Am Acad Child Adolesc Psychiatry 1999; 38:429.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32665/abstract/78\">",
"      Mattison RE, Hooper SR, Glassberg LA. Three-year course of learning disorders in special education students classified as behavioral disorder. J Am Acad Child Adolesc Psychiatry 2002; 41:1454.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32665/abstract/79\">",
"      Fennell EB. The role of neuropsychological assessment in learning disabilities. J Child Neurol 1995; 10 Suppl 1:S36.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 610 Version 13.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1105-178.219.2.221-D2DE38DEA4-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_57_32665=[""].join("\n");
var outline_f31_57_32665=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H20\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      TERMINOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      DEFINITION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Prevalence",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Risk factors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      ETIOLOGY AND PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      CLINICAL FEATURES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      LD syndromes",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Reading disability",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Writing disability",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Math LDs",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Nonverbal LD",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Language-based LD",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Clinical expression",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Clinical presentation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Clinical course",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Comorbidities",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/610\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/610|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?30/34/31276\" title=\"table 1\">",
"      Definitions of LD",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?15/20/15689?source=related_link\">",
"      Asperger disorder: Clinical features and diagnosis in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/18/26922?source=related_link\">",
"      Attention deficit hyperactivity disorder in children and adolescents: Clinical features and evaluation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/61/32730?source=related_link\">",
"      Attention deficit hyperactivity disorder in children and adolescents: Overview of treatment and prognosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/4/34889?source=related_link\">",
"      Clinical features and diagnosis of fragile X syndrome in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/21/1370?source=related_link\">",
"      Clinical features and evaluation of reading difficulty in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/41/664?source=related_link\">",
"      Clinical features of autism spectrum disorders",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/42/33449?source=related_link\">",
"      Clinical manifestations and diagnosis of Turner syndrome (gonadal dysgenesis)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?39/29/40410?source=related_link\">",
"      Complications and screening in children and adolescents with type 1 diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/22/37226?source=related_link\">",
"      Complications of cranial irradiation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/38/37480?source=related_link\">",
"      Definitions of specific learning disability and laws pertaining to learning disabilities",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?5/10/5289?source=related_link\">",
"      Depression in adolescents: Epidemiology, clinical manifestations, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?20/57/21399?source=related_link\">",
"      Etiology of speech and language disorders in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/46/26343?source=related_link\">",
"      Evaluation and treatment of speech and language disorders in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/10/26793?source=related_link\">",
"      Intellectual disability (mental retardation) in children: Definition; causes; and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?5/8/5257?source=related_link\">",
"      Intellectual disability (mental retardation) in children: Evaluation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?39/59/40887?source=related_link\">",
"      Intellectual disability (mental retardation) in children: Management; outcomes; and prevention",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?17/11/17592?source=related_link\">",
"      Interventions for children with reading difficulty",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/6/34922?source=related_link\">",
"      Long-term neurodevelopmental outcome of premature infants",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?3/3/3130?source=related_link\">",
"      Natural history and classification of pediatric HIV infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/50/36650?source=related_link\">",
"      Neurofibromatosis type 1 (von Recklinghausen's disease)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/58/31656?source=related_link\">",
"      Neurologic complications of bacterial meningitis in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?6/16/6409?source=related_link\">",
"      Normal reading development and etiology of reading difficulty in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/28/13770?source=related_link\">",
"      Overview of developmental coordination disorder",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?37/47/38641?source=related_link\">",
"      Patient information: Learning disabilities (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/27/37306?source=related_link\">",
"      Specific learning disabilities in children: Educational management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/6/35944?source=related_link\">",
"      Specific learning disabilities in children: Evaluation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?43/18/44329?source=related_link\">",
"      Specific learning disabilities in children: Role of the primary care provider",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/8/22664?source=related_link\">",
"      Tourette syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/38/34410?source=related_link\">",
"      Tuberous sclerosis complex: Genetics, clinical features, and diagnosis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f31_57_32666="Prophylaxis of infections in hematopoietic cell transplant recipients";
var content_f31_57_32666=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Prophylaxis of infections in hematopoietic cell transplant recipients",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?31/57/32666/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?31/57/32666/contributors\">",
"     Elias Anaissie, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?31/57/32666/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?31/57/32666/contributors\">",
"     Kieren A Marr, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?31/57/32666/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?31/57/32666/contributors\">",
"     Anna R Thorner, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?31/57/32666/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jun 17, 2010.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Allogeneic hematopoietic cell transplant (HCT) recipients are at increased risk for a variety of infections based upon their degree of immunosuppression and exposures. Autologous HCT recipients are also at increased risk for infection, although to a lesser degree than those who have undergone allogeneic HCT.",
"   </p>",
"   <p>",
"    The types of infections to which these hosts are most vulnerable can be roughly divided based upon the approximate time elapsed since transplantation (",
"    <a class=\"graphic graphic_figure graphicRef52716 \" href=\"mobipreview.htm?8/10/8362\">",
"     figure 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_figure graphicRef64491 \" href=\"mobipreview.htm?4/7/4223\">",
"     figure 2",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Preengraftment &mdash; less than three weeks",
"     </li>",
"     <li>",
"      Immediate postengraftment &mdash; three weeks to three months",
"     </li>",
"     <li>",
"      Late postengraftment &mdash; more than three months",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?19/32/19974?source=see_link\">",
"     \"Evaluation for infection before hematopoietic cell transplantation\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/30/25066?source=see_link\">",
"     \"Overview of infections following hematopoietic cell transplantation\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The Infectious Diseases Society of America (IDSA) clinical practice guidelines for preventing opportunistic infections among HCT recipients, as well as other IDSA guidelines, can be accessed through their website [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32666/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The term \"hematopoietic cell transplantation\" (HCT) will be used throughout this review as a general term to cover transplantation of progenitor cells from any source (eg, bone marrow, peripheral blood, cord blood). Otherwise, the source of such cells will be specified (eg, autologous peripheral blood progenitor cell transplantation). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/49/38682?source=see_link\">",
"     \"Sources of hematopoietic stem cells\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients can develop bacterial, fungal, viral, or parasitic infections. Infection in HCT recipients is associated with high morbidity and mortality. Thus, prevention of infection is a major goal involving determination of risk, careful selection of donors, infection control measures, and prophylactic and preemptive antimicrobial therapy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     DEFINITION OF RISK",
"    </span>",
"    &nbsp;&mdash;&nbsp;It is important to identify the population at high risk for infections and also the magnitude of and the period of maximum risk in order to predict those patients likely to benefit from prophylaxis. There are three factors that interact to determine the risk of infection in HCT recipients:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      The patient's net state of immunosuppression",
"     </li>",
"     <li>",
"      The patient's exposure to pathogens",
"     </li>",
"     <li>",
"      The presence of organ damage",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In HCT patients, the risk of infection is not limited to the period of granulocytopenia, but persists for 12 to 24 months until immune recovery occurs [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32666/abstract/2\">",
"     2",
"    </a>",
"    ]. This prolonged period of risk particularly applies to allogeneic recipients who develop chronic graft-versus-host disease (GVHD) and require additional immunosuppression therapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32666/abstract/3\">",
"     3",
"    </a>",
"    ]&nbsp;(",
"    <a class=\"graphic graphic_figure graphicRef52716 \" href=\"mobipreview.htm?8/10/8362\">",
"     figure 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     DONOR SELECTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Transplantation of bone marrow from donors who are not fully histocompatible for HLA gene donor cells is more frequently associated with graft failure and GVHD [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32666/abstract/4\">",
"     4",
"    </a>",
"    ]. Better selection of donor and recipient and T cell depletion of the marrow prior to transplantation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32666/abstract/5\">",
"     5",
"    </a>",
"    ] can prevent such complications. GVHD itself has a prominent immunosuppressive effect and may delay immunologic reconstitution after HCT [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32666/abstract/6\">",
"     6",
"    </a>",
"    ]&nbsp;(",
"    <a class=\"graphic graphic_table graphicRef50318 graphicRef63086 \" href=\"mobipreview.htm?12/63/13310\">",
"     table 1A-B",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?19/32/19974?source=see_link\">",
"     \"Evaluation for infection before hematopoietic cell transplantation\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Steroids are best avoided in efforts to prevent GVHD. When needed for GVHD therapy, the lowest possible dose of corticosteroids should be used followed by a rapid taper [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32666/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     INFECTION CONTROL MEASURES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Effective infection control measures can reduce exposure of HCT recipients to potential nosocomial pathogens. Patients and healthcare workers should be educated about the risk of and methods to prevent acquisition of these organisms. These methods include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Attention to personal hygiene",
"     </li>",
"     <li>",
"      Environmental controls including air inspections and air filtering in high-risk patient care areas. Dust accumulation should be avoided, and all surfaces in clinical areas should be kept clean and dry [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/57/32666/abstract/8\">",
"       8",
"      </a>",
"      ]. Patient rooms should be sealed against air leaks by keeping windows and doors closed with pressure sensors for monitoring.",
"     </li>",
"     <li>",
"      High efficiency particulate air (HEPA) filters units should be installed and maintained properly in patient rooms [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/57/32666/abstract/8\">",
"       8",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Aerosolization of water within the patient room may be an additional source of pathogenic molds, such as Aspergillus spp, even when strict attention is paid to the air quality from outside of the room [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/57/32666/abstract/9\">",
"       9",
"      </a>",
"      ]. Although no randomized trials have been performed to document efficacy of masks in preventing infection, HEPA-filtered masks may be useful when the patient leaves the protected environment. The use of laminar airflow remains controversial [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/57/32666/abstract/10\">",
"       10",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Proper handling of food and water; patients should receive a diet less likely to expose the individual to microbes, and sterile water [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/57/32666/abstract/11\">",
"       11",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Proper care for indwelling devices.",
"     </li>",
"     <li>",
"      Reduction in the number of invasive procedures [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/57/32666/abstract/12\">",
"       12",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     ANTIMICROBIAL PROPHYLAXIS OR PREEMPTIVE THERAPY",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Definitions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Approaches to the prevention of infection in HCT recipients include primary prophylaxis, secondary prophylaxis, and preemptive therapy.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Primary prophylaxis &mdash; Primary prophylaxis involves the administration of an antimicrobial drug to prevent infection in patients at increased risk.",
"     </li>",
"     <li>",
"      Secondary prophylaxis &mdash; Secondary prophylaxis involves the administration of prophylactic doses of an antimicrobial drug to prevent recurrent infection.",
"     </li>",
"     <li>",
"      Preemptive therapy &mdash; Preemptive therapy provides therapy based upon screening with a sensitive microbiology assay (eg, antigen detection or molecular assays) in an attempt to detect early infection. Patients thus identified are treated to avoid progression to invasive disease.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Antibacterial prophylaxis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The frequency and severity of gram-negative bacterial infections during neutropenia led to an early emphasis on suppressing the intestinal flora to prevent invasive infections. Use of oral nonabsorbable antibiotics (gentamicin,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?41/41/42649?source=see_link\">",
"     vancomycin",
"    </a>",
"    , neomycin, colistin, and nystatin) has now been replaced by absorbable broad-spectrum antibiotics such as the fluoroquinolones [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32666/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Prophylaxis with ciprofloxacin reduces the frequency of gram-negative infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32666/abstract/13\">",
"     13",
"    </a>",
"    ] but is associated with a concomitant increase in the frequency of infections caused by gram-positive cocci, such as alpha-hemolytic streptococci [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32666/abstract/14\">",
"     14",
"    </a>",
"    ]. These streptococcal infections may be prevented by the addition of penicillin or newer macrolides to the prophylactic regimen [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32666/abstract/15\">",
"     15",
"    </a>",
"    ]. However, resistance of streptococci to penicillin and the new macrolides is rising [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32666/abstract/16\">",
"     16",
"    </a>",
"    ]. Intravenous",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?41/41/42649?source=see_link\">",
"     vancomycin",
"    </a>",
"    prevents gram-positive infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32666/abstract/17\">",
"     17",
"    </a>",
"    ], but remains controversial because of the concerns about the emergence of resistance [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32666/abstract/18\">",
"     18",
"    </a>",
"    ]. Studies using",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?4/58/5034?source=see_link\">",
"     trimethoprim-sulfamethoxazole",
"    </a>",
"    in HCT recipients have had mixed results [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32666/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The newer fluoroquinolones (eg, levofloxacin) provide excellent coverage against gram-positive infections, including streptococci [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32666/abstract/19\">",
"     19",
"    </a>",
"    ], and may become the prophylactic agents of choice. We suggest using a newer fluoroquinolone, such as levofloxacin 500 mg orally once daily, at least through engraftment in both allogeneic and autologous HCT recipients.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     After engraftment",
"    </span>",
"    &nbsp;&mdash;&nbsp;After engraftment, allogeneic HCT recipients, particularly those with severe graft-versus-host disease (GVHD) receiving immunosuppressive drugs, typically continue to receive antibacterial prophylaxis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32666/abstract/20\">",
"     20",
"    </a>",
"    ]. The duration of prophylaxis varies depending upon the degree of immunosuppression and institutional protocols.",
"   </p>",
"   <p>",
"    Some centers give antibacterial prophylaxis to all allogeneic HCT recipients until day 70 following engraftment, while others discontinue prophylaxis after engraftment. However, patients with severe GVHD requiring immunosuppressive drugs typically remain on both antibacterial and antifungal prophylaxis until the immunosuppressive drugs are no longer necessary. (See",
"    <a class=\"local\" href=\"#H16\">",
"     'Antifungal prophylaxis'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Some centers give lifelong prophylaxis against the pneumococcus and other encapsulated bacteria to all allogeneic HCT recipients. Antibiotics with activity against encapsulated bacteria include penicillin,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?4/58/5034?source=see_link\">",
"     trimethoprim-sulfamethoxazole",
"    </a>",
"    , and newer fluoroquinolones, as discussed above. The choice of antibacterial drug should be based upon local resistance patterns. Fluoroquinolones should be a last option for lifelong prophylaxis to minimize the development of resistant organisms.",
"   </p>",
"   <p>",
"    Recipients of autologous HCT do not require routine prophylaxis directed at the pneumococcus following engraftment unless they are at additional risk for severe pneumococcal infection based upon the underlying illness (eg, multiple myeloma, chronic lymphocytic leukemia, splenectomy) or are receiving ongoing immunosuppressive therapy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Antiviral prophylaxis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Viral reactivation after HCT is common [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32666/abstract/21\">",
"     21",
"    </a>",
"    ]. Both prophylaxis and preemptive strategies are employed for a variety of viral infections.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Herpes simplex virus",
"    </span>",
"    &nbsp;&mdash;&nbsp;Intravenous acyclovir (5",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    intravenously every 12 hours or 250",
"    <span class=\"nowrap\">",
"     mg/m2",
"    </span>",
"    intravenously every 12 hours) from marrow infusion until engraftment, prevents reactivation of HSV in seropositive marrow recipients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32666/abstract/22\">",
"     22",
"    </a>",
"    ]. When tolerated, oral acyclovir (800 mg twice daily) is equally effective and costs considerably less than the intravenous preparation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32666/abstract/23\">",
"     23",
"    </a>",
"    ]. Oral acyclovir regimens of 800 mg twice daily and 400 mg three or four times daily have been used successfully for HSV prophylaxis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32666/abstract/23,24\">",
"     23,24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    HCT recipients should continue acyclovir as long as the patient is severely immunosuppressed (CD4 count",
"    <span class=\"nowrap\">",
"     &lt;200/mm3).",
"    </span>",
"    A retrospective review of various prophylactic strategies in three large cohorts of VZV and HSV-seropositive HCT patients demonstrated that extended use of acyclovir (greater than one year) was associated with optimal suppression of disease compared to shorter durations of prophylaxis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32666/abstract/23\">",
"     23",
"    </a>",
"    ]. Furthermore, long-term prophylactic therapy was not associated with the emergence of acyclovir resistance. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?9/60/10183?source=see_link\">",
"     \"Acyclovir: An overview\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Cytomegalovirus",
"    </span>",
"    &nbsp;&mdash;&nbsp;CMV prophylaxis has been studied using a variety of agents, including",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/30/33248?source=see_link\">",
"     ganciclovir",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?28/56/29575?source=see_link\">",
"     foscarnet",
"    </a>",
"    , acyclovir, and valacyclovir&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32666/abstract/25-32\">",
"     25-32",
"    </a>",
"    ]. Intravenous ganciclovir has been the most effective, but its use is limited by bone marrow toxicity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32666/abstract/25,26\">",
"     25,26",
"    </a>",
"    ]. High-dose acyclovir and valacyclovir are less myelosuppressive than ganciclovir and may have some efficacy for CMV prophylaxis, but have inferior in vitro activity against CMV [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32666/abstract/28-32\">",
"     28-32",
"    </a>",
"    ]. Thus, many centers favor a preemptive approach as discussed in the next section.",
"   </p>",
"   <p>",
"    Maribavir is a novel DNA synthesis inhibitor that is being evaluated for use against CMV. In a randomized placebo-controlled trial of 111 allogeneic HCT recipients, maribavir was associated with significant suppression of CMV reactivation and prevention of disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32666/abstract/33\">",
"     33",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Maribavir may be particularly useful in HCT recipients because it does not cause myelosuppression. However, more data are required before maribavir can be recommended for CMV prophylaxis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Preemptive therapy for CMV",
"    </span>",
"    &nbsp;&mdash;&nbsp;Despite the benefits of CMV prophylaxis, many centers favor a preemptive approach rather than prophylaxis to minimize toxicity. A preemptive approach is based upon active screening for CMV following transplantation and treating only those shedding antigen.",
"   </p>",
"   <p>",
"    The risk for CMV disease is significantly reduced by the preemptive administration of GCV in patients with CMV infection on the basis of BAL culture or monoclonal antibody testing [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32666/abstract/34,35\">",
"     34,35",
"    </a>",
"    ], culture of throat swabs, blood, and urine [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32666/abstract/36\">",
"     36",
"    </a>",
"    ], detection of antigenemia by plasma polymerase chain reaction (PCR) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32666/abstract/37\">",
"     37",
"    </a>",
"    ], or leukocyte PCR or monoclonal antibody testing [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32666/abstract/35,38\">",
"     35,38",
"    </a>",
"    ]. One group demonstrated that initial CMV viral load and the rate of increase of virus in the blood correlate with the risk of developing CMV disease in liver, renal, and HCT recipients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32666/abstract/39\">",
"     39",
"    </a>",
"    ]. The antigenemia assay is the most practical tool for preemptive CMV therapy, although studies suggest that quantitative PCR assays may be more sensitive [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32666/abstract/40\">",
"     40",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The efficacy of preemptive therapy was illustrated in a controlled trial in which allogeneic HCT recipients who were CMV-positive or who received CMV-positive marrow were screened for CMV excretion by cultures from multiple sites [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32666/abstract/36\">",
"     36",
"    </a>",
"    ]. Seventy-two patients who were virus excretors were randomly assigned to GCV (5",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day for the first 100 days) or placebo. The incidence of CMV disease was markedly reduced by GCV (3 versus 43 percent) and overall survival was significantly increased. The primary side effect was neutropenia, which occurred in 30 percent.",
"   </p>",
"   <p>",
"    Another randomized trial showed that",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?28/56/29575?source=see_link\">",
"     foscarnet",
"    </a>",
"    (90",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    IV twice daily) was as effective as",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/30/33248?source=see_link\">",
"     ganciclovir",
"    </a>",
"    (5",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    IV twice daily) for preemptive therapy of CMV infection in allogeneic HCT recipients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32666/abstract/41,42\">",
"     41,42",
"    </a>",
"    ]. However, despite in vitro synergy between ganciclovir and foscarnet, the combination of the two drugs (both at one-half of the usual dose) was not more effective than full-dose ganciclovir in preemptive CMV therapy in a randomized trial of 48 transplant recipients, 17 of whom had undergone HCT [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32666/abstract/43\">",
"     43",
"    </a>",
"    ]. The combination regimen also was associated with more toxicity. The efficacy of cidofovir (5",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    IV q week for two weeks) has been less well studied [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32666/abstract/42\">",
"     42",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?5/37/5718?source=see_link\">",
"     Valganciclovir",
"    </a>",
"    is a valyl-ester prodrug of oral GCV that has a bioavailability of nearly 70 percent (compared to 7 percent for oral",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/30/33248?source=see_link\">",
"     ganciclovir",
"    </a>",
"    ) and at doses of 450 to 900 mg, produces serum GCV levels that are similar to that measured with intravenous GCV administered at 2.5 to 5",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32666/abstract/44\">",
"     44",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    However, because the development of GVHD after HCT can alter the absorption of orally administered drugs, the pharmacokinetics of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?5/37/5718?source=see_link\">",
"     valganciclovir",
"    </a>",
"    were assessed in the HCT population prior to efficacy trials. A randomized, multicenter, crossover clinical trial compared the exposure (area under the curve, AUC) to GCV after valganciclovir (900 mg twice daily) and intravenous GCV (5",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    twice daily) during preemptive therapy for CMV disease in 48 adults following HCT [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32666/abstract/45\">",
"     45",
"    </a>",
"    ]. The following findings were noted:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients with and without intestinal GVHD had a higher exposure to GCV after",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?5/37/5718?source=see_link\">",
"       valganciclovir",
"      </a>",
"      than after IV GCV (mean AUC after 12 hours, 53.8 &plusmn; 18.0",
"      <span class=\"nowrap\">",
"       mcg/mL",
"      </span>",
"      per hour versus 39.5 &plusmn; 13.9 with IV",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?32/30/33248?source=see_link\">",
"       ganciclovir",
"      </a>",
"      for patients with no GVHD; 52.9 &plusmn; 21.8 versus 33.1 &plusmn; 13.0 for patients with intestinal GVHD).",
"     </li>",
"     <li>",
"      Absolute bioavailability of GCV after",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?5/37/5718?source=see_link\">",
"       valganciclovir",
"      </a>",
"      administration was about 75 percent in patients with or without intestinal GVHD.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    No differences in severe GCV-related toxicity were observed between the two groups and efficacy and safety were comparable at 84-day follow-up.",
"   </p>",
"   <p>",
"    Although the data with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?5/37/5718?source=see_link\">",
"     valganciclovir",
"    </a>",
"    look promising, a larger confirmative trial is needed to evaluate the safety and efficacy of this therapy in HCT patients.",
"   </p>",
"   <p>",
"    The clinical importance of increases in pp65 antigenemia during preemptive therapy was evaluated in a report of 119 HCT recipients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32666/abstract/46\">",
"     46",
"    </a>",
"    ]. A rise in antigenemia two- to fivefold was associated with corticosteroid administration, most often for GVHD. Increases in antigenemia were not significantly associated with the development of active CMV disease, but the investigators opted to change the center's preemptive protocol to include reinduction antiviral therapy for those patients in whom an increase in pp65 antigenemia was detected during maintenance treatment. Although drug resistance in CMV causing disease in HCT recipient has been reported [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32666/abstract/47\">",
"     47",
"    </a>",
"    ], it does not yet appear to be as great a problem as in other populations exposed to long durations of GCV.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Varicella zoster virus",
"    </span>",
"    &nbsp;&mdash;&nbsp;Varicella zoster virus (VZV) can cause severe disease in patients who have undergone HCT. VZV prophylaxis following allogeneic HCT has been shown to be effective in at least two randomized trials [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32666/abstract/48,49\">",
"     48,49",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In the larger trial, 77 allogeneic HCT recipients were randomly assigned to acyclovir 800 mg twice daily or placebo given from one to two months until one year following transplant [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32666/abstract/48\">",
"     48",
"    </a>",
"    ]. Acyclovir significantly reduced VZV infections at one year (hazard ratio 0.16, 95% CI 0.04 - 0.74). There was no difference in VZV-specific T helper cell responses or survival between the groups.",
"   </p>",
"   <p>",
"    Post-study VZV disease primarily occurred in patients with continued need for systemic immunosuppression, suggesting that continuation of prophylaxis beyond one year might be beneficial in such patients. There is no consensus regarding the duration of VZV prophylaxis and the possible development of rebound disease after cessation.",
"   </p>",
"   <p>",
"    These issues were addressed in a retrospective population-based study of three sequential cohorts of VZV-seropositive patients who were undergoing allogeneic or autologous HCT [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32666/abstract/50\">",
"     50",
"    </a>",
"    ]. The first cohort received acyclovir from the day of transplantation until engraftment (n = 932), the second cohort received acyclovir or valacyclovir for one year (n = 1117), and the third cohort received acyclovir or valacyclovir for one year or for six months after immunosuppressive drugs were discontinued, whichever was longer (n = 586).",
"   </p>",
"   <p>",
"    The following findings were noted:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Consistent with the findings in the randomized trials, prophylaxis for one year or more significantly reduced VZV disease compared to prophylaxis only through engraftment (8.8 versus 25 percent in allogeneic HCT recipients, and 8.2 versus 22 percent in autologous HCT recipients).",
"     </li>",
"     <li>",
"      The magnitude of benefit after one year of prophylaxis persisted after drug discontinuation compared to patients treated only through engraftment. Thus, there was no evidence of rebound VZV disease.",
"     </li>",
"     <li>",
"      Continuation of prophylaxis beyond one year in allogeneic HCT recipients who remained on immunosuppressive therapy led to a further significant reduction in VZV disease (4.5 percent) compared to prophylaxis for one year.\",
"     </li>",
"     <li>",
"      Administration of VZV prophylaxis for one year led to a significant improvement in overall survival in both allogeneic and autologous HCT recipients (eg, adjusted hazard ratio 0.8 in allogeneic transplants compared to prophylaxis only through engraftment).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    This study confirms the benefit of VZV prophylaxis for at least one year following HCT in both allogeneic and autologous HCT recipients. We recommend that VZV-seropositive allogeneic and autologous HCT recipients be given an oral prophylaxis regimen of acyclovir 800 twice daily for one year following transplantation and suggest that longer prophylaxis be given to patients requiring ongoing immunosuppression (eg, graft-versus-host disease).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Epstein-Barr virus",
"    </span>",
"    &nbsp;&mdash;&nbsp;Epstein-Barr virus (EBV) reactivation is a frequent event following receipt of HCT and may progress to life-threatening EBV-related posttransplantation lymphoproliferative disorder (PTLD), which is associated with uncontrolled proliferation of B cells [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32666/abstract/51\">",
"     51",
"    </a>",
"    ]. Risk factors for EBV reactivation and subsequent PTLD include the use of unrelated or mismatched family donors, T-cell depletion of stem cell grafts, antithymocyte globulin use, and nonmyeloablative stem cell transplants [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32666/abstract/52\">",
"     52",
"    </a>",
"    ]. Furthermore, interventions that prevent graft-versus-host disease also reduce the rate of T cell reconstitution, a factor that compromises immune surveillance against endogenous viruses [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32666/abstract/53\">",
"     53",
"    </a>",
"    ]. This topic is discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/50/23338?source=see_link\">",
"     \"Treatment and prevention of post-transplant lymphoproliferative disorders\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Since clinical symptoms are often lacking, use of polymerase chain reaction assays has become an important tool for monitoring EBV reactivation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32666/abstract/54\">",
"     54",
"    </a>",
"    ]. Another useful predictor of risk is the absence of EBV-specific memory T cells [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32666/abstract/55\">",
"     55",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Adoptive transfer of EBV-specific cytotoxic T cell responses by infusion of cloned donor T cell lines has been used for the prevention of PTLD in high-risk HCT recipients receiving T cell depleted bone marrow [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32666/abstract/55-57\">",
"     55-57",
"    </a>",
"    ]. Preemptive treatment with CD20 monoclonal antibodies (rituximab) is effective in rapidly reducing levels of proliferating B cells [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32666/abstract/58\">",
"     58",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although acyclovir and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/30/33248?source=see_link\">",
"     ganciclovir",
"    </a>",
"    inhibit Epstein-Barr virus (EBV) replication in vitro, PTLD still arises in patients receiving these drugs [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32666/abstract/59\">",
"     59",
"    </a>",
"    ]. This may be related to the inability of these drugs to limit B cell proliferation once they have acquired an autonomous growth pattern [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32666/abstract/58\">",
"     58",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/30/25066?source=see_link\">",
"     \"Overview of infections following hematopoietic cell transplantation\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/55/14202?source=see_link\">",
"     \"Clinical manifestations and treatment of Epstein-Barr virus infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Other viruses",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is no known form of prophylaxis for adenovirus, respiratory viruses, human herpesvirus (HHV)-6, HHV-7, parvovirus B19, enterovirus, BK, or JC virus.",
"   </p>",
"   <p>",
"    Amantadine has not been evaluated for the prevention of influenza A infection in these patients. Oseltamivir, which has been reported to be effective in preventing influenza infection in multiple outbreak settings, may have efficacy in this population. Experience in the HCT population suggests that oseltamivir is safe and potentially effective when administered for suspected infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32666/abstract/60\">",
"     60",
"    </a>",
"    ]; however, randomized trials have yet to be performed to definitively demonstrate efficacy. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/13/44249?source=see_link\">",
"     \"Prevention of seasonal influenza in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Antifungal prophylaxis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fungal infections are particularly worrisome in HCT recipients and are a frequent cause of transplant-related mortality. These are most commonly due to Candida and Aspergillus species. Treatment of established infections is difficult and prevention is clearly preferred.",
"   </p>",
"   <p>",
"    Several randomized trials of antifungal prophylaxis have been undertaken. They are limited by the relatively low incidence of severe fungal infections, and the difficulty in clearly documenting a fungal etiology. As a result, other end points such as surveillance cultures or colonization have been used, which may not be truly predictive.",
"   </p>",
"   <p>",
"    In randomized trials, fluconazole, itraconazole, posaconazole, and micafungin prevent invasive fungal infections in HCT recipients without causing significant toxicity.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Fluconazole",
"    </span>",
"    &nbsp;&mdash;&nbsp;The efficacy of fluconazole was demonstrated in a randomized trial in which 356 patients were assigned to fluconazole (400",
"    <span class=\"nowrap\">",
"     mg/day)",
"    </span>",
"    or placebo from the start of the conditioning regimen until the absolute neutrophil count was over",
"    <span class=\"nowrap\">",
"     1000/microL",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32666/abstract/61\">",
"     61",
"    </a>",
"    ]. By the end of the treatment period, patients treated with fluconazole had significantly fewer positive fungal cultures in specimens from any site (30 versus 67 percent) and significantly fewer systemic fungal infections (3 versus 16 percent).",
"   </p>",
"   <p>",
"    Similar short-term benefits were noted in a second placebo-controlled trial of 300 patients who were randomly assigned to fluconazole (400",
"    <span class=\"nowrap\">",
"     mg/day)",
"    </span>",
"    or placebo for 75 days after allogeneic HCT [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32666/abstract/62\">",
"     62",
"    </a>",
"    ]. Fluconazole prophylaxis was associated with significant reductions in fungal colonization, systemic fungal infection (7 versus 18 percent), and mortality at 110 days (20 versus 35 percent).",
"   </p>",
"   <p>",
"    The benefits persisted with long-term follow-up [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32666/abstract/63\">",
"     63",
"    </a>",
"    ]. At eight years, the patients treated with fluconazole had significant reductions in the overall incidence of invasive candidiasis (2.6 versus 20.3 percent with placebo), severe acute graft-versus-host disease involving the gut (5.5 versus 14 percent), and overall mortality (55 versus 72 percent).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Itraconazole",
"    </span>",
"    &nbsp;&mdash;&nbsp;Itraconazole was compared to fluconazole in a multicenter randomized trial of 140 patients undergoing allogeneic HCT; prophylaxis was given for 100 days, starting the day after stem cell infusion [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32666/abstract/64\">",
"     64",
"    </a>",
"    ]. Itraconazole was associated with a significantly lower rate of invasive fungal infection at 180 days (9 versus 25 percent, adjusted odds ratio 0.3, 95% CI 0.11-0.81). Overall mortality was similar in both groups (45 versus 42 percent).",
"   </p>",
"   <p>",
"    In an intent-to-treat analysis from another randomized trial of 304 allogeneic HCT recipients, itraconazole was not shown to decrease the incidence of invasive fungal infections (IFI) compared to fluconazole&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32666/abstract/65\">",
"     65",
"    </a>",
"    ]. However, fewer patients in the itraconazole group developed IFI on treatment compared to those in the fluconazole (7 versus 15 percent). Itraconazole was superior to fluconazole in preventing invasive mold infections (12 versus 5 percent compared to fluconazole), but similar in preventing candidiasis. There was no difference in fungal-free survival. Itraconazole was poorly tolerated due to hepatotoxicity and gastrointestinal intolerance.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     Posaconazole",
"    </span>",
"    &nbsp;&mdash;&nbsp;Posaconazole is approved for prevention of invasive Aspergillus and Candida infections in patients undergoing HCT [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32666/abstract/66,67\">",
"     66,67",
"    </a>",
"    ]. The approval was based in part upon a randomized double-blind trial in which 600 allogeneic HCT patients with severe GVHD were assigned to posaconazole (200 mg three times daily) or fluconazole (400 mg once daily) for prophylaxis of invasive fungal infections [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32666/abstract/68\">",
"     68",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    At the end of the 112 day treatment period, posaconazole was associated with an almost significant reduction in all proven and probable invasive fungal infections (5.3 versus 9.0 percent, odds ratio 0.56, 95% CI 0.30-1.07) and a significant reduction in invasive aspergillosis, which accounted for the majority of infections (2.3 versus 7.0 percent, odds ratio 0.31, 95% CI 0.13-0.75).",
"   </p>",
"   <p>",
"    Although there were no significant differences in invasive fungal infections among the study groups, significantly fewer patients receiving posaconazole, developed invasive aspergillosis (2.4 versus 7.6 percent). Mortality from invasive fungal infections was also lower in the posaconazole group (1 versus 4 percent). Treatment-related adverse events were similar in both groups. Posaconazole prophylaxis also produced better outcomes than fluconazole or itraconazole in a randomized trial of neutropenic patients receiving chemotherapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32666/abstract/69\">",
"     69",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h3\">",
"     Micafungin",
"    </span>",
"    &nbsp;&mdash;&nbsp;Micafungin, an echinocandin with activity against Candida and Aspergillus, is approved for prophylaxis of Candida infections in patients undergoing HCT [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32666/abstract/70\">",
"     70",
"    </a>",
"    ]. This approval was based upon a randomized, double-blind, phase III trial, which compared 50 mg daily of micafungin to 400 mg daily of fluconazole for antifungal prophylaxis in 882 patients undergoing HCT [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32666/abstract/71\">",
"     71",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The overall antifungal efficacy of micafungin (absence of suspected, proven, or probable invasive fungal infection through the end of therapy, and the absence of proven or probable invasive fungal infection through the end of the 4-week period after treatment) was significantly better than that of fluconazole during the neutropenic phase after HCT (80 versus 74 percent). There was also trend towards superior efficacy against Aspergillus infections; one probable case was identified in the micafungin arm versus seven cases (four proven and three probable) in the fluconazole arm.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h3\">",
"     Amphotericin B",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several trials have evaluated low-dose intravenous amphotericin B for the prophylaxis of invasive fungal infections in patients undergoing HCT, with conflicting results. In a randomized trial, significantly more patients in the placebo group developed systemic fungal infection within the first 30 days following HCT compared to those receiving low-dose amphotericin B (5 of 18 versus none of 17 patients) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32666/abstract/72\">",
"     72",
"    </a>",
"    ]. Benefit for liposomal low-dose amphotericin B in terms of fewer cases of invasive aspergillosis (but not invasive candidiasis) was also suggested in an open-label trial involving 132 patients with prolonged neutropenia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32666/abstract/73\">",
"     73",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In contrast, two other randomized, placebo-controlled trials showed no reduction in invasive fungal infections in patients who received liposomal amphotericin B&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32666/abstract/74,75\">",
"     74,75",
"    </a>",
"    ]. Thus, the benefit of prophylactic amphotericin B remains uncertain.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h3\">",
"     Meta-analysis",
"    </span>",
"    &nbsp;&mdash;&nbsp;A meta-analysis included 29 randomized trials that compared systemic antifungal prophylaxis (mostly azoles) versus a control arm (placebo, no intervention, or a nonsystemic antifungal agents [eg, clotrimazole]) in HCT recipients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32666/abstract/76\">",
"     76",
"    </a>",
"    ]. In allogeneic HCT recipients, antifungal prophylaxis was associated with significant reductions in all-cause mortality (relative risk [RR] 0.62; 95% CI, 0.45-0.85), fungal-related mortality (RR 0.52; 95% CI, 0.27-0.99), and documented invasive fungal infections (RR 0.33; 95% CI, 0.18-0.63). Significant mortality benefits were also seen in the smaller number of patients with autologous HCT.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h3\">",
"     Limitations to broad antifungal prophylaxis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although these data suggest overall benefit for broad antifungal prophylaxis, there are several drawbacks:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The relatively low incidence of invasive fungal infections in these patients",
"     </li>",
"     <li>",
"      The availability of novel diagnostic serum and radiologic markers that allow earlier and better diagnosis of invasive aspergillosis. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?3/52/3913?source=see_link\">",
"       \"Diagnosis of invasive aspergillosis\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?33/51/34616?source=see_link&amp;anchor=H429431#H429431\">",
"       \"Epidemiology and clinical manifestations of invasive aspergillosis\", section on 'Imaging'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Issues related to toxicity, cost, and development of resistance.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Because of these concerns, we suggest an alternative strategy of prophylaxis for candidiasis and preemptive therapy for Aspergillus.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h3\">",
"     Prophylaxis for candidiasis",
"    </span>",
"    &nbsp;&mdash;&nbsp;With respect to prophylaxis for candidiasis, the choice of therapy depends upon the risk of resistant Candida species:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Among allogeneic HCT recipients who are not suspected to be colonized with resistant Candida spp, such as C. glabrata or C. krusei, we suggest fluconazole (200 to 400 orally once daily), starting the first day of neutropenia and continuing until immunosuppression has resolved and preferably until at least day 100&nbsp;[",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/57/32666/abstract/77\">",
"       77",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Allogeneic HCT recipients with severe GVHD requiring immunosuppressive drugs typically remain on both antibacterial and antifungal prophylaxis until the immunosuppressive drugs are no longer necessary. (See",
"    <a class=\"local\" href=\"#H7\">",
"     'Antibacterial prophylaxis'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    The same approach should be used in high-risk autologous HCT recipients, such as those with multiple myeloma. In contrast, autologous HCT recipients who do not remain at high risk of candidiasis should continue Candida prophylaxis only through engraftment.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Among patients colonized with fluconazole-resistant Candida spp (eg, C. glabrata or C. krusei), an echinocandin, such as caspofungin, micafungin, or anidulafungin, should be considered.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Preemptive therapy for aspergillosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Preemptive therapy for aspergillosis involves targeted screening of high-risk patients for markers of colonization",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    infection in an attempt to prevent invasive infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32666/abstract/78\">",
"     78",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    These tests include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Nasal culture for Aspergillus before transplantation.",
"     </li>",
"     <li>",
"      Measurement of serum Aspergillus galactomannan, which is specific for aspergillosis",
"     </li>",
"     <li>",
"      Measurement of serum beta-D-glucan, which can detect several fungal infections including aspergillosis and candidiasis",
"     </li>",
"     <li>",
"      Aspergillus polymerase chain reaction (PCR) of serum. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?3/52/3913?source=see_link\">",
"       \"Diagnosis of invasive aspergillosis\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    There is no broadly accepted schedule for such testing. Some centers test periodically (eg, twice weekly until engraftment), while others test only when there is concern for infection. We suggest twice weekly serum galactomannan testing in allogeneic HCT recipients who have severe GVHD and in others at increased risk for invasive aspergillosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32666/abstract/79\">",
"     79",
"    </a>",
"    ]. We also suggest serial monitoring of galactomannan among high-risk autologous HCT recipients, such as those with multiple myeloma.",
"   </p>",
"   <p>",
"    Among patients with a positive serum galactomannan or Aspergillus PCR, we recommend obtaining a high-resolution CT scan of the chest and if clinically indicated, a CT scan of the sinuses",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    other potential sites of infection. If a source is not identified, we suggest repeating the serum markers, searching more extensively for the focus of infection, and excluding possible causes of a false-positive galactomannan (eg, piperacillin-tazobactam and amoxicillin-clavulanate). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?3/52/3913?source=see_link\">",
"     \"Diagnosis of invasive aspergillosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/51/34616?source=see_link&amp;anchor=H429431#H429431\">",
"     \"Epidemiology and clinical manifestations of invasive aspergillosis\", section on 'Imaging'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    We recommend prompt initiation of voriconazole if repeat serum testing",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    imaging are consistent with invasive aspergillosis. If a false-positive galactomannan result is excluded, but a source has not been identified, initiation of voriconazole should be strongly considered, especially in the following settings:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Patients at high risk of invasive aspergillosis",
"     </li>",
"     <li>",
"      High galactomannan values",
"     </li>",
"     <li>",
"      A positive galactomannan in combination with a positive beta-D-glucan",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The recommended dosing regimen for voriconazole is 6",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    IV twice a day on day one followed by 4",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    IV twice daily. If the patient is stable and is able to take oral medications, one can consider switching to 200 mg orally twice daily. If voriconazole cannot be given, a lipid formulation of amphotericin B is the preferred alternative. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/18/28970?source=see_link\">",
"     \"Treatment and prevention of invasive aspergillosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Among patients who have previously received preemptive therapy for aspergillosis, such therapy should be reinstituted during subsequent periods of high risk for invasive fungal infections, most often in patients receiving therapy for severe GVHD.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Prophylaxis for aspergillosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;An alternative to preemptive therapy for Aspergillus in conjunction with Candida prophylaxis, is prophylaxis against Aspergillus which will also provide prophylaxis against Candida [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32666/abstract/80\">",
"     80",
"    </a>",
"    ]. Appropriate regimens include posaconazole (200 mg orally three times daily) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32666/abstract/68\">",
"     68",
"    </a>",
"    ] and voriconazole (200 mg orally twice daily) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32666/abstract/81\">",
"     81",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Allogeneic HCT recipients with severe GVHD requiring immunosuppressive drugs typically remain on both antibacterial and antifungal prophylaxis until the immunosuppressive drugs are no longer necessary. (See",
"    <a class=\"local\" href=\"#H7\">",
"     'Antibacterial prophylaxis'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h3\">",
"     Secondary prophylaxis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Secondary prophylaxis involves the administration of prophylactic doses of an antimicrobial in order to prevent recurrent infection. The risk of recrudescence of candidiasis or aspergillosis is high in patients with previous episodes of these fungal infections who undergo HCT or intensive chemotherapy; as a result, secondary prophylaxis is indicated in such patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32666/abstract/82-85\">",
"     82-85",
"    </a>",
"    ]. Both amphotericin B and its lipid formulations and itraconazole may be effective in such patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32666/abstract/82-84,86\">",
"     82-84,86",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Surgical resection of residual infected sites may also be indicated to reduce the likelihood of relapse and the risk of serious hemoptysis in patients with cavitary aspergillosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32666/abstract/87\">",
"     87",
"    </a>",
"    ]. Other potential strategies include: improvement in neutropenia with granulocyte transfusions (following stimulation with granulocyte colony-stimulating factors); intensive monitoring for signs of Aspergillus with computed tomography (CT scan) and Aspergillus antigenemia or PCR; and improvement of host defenses with the administration of cytokines.",
"   </p>",
"   <p>",
"    Patients who have survived an episode of invasive aspergillosis related to an illness associated with permanent immunosuppression should also receive long-term suppressive therapy with an Aspergillus-active antifungal agent such as voriconazole (200 mg orally twice daily), posaconazole (200 mg orally three times daily), itraconazole (200 mg orally twice daily), or an amphotericin B preparation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32666/abstract/88\">",
"     88",
"    </a>",
"    ]. Secondary prophylaxis can be stopped when immunosuppression is no longer present.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h3\">",
"     Breakthrough fungal infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fluconazole prophylaxis is associated with a low risk of breakthrough infections with fluconazole-resistant strains (eg, C. glabrata and C. krusei) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32666/abstract/89\">",
"     89",
"    </a>",
"    ]. Whether the same risk exists with the mold-active azoles (itraconazole, voriconazole, and posaconazole) remains to be determined, although voriconazole and posaconazole have activity against C. krusei.",
"   </p>",
"   <p>",
"    A potential problem with prophylaxis with voriconazole (a potent broad-spectrum antifungal agent that lacks activity against zygomycetes) is emergence of breakthrough zygomycosis (mucormycosis) and other rare fungi [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32666/abstract/90-94\">",
"     90-94",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The largest series evaluated 139 HCT recipients in Seattle who were treated with voriconazole between 1998 and 2003 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32666/abstract/90\">",
"     90",
"    </a>",
"    ]. The following findings were noted:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A breakthrough fungal infection developed in 13 (9.4 percent), mostly Zygomycetes (mucor) and C. glabrata. Less common organisms were non-fumigatus Aspergillus, Scedosporium prolificans, or Acremonium species. The voriconazole MIC was &ge;1",
"      <span class=\"nowrap\">",
"       microgram/mL",
"      </span>",
"      for all isolates (range 1 to 32",
"      <span class=\"nowrap\">",
"       mcg/mL).",
"      </span>",
"     </li>",
"     <li>",
"      The time of breakthrough infection after transplantation ranged from 11 to 949 days (median 180 days). The duration of voriconazole exposure before breakthrough ranged from 4 to 110 days. Three cases occurred within the first week of voriconazole therapy, suggesting a major role for underlying immunosuppression.",
"     </li>",
"     <li>",
"      All but three patients with breakthrough infection had severe acute or chronic graft-versus-host disease (GVHD). The latter finding is consistent with previous observations that zygomycosis after HCT is typically associated with GVHD, rather than neutropenia.",
"     </li>",
"     <li>",
"      At the time of breakthrough infection, voriconazole was being given for proven or probable invasive aspergillosis in eight, proven fusariosis in one, refractory fever in two, and prophylaxis because of perceived high risk in two.",
"     </li>",
"     <li>",
"      Despite therapy of the breakthrough infection with a lipid formulation of amphotericin B, nine patients died of progressive fungal infection or alternative infections.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These data suggest that host variables (severe immunosuppression and disruption of anatomical barriers) allow the development of zygomycosis in patients who are now living longer because of aspergillus-active antifungal agents (such as voriconazole and itraconazole). This is further supported by the findings of a randomized controlled trial of voriconazole versus fluconazole prophylaxis in allogeneic HCT in which no increase in breakthrough zygomycosis was observed with voriconazole [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32666/abstract/81\">",
"     81",
"    </a>",
"    ]. Increasing zygomycosis was also seen prior to the introduction of voriconazole [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32666/abstract/95\">",
"     95",
"    </a>",
"    ] at the same center from which emergence of zygomycosis as a result of voriconazole exposure was later reported [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32666/abstract/92\">",
"     92",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h2\">",
"     Pneumocystis carinii (jirovecii) prophylaxis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Among allogeneic HCT recipients, it is generally recommended that prophylaxis against Pneumocystis jirovecii (formerly P. carinii) pneumonia (PCP) be started after engraftment and continued for as long as immunosuppressive therapy is given and the CD4 cell count is &lt;200",
"    <span class=\"nowrap\">",
"     cells/microL.",
"    </span>",
"    Early discontinuation of PCP prophylaxis in allogeneic HCT recipients has been associated with PCP [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32666/abstract/96\">",
"     96",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Among autologous HCT recipients, PCP prophylaxis should be considered for those with underlying hematologic malignancies such as lymphoma, myeloma, or leukemia, those receiving intense conditioning regimens, those with graft manipulations (eg, CD34 selection), and those who have recently received purine analogs.",
"   </p>",
"   <p>",
"    Regimens for PCP prophylaxis are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?9/4/9289?source=see_link&amp;anchor=H15#H15\">",
"     \"Treatment and prevention of Pneumocystis pneumonia in non-HIV-infected patients\", section on 'Hematopoietic stem cell transplant recipients'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?9/4/9289?source=see_link&amp;anchor=H14#H14\">",
"     \"Treatment and prevention of Pneumocystis pneumonia in non-HIV-infected patients\", section on 'Regimens'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h2\">",
"     Toxoplasma gondii prophylaxis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Toxoplasmosis is an uncommon but often fatal opportunistic parasitic infection that can occur in HCT recipients, particularly in endemic areas. Approximately 150 cases have been reported in HCT recipients worldwide [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32666/abstract/97\">",
"     97",
"    </a>",
"    ], while a 20-year study of 2000 HCT recipients in North America identified only 12 cases of toxoplasmosis, ten of which were diagnosed at autopsy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32666/abstract/98\">",
"     98",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In highly endemic areas, chemoprophylaxis for toxoplasmosis after engraftment may be helpful in seropositive patients. A study from France evaluated the efficacy of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?22/51/23350?source=see_link\">",
"     pyrimethamine",
"    </a>",
"    sulfadoxine (Fansidar) given for two to six months following transplantation in 69 seropositive bone marrow recipients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32666/abstract/99\">",
"     99",
"    </a>",
"    ]. There were no proven cases of toxoplasmosis but 12 patients developed bone marrow suppression that required either the cessation or interruption of therapy.",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/43/33456?source=see_link\">",
"     Azithromycin",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/21/33104?source=see_link\">",
"     clindamycin",
"    </a>",
"    are effective in experimental toxoplasmosis and better tolerated than Fansidar.",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?4/58/5034?source=see_link\">",
"     Trimethoprim-sulfamethoxazole",
"    </a>",
"    is also effective [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32666/abstract/100\">",
"     100",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Since the disease mostly reflects reactivation of latent infection, it is advisable to determine the toxoplasma serologic status of all patients undergoing transplantation. Screening seropositive patients with PCR-based tests following transplantation is recommended, with initiation of preemptive therapy in high-risk patients (especially matched unrelated donor recipients) who have positive PCR assays.",
"   </p>",
"   <p>",
"    The utility of this approach was demonstrated in a prospective European multicenter study of 106 seropositive Toxoplasma HCT recipients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32666/abstract/100\">",
"     100",
"    </a>",
"    ]. Patients were monitored prospectively with a real-time quantitative PCR assay at baseline and then weekly for the first 100 days and once every two weeks until day 180 after transplantation. Approximately one-half of the patients received",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?4/58/5034?source=see_link\">",
"     trimethoprim-sulfamethoxazole",
"    </a>",
"    (TMP-SMX) for Toxoplasma prophylaxis.",
"   </p>",
"   <p>",
"    During the first six months, 16 patients developed Toxoplasma infection (15 percent), as defined by a positive PCR result in peripheral blood specimens; 14 had not received TMP-SMX prophylaxis. Invasive disease occurred in six of these patients, but in none of those with negative PCR tests. The onset of invasive disease was usually preceded by a PCR-detected increase in the parasite load in peripheral blood samples.",
"   </p>",
"   <p>",
"    Limitations to these uncontrolled observations are that real-time PCR tests are not commercially available and their utility in guiding preemptive therapy is unproven [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32666/abstract/97\">",
"     97",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h2\">",
"     Anti-mycobacterial prophylaxis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Prophylaxis of mycobacterial infection in HCT recipients should be reserved for patients identified as high-risk during the pretransplant evaluation. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?19/32/19974?source=see_link\">",
"     \"Evaluation for infection before hematopoietic cell transplantation\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/21/40279?source=see_link\">",
"     Isoniazid",
"    </a>",
"    prophylaxis, starting before transplantation and continuing during the transplant period has been suggested. However, the efficacy of this approach has not been evaluated and the appropriate duration of such treatment is unknown [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32666/abstract/101,102\">",
"     101,102",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32\">",
"    <span class=\"h1\">",
"     OTHER APPROACHES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other strategies have been employed to reduce the risk of infection in HCT recipients.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H33\">",
"    <span class=\"h2\">",
"     Blood product screening",
"    </span>",
"    &nbsp;&mdash;&nbsp;The use of seronegative or properly filtered blood products to reduce the number of leukocytes present significantly reduces the risk of CMV infections in CMV seronegative bone marrow recipients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32666/abstract/103\">",
"     103",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/5/24665?source=see_link&amp;anchor=H11#H11\">",
"     \"Leukoreduction to prevent complications of blood transfusion\", section on 'Viral diseases'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H34\">",
"    <span class=\"h2\">",
"     Immunomodulation with hematopoietic growth factors and cytokines",
"    </span>",
"    &nbsp;&mdash;&nbsp;Various cytokines have been used to improve the host's immune defenses. These agents include: granulocyte colony stimulating factor (G-CSF),",
"    <span class=\"nowrap\">",
"     granulocyte/macrophage",
"    </span>",
"    colony stimulating factor (GM-CSF), macrophage colony stimulating factor (M-CSF), and interferon-gamma (",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?19/53/20308?source=see_link\">",
"     interferon gamma-1b",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H35\">",
"    <span class=\"h3\">",
"     Use in the prevention of bacterial or fungal infections",
"    </span>",
"    &nbsp;&mdash;&nbsp;Some studies have confirmed the efficacy of G-CSF in decreasing the incidence of fever, and others have demonstrated a reduction in the duration of antibiotic therapy and hospitalization [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32666/abstract/104\">",
"     104",
"    </a>",
"    ]. However, a significant effect on survival has never been shown [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32666/abstract/105-108\">",
"     105-108",
"    </a>",
"    ]. There are no controlled data to date to support the routine use of these colony stimulating factors (CSFs) for the prevention of fungal infections in cancer patients. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/54/34664?source=see_link\">",
"     \"Hematopoietic support after hematopoietic cell transplantation\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The use of interferon-gamma (IFN-gamma) for antifungal prophylaxis is based on the observation that IFN-gamma in vitro improves the abnormal function of corticosteroid-treated neutrophils and enhances neutrophil-mediated antifungal activity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32666/abstract/109\">",
"     109",
"    </a>",
"    ]. In addition, IFN-gamma in vitro can prime neutrophils antifungal activity against Aspergillus fumigatus and other opportunistic fungal pathogens [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32666/abstract/110\">",
"     110",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    As a result of these observations, there is interest in evaluating IFN-gamma (",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?19/53/20308?source=see_link\">",
"     Interferon gamma-1b",
"    </a>",
"    ) as an adjunctive therapeutic modality in HCT recipients with fungal and other infections. However, no clinical trial has yet been performed. Potential concerns about the use of IFN-gamma in this setting are that it can cause neutropenia and may have a role in the pathogenesis of GVHD.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H36\">",
"    <span class=\"h3\">",
"     Use as stimulating agents for granulocyte transfusions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Another potential role for CSFs is as stimulating agents for the production of granulocytes in healthy donors. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?4/18/4393?source=see_link\">",
"     \"Granulocyte transfusions\"",
"    </a>",
"    .) Transfusion of granulocytes from healthy donors pretreated with CSFs is a promising treatment modality [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32666/abstract/111\">",
"     111",
"    </a>",
"    ]. HCT recipients with prior mold infections would appear to be an important group of patients in whom to study CSF-stimulated donor granulocyte transfusions in an effort to prevent recrudescence of the fungal infection during the phase of severe immunosuppression.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H37\">",
"    <span class=\"h2\">",
"     Immunoglobulins",
"    </span>",
"    &nbsp;&mdash;&nbsp;Use of intravenous immunoglobulin (IVIG) can reduce the incidence of a variety of infectious complications following allogeneic HCT when given during the first three months posttransplantation but not when given from day 90 to day 360 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32666/abstract/112,113\">",
"     112,113",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The potential benefit of this approach was illustrated in a randomized trial of 382 allogeneic HCT recipients in the late 1980s who were given IVIG (500",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    weekly to day 90, then monthly to day 360) or no IVIG [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32666/abstract/112\">",
"     112",
"    </a>",
"    ]. Compared to the controls, patients who received IVIG had:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A lower incidence of acute graft-versus-host disease (34 versus 51 percent) in patients over 20 years of age",
"     </li>",
"     <li>",
"      Significantly lower incidence of interstitial pneumonia (13 versus 22 percent) among CMV seropositive patients",
"     </li>",
"     <li>",
"      Reduced risk of gram-negative septicemia (relative risk 0.38) and local infections",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    However, neither survival nor the risk of relapse was altered by IVIG. Furthermore, the significant advances made over the past three decades in diagnosis and therapy of infections caused by CMV and gram-negative infections suggest that the protection now provided by IVIG against infection is likely to be limited.",
"   </p>",
"   <p>",
"    A separate randomized trial of 250 patients conducted by the same group evaluated the effects of IVIG (500",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per month) when given between days 90 and 360 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32666/abstract/113\">",
"     113",
"    </a>",
"    ]. There was no beneficial effect on the incidence of bacteremia or septicemia, localized infection, or obliterative bronchiolitis, or on overall survival or the incidence or mortality of chronic GVHD.",
"   </p>",
"   <p>",
"    The usual prophylactic dose is 100",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    IV weekly between days 7 and 100 or as long as chronic GVHD persists. IVIG is not indicated beyond one year because of marginal benefit (decrease in soft tissue infections) and an increase in immunosuppression (decrease in IgG1 and IgA levels), leading to a higher incidence of infections in the following year.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H38\">",
"    <span class=\"h3\">",
"     Use in the prophylaxis of CMV infections",
"    </span>",
"    &nbsp;&mdash;&nbsp;IVIG and CMV-specific immunoglobulin are not effective alone as CMV prophylaxis in HCT recipients. Anti-CMV hyperimmune globulin prevented CMV infection among CMV-seronegative HCT recipients in one study [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32666/abstract/114\">",
"     114",
"    </a>",
"    ], but not in others [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32666/abstract/115\">",
"     115",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H39\">",
"    <span class=\"h3\">",
"     Use in the prophylaxis of VZV infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is no evidence that passive antibody prophylaxis will reduce the risk of VZV reactivation after HCT in patients who have serologic evidence of prior VZV infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32666/abstract/116\">",
"     116",
"    </a>",
"    ]. However, early administration of varicella zoster immune globulin (VZIG) as postexposure prophylaxis may have a significant role in the prophylaxis of infection among high-risk seronegative patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/57/32666/abstract/117\">",
"     117",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    VZIG is no longer manufactured in the United States but is available under an investigational new drug application expanded access protocol.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H40\">",
"    <span class=\"h3\">",
"     Other use",
"    </span>",
"    &nbsp;&mdash;&nbsp;Prophylaxis of respiratory syncytial virus (RSV) infection with RSV-enriched immune globulin has not been tested in patients with hematologic malignancies and should not be used routinely in this setting. Passive immunization is indicated in susceptible patients exposed to hepatitis A, hepatitis B, or measles viruses.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H41\">",
"    <span class=\"h2\">",
"     Vaccination",
"    </span>",
"    &nbsp;&mdash;&nbsp;HCT is associated with loss of specific antibody and defective B cell and T cell functions. Vaccination of HCT recipients following transplantation is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/57/25498?source=see_link\">",
"     \"Immunizations after hematopoietic cell transplantation\"",
"    </a>",
"    .)",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     file://www.idsociety.org/Content.aspx?id=9088 (Accessed on February 26, 2008).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32666/abstract/2\">",
"      Lum LG. The kinetics of immune reconstitution after human marrow transplantation. Blood 1987; 69:369.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32666/abstract/3\">",
"      Shenoy S, Mohanakumar T, Todd G, et al. Immune reconstitution following allogeneic peripheral blood stem cell transplants. Bone Marrow Transplant 1999; 23:335.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32666/abstract/4\">",
"      Goulmy E, Schipper R, Pool J, et al. Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation. N Engl J Med 1996; 334:281.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32666/abstract/5\">",
"      Aversa F, Tabilio A, Velardi A, et al. Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype. N Engl J Med 1998; 339:1186.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32666/abstract/6\">",
"      Haddad E, Landais P, Friedrich W, et al. Long-term immune reconstitution and outcome after HLA-nonidentical T-cell-depleted bone marrow transplantation for severe combined immunodeficiency: a European retrospective study of 116 patients. Blood 1998; 91:3646.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32666/abstract/7\">",
"      Devine SM, Geller RB, Lin LB, et al. The outcome of unrelated donor bone marrow transplantation in patients with hematologic malignancies using tacrolimus (FK506) and low dose methotrexate for graft-versus-host disease prophylaxis. Biol Blood Marrow Transplant 1997; 3:25.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32666/abstract/8\">",
"      Loo VG, Bertrand C, Dixon C, et al. Control of construction-associated nosocomial aspergillosis in an antiquated hematology unit. Infect Control Hosp Epidemiol 1996; 17:360.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32666/abstract/9\">",
"      Anaissie EJ, Stratton SL, Dignani MC, et al. Pathogenic molds (including Aspergillus species) in hospital water distribution systems: a 3-year prospective study and clinical implications for patients with hematologic malignancies. Blood 2003; 101:2542.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32666/abstract/10\">",
"      Petersen F, Thornquist M, Buckner C, et al. The effects of infection prevention regimens on early infectious complications in marrow transplant patients: a four arm randomized study. Infection 1988; 16:199.",
"     </a>",
"    </li>",
"    <li>",
"     Anaissie, E. Emerging fungal infections: Don't drink the water. In: Interscience Conference of Antimicrobial agents and Chemotherapy; 1998 September 24-27, 1998; San-Diego, California.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32666/abstract/12\">",
"      Martin MA, Reichelderfer M. APIC guidelines for infection prevention and control in flexible endoscopy. Association for Professionals in Infection Control and Epidemiology, Inc. 1991, 1992, and 1993 APIC Guidelines Committee. Am J Infect Control 1994; 22:19.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32666/abstract/13\">",
"      Lew MA, Kehoe K, Ritz J, et al. Ciprofloxacin versus trimethoprim/sulfamethoxazole for prophylaxis of bacterial infections in bone marrow transplant recipients: a randomized, controlled trial. J Clin Oncol 1995; 13:239.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32666/abstract/14\">",
"      Classen DC, Burke JP, Ford CD, et al. Streptococcus mitis sepsis in bone marrow transplant patients receiving oral antimicrobial prophylaxis. Am J Med 1990; 89:441.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32666/abstract/15\">",
"      Broun ER, Wheat JL, Kneebone PH, et al. Randomized trial of the addition of gram-positive prophylaxis to standard antimicrobial prophylaxis for patients undergoing autologous bone marrow transplantation. Antimicrob Agents Chemother 1994; 38:576.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32666/abstract/16\">",
"      Arns da Cunha C, Weisdorf D, Shu XO, et al. Early gram-positive bacteremia in BMT recipients: impact of three different approaches to antimicrobial prophylaxis. Bone Marrow Transplant 1998; 21:173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32666/abstract/17\">",
"      Attal M, Schlaifer D, Rubie H, et al. Prevention of gram-positive infections after bone marrow transplantation by systemic vancomycin: a prospective, randomized trial. J Clin Oncol 1991; 9:865.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32666/abstract/18\">",
"      Barb&eacute; G, Ploton C, Pondarr&eacute; C, et al. [Vancomycin-resistant enterococci in pediatric hematology: don't panic!]. Pathol Biol (Paris) 1998; 46:408.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32666/abstract/19\">",
"      Schmeiser T, Kern WV, Hay B, et al. Single-drug oral antibacterial prophylaxis with ofloxacin in BMT recipients. Bone Marrow Transplant 1993; 12:57.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32666/abstract/20\">",
"      Roy V, Ochs L, Weisdorf D. Late infections following allogeneic bone marrow transplantation: suggested strategies for prophylaxis. Leuk Lymphoma 1997; 26:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32666/abstract/21\">",
"      Angarone M, Ison MG. Prevention and early treatment of opportunistic viral infections in patients with leukemia and allogeneic stem cell transplantation recipients. J Natl Compr Canc Netw 2008; 6:191.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32666/abstract/22\">",
"      Meyers JD. Chemoprophylaxis of viral infection in immunocompromised patients. Eur J Cancer Clin Oncol 1989; 25:1369.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32666/abstract/23\">",
"      Erard V, Wald A, Corey L, et al. Use of long-term suppressive acyclovir after hematopoietic stem-cell transplantation: impact on herpes simplex virus (HSV) disease and drug-resistant HSV disease. J Infect Dis 2007; 196:266.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32666/abstract/24\">",
"      Segal BH, Freifeld AG, Baden LR, et al. Prevention and treatment of cancer-related infections. J Natl Compr Canc Netw 2008; 6:122.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32666/abstract/25\">",
"      Goodrich JM, Bowden RA, Fisher L, et al. Ganciclovir prophylaxis to prevent cytomegalovirus disease after allogeneic marrow transplant. Ann Intern Med 1993; 118:173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32666/abstract/26\">",
"      Winston DJ, Ho WG, Bartoni K, et al. Ganciclovir prophylaxis of cytomegalovirus infection and disease in allogeneic bone marrow transplant recipients. Results of a placebo-controlled, double-blind trial. Ann Intern Med 1993; 118:179.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32666/abstract/27\">",
"      Reusser P, Gambertoglio JG, Lilleby K, Meyers JD. Phase I-II trial of foscarnet for prevention of cytomegalovirus infection in autologous and allogeneic marrow transplant recipients. J Infect Dis 1992; 166:473.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32666/abstract/28\">",
"      Meyers JD, Reed EC, Shepp DH, et al. Acyclovir for prevention of cytomegalovirus infection and disease after allogeneic marrow transplantation. N Engl J Med 1988; 318:70.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32666/abstract/29\">",
"      Prentice HG, Gluckman E, Powles RL, et al. Impact of long-term acyclovir on cytomegalovirus infection and survival after allogeneic bone marrow transplantation. European Acyclovir for CMV Prophylaxis Study Group. Lancet 1994; 343:749.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32666/abstract/30\">",
"      Prentice HG, Gluckman E, Powles RL, et al. Long-term survival in allogeneic bone marrow transplant recipients following acyclovir prophylaxis for CMV infection. The European Acyclovir for CMV Prophylaxis Study Group. Bone Marrow Transplant 1997; 19:129.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32666/abstract/31\">",
"      Winston DJ, Yeager AM, Chandrasekar PH, et al. Randomized comparison of oral valacyclovir and intravenous ganciclovir for prevention of cytomegalovirus disease after allogeneic bone marrow transplantation. Clin Infect Dis 2003; 36:749.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32666/abstract/32\">",
"      Ljungman P, de La Camara R, Milpied N, et al. Randomized study of valacyclovir as prophylaxis against cytomegalovirus reactivation in recipients of allogeneic bone marrow transplants. Blood 2002; 99:3050.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32666/abstract/33\">",
"      Winston DJ, Young JA, Pullarkat V, et al. Maribavir prophylaxis for prevention of cytomegalovirus infection in allogeneic stem cell transplant recipients: a multicenter, randomized, double-blind, placebo-controlled, dose-ranging study. Blood 2008; 111:5403.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32666/abstract/34\">",
"      Zaia JA, Gallez-Hawkins GM, Tegtmeier BR, et al. Late cytomegalovirus disease in marrow transplantation is predicted by virus load in plasma. J Infect Dis 1997; 176:782.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32666/abstract/35\">",
"      Broers AE, van Der Holt R, van Esser JW, et al. Increased transplant-related morbidity and mortality in CMV-seropositive patients despite highly effective prevention of CMV disease after allogeneic T-cell-depleted stem cell transplantation. Blood 2000; 95:2240.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32666/abstract/36\">",
"      Goodrich JM, Mori M, Gleaves CA, et al. Early treatment with ganciclovir to prevent cytomegalovirus disease after allogeneic bone marrow transplantation. N Engl J Med 1991; 325:1601.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32666/abstract/37\">",
"      Boeckh M, Gooley TA, Myerson D, et al. Cytomegalovirus pp65 antigenemia-guided early treatment with ganciclovir versus ganciclovir at engraftment after allogeneic marrow transplantation: a randomized double-blind study. Blood 1996; 88:4063.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32666/abstract/38\">",
"      Einsele H, Ehninger G, Hebart H, et al. Polymerase chain reaction monitoring reduces the incidence of cytomegalovirus disease and the duration and side effects of antiviral therapy after bone marrow transplantation. Blood 1995; 86:2815.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32666/abstract/39\">",
"      Emery VC, Sabin CA, Cope AV, et al. Application of viral-load kinetics to identify patients who develop cytomegalovirus disease after transplantation. Lancet 2000; 355:2032.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32666/abstract/40\">",
"      Boeckh M, Huang M, Ferrenberg J, et al. Optimization of quantitative detection of cytomegalovirus DNA in plasma by real-time PCR. J Clin Microbiol 2004; 42:1142.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32666/abstract/41\">",
"      Reusser P, Einsele H, Lee J, et al. Randomized multicenter trial of foscarnet versus ganciclovir for preemptive therapy of cytomegalovirus infection after allogeneic stem cell transplantation. Blood 2002; 99:1159.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32666/abstract/42\">",
"      Ljungman P, Deliliers GL, Platzbecker U, et al. Cidofovir for cytomegalovirus infection and disease in allogeneic stem cell transplant recipients. The Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Blood 2001; 97:388.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32666/abstract/43\">",
"      Mattes FM, Hainsworth EG, Geretti AM, et al. A randomized, controlled trial comparing ganciclovir to ganciclovir plus foscarnet (each at half dose) for preemptive therapy of cytomegalovirus infection in transplant recipients. J Infect Dis 2004; 189:1355.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32666/abstract/44\">",
"      Pescovitz MD, Rabkin J, Merion RM, et al. Valganciclovir results in improved oral absorption of ganciclovir in liver transplant recipients. Antimicrob Agents Chemother 2000; 44:2811.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32666/abstract/45\">",
"      Einsele H, Reusser P, Bornh&auml;user M, et al. Oral valganciclovir leads to higher exposure to ganciclovir than intravenous ganciclovir in patients following allogeneic stem cell transplantation. Blood 2006; 107:3002.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32666/abstract/46\">",
"      Nichols WG, Corey L, Gooley T, et al. Rising pp65 antigenemia during preemptive anticytomegalovirus therapy after allogeneic hematopoietic stem cell transplantation: risk factors, correlation with DNA load, and outcomes. Blood 2001; 97:867.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32666/abstract/47\">",
"      Springer KL, Chou S, Li S, et al. How evolution of mutations conferring drug resistance affects viral dynamics and clinical outcomes of cytomegalovirus-infected hematopoietic cell transplant recipients. J Clin Microbiol 2005; 43:208.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32666/abstract/48\">",
"      Boeckh M, Kim HW, Flowers ME, et al. Long-term acyclovir for prevention of varicella zoster virus disease after allogeneic hematopoietic cell transplantation--a randomized double-blind placebo-controlled study. Blood 2006; 107:1800.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32666/abstract/49\">",
"      Selby PJ, Powles RL, Easton D, et al. The prophylactic role of intravenous and long-term oral acyclovir after allogeneic bone marrow transplantation. Br J Cancer 1989; 59:434.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32666/abstract/50\">",
"      Erard V, Guthrie KA, Varley C, et al. One-year acyclovir prophylaxis for preventing varicella-zoster virus disease after hematopoietic cell transplantation: no evidence of rebound varicella-zoster virus disease after drug discontinuation. Blood 2007; 110:3071.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32666/abstract/51\">",
"      Shapiro RS, McClain K, Frizzera G, et al. Epstein-Barr virus associated B cell lymphoproliferative disorders following bone marrow transplantation. Blood 1988; 71:1234.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32666/abstract/52\">",
"      Gottschalk S, Rooney CM, Heslop HE. Post-transplant lymphoproliferative disorders. Annu Rev Med 2005; 56:29.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32666/abstract/53\">",
"      Bitan M. Paving the way toward a better understanding of viral T cell interactions after stem cell transplantation. Clin Infect Dis 2006; 42:1749.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32666/abstract/54\">",
"      Lankester AC, van Tol MJ, Vossen JM, et al. Epstein-Barr virus (EBV)-DNA quantification in pediatric allogenic stem cell recipients: prediction of EBV-associated lymphoproliferative disease. Blood 2002; 99:2630.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32666/abstract/55\">",
"      Annels NE, Kalpoe JS, Bredius RG, et al. Management of Epstein-Barr virus (EBV) reactivation after allogeneic stem cell transplantation by simultaneous analysis of EBV DNA load and EBV-specific T cell reconstitution. Clin Infect Dis 2006; 42:1743.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32666/abstract/56\">",
"      Rooney CM, Smith CA, Ng CY, et al. Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation. Lancet 1995; 345:9.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32666/abstract/57\">",
"      Papadopoulos EB, Ladanyi M, Emanuel D, et al. Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation. N Engl J Med 1994; 330:1185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32666/abstract/58\">",
"      van Esser JW, Niesters HG, van der Holt B, et al. Prevention of Epstein-Barr virus-lymphoproliferative disease by molecular monitoring and preemptive rituximab in high-risk patients after allogeneic stem cell transplantation. Blood 2002; 99:4364.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32666/abstract/59\">",
"      Filipovich AH, Mathur A, Kamat D, et al. Lymphoproliferative disorders and other tumors complicating immunodeficiencies. Immunodeficiency 1994; 5:91.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32666/abstract/60\">",
"      Machado CM, Boas LS, Mendes AV, et al. Use of Oseltamivir to control influenza complications after bone marrow transplantation. Bone Marrow Transplant 2004; 34:111.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32666/abstract/61\">",
"      Goodman JL, Winston DJ, Greenfield RA, et al. A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. N Engl J Med 1992; 326:845.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32666/abstract/62\">",
"      Slavin MA, Osborne B, Adams R, et al. Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation--a prospective, randomized, double-blind study. J Infect Dis 1995; 171:1545.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32666/abstract/63\">",
"      Marr KA, Seidel K, Slavin MA, et al. Prolonged fluconazole prophylaxis is associated with persistent protection against candidiasis-related death in allogeneic marrow transplant recipients: long-term follow-up of a randomized, placebo-controlled trial. Blood 2000; 96:2055.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32666/abstract/64\">",
"      Winston DJ, Maziarz RT, Chandrasekar PH, et al. Intravenous and oral itraconazole versus intravenous and oral fluconazole for long-term antifungal prophylaxis in allogeneic hematopoietic stem-cell transplant recipients. A multicenter, randomized trial. Ann Intern Med 2003; 138:705.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32666/abstract/65\">",
"      Marr KA, Crippa F, Leisenring W, et al. Itraconazole versus fluconazole for prevention of fungal infections in patients receiving allogeneic stem cell transplants. Blood 2004; 103:1527.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32666/abstract/66\">",
"      Schering-Plough's Noxafil clears Food and Drug Administration for Aspergillus prophylaxis. \"The Pink Sheet\" 2006; 68:19.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32666/abstract/67\">",
"      Posaconazole (Noxafil) for invasive fungal infections. Med Lett Drugs Ther 2006; 48:93.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32666/abstract/68\">",
"      Ullmann AJ, Lipton JH, Vesole DH, et al. Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease. N Engl J Med 2007; 356:335.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32666/abstract/69\">",
"      Cornely OA, Maertens J, Winston DJ, et al. Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia. N Engl J Med 2007; 356:348.",
"     </a>",
"    </li>",
"    <li>",
"     \"The Pink Sheet\" 2005; 67:14.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32666/abstract/71\">",
"      van Burik JA, Ratanatharathorn V, Stepan DE, et al. Micafungin versus fluconazole for prophylaxis against invasive fungal infections during neutropenia in patients undergoing hematopoietic stem cell transplantation. Clin Infect Dis 2004; 39:1407.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32666/abstract/72\">",
"      Riley DK, Pavia AT, Beatty PG, et al. The prophylactic use of low-dose amphotericin B in bone marrow transplant patients. Am J Med 1994; 97:509.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32666/abstract/73\">",
"      Penack O, Schwartz S, Martus P, et al. Low-dose liposomal amphotericin B in the prevention of invasive fungal infections in patients with prolonged neutropenia: results from a randomized, single-center trial. Ann Oncol 2006; 17:1306.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32666/abstract/74\">",
"      Tollemar J, Ringd&eacute;n O, Andersson S, et al. Randomized double-blind study of liposomal amphotericin B (Ambisome) prophylaxis of invasive fungal infections in bone marrow transplant recipients. Bone Marrow Transplant 1993; 12:577.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32666/abstract/75\">",
"      Kelsey SM, Goldman JM, McCann S, et al. Liposomal amphotericin (AmBisome) in the prophylaxis of fungal infections in neutropenic patients: a randomised, double-blind, placebo-controlled study. Bone Marrow Transplant 1999; 23:163.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32666/abstract/76\">",
"      Robenshtok E, Gafter-Gvili A, Goldberg E, et al. Antifungal prophylaxis in cancer patients after chemotherapy or hematopoietic stem-cell transplantation: systematic review and meta-analysis. J Clin Oncol 2007; 25:5471.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32666/abstract/77\">",
"      Uzun O, Anaissie EJ. Antifungal prophylaxis in patients with hematologic malignancies: a reappraisal. Blood 1995; 86:2063.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32666/abstract/78\">",
"      Maertens J, Buv&eacute; K, Anaissie E. Broad-spectrum antifungal prophylaxis in patients with cancer at high risk for invasive mold infections: counterpoint. J Natl Compr Canc Netw 2008; 6:183.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32666/abstract/79\">",
"      Maertens JA, Klont R, Masson C, et al. Optimization of the cutoff value for the Aspergillus double-sandwich enzyme immunoassay. Clin Infect Dis 2007; 44:1329.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32666/abstract/80\">",
"      Gonzalez AV, Ullmann AJ, Almyroudis NG, Segal BH. Broad-spectrum antifungal prophylaxis in patients with cancer at high risk for invasive mold infections: point. J Natl Compr Canc Netw 2008; 6:175.",
"     </a>",
"    </li>",
"    <li>",
"     Wingard, JR, Carter, SL, Walsh, TJ. Results of a randomized, double-blind trial of fluconazole (flu) vs. voriconazole (vori) for the prevention of invasive fungal infections (IFI) in 600 allogeneic blood and marrow transplant (BMT) patients, Abstract: Oral Session. American Society of Hematology 2007, Atlanta Dec 2007.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32666/abstract/82\">",
"      Bjerke JW, Meyers JD, Bowden RA. Hepatosplenic candidiasis--a contraindication to marrow transplantation? Blood 1994; 84:2811.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32666/abstract/83\">",
"      Offner F, Cordonnier C, Ljungman P, et al. Impact of previous aspergillosis on the outcome of bone marrow transplantation. Clin Infect Dis 1998; 26:1098.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32666/abstract/84\">",
"      Karp JE, Burch PA, Merz WG. An approach to intensive antileukemia therapy in patients with previous invasive aspergillosis. Am J Med 1988; 85:203.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32666/abstract/85\">",
"      Sipsas NV, Kontoyiannis DP. Clinical issues regarding relapsing aspergillosis and the efficacy of secondary antifungal prophylaxis in patients with hematological malignancies. Clin Infect Dis 2006; 42:1584.",
"     </a>",
"    </li>",
"    <li>",
"     Lange, T, Wolff, D, Skibbe, T, et al. Successful bone marrow/stem cell transplantation in patients with previous Aspergillus infection and present signs of residual disease. In: 25th Annual Meeting European group for Blood and Marrow Transplantation and 15th Meeting of the Nurses group. March 10, 1999. Hamburg, Germany.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32666/abstract/87\">",
"      Bernard A, Loire J, Caillot D, et al. [Emergency lung resections for invasive aspergillosis in neutropenic patients]. Ann Chir 1995; 49:849.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32666/abstract/88\">",
"      Denning DW. Treatment of invasive aspergillosis. J Infect 1994; 28 Suppl 1:25.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32666/abstract/89\">",
"      Wingard JR, Merz WG, Rinaldi MG, et al. Association of Torulopsis glabrata infections with fluconazole prophylaxis in neutropenic bone marrow transplant patients. Antimicrob Agents Chemother 1993; 37:1847.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32666/abstract/90\">",
"      Imhof A, Balajee SA, Fredricks DN, et al. Breakthrough fungal infections in stem cell transplant recipients receiving voriconazole. Clin Infect Dis 2004; 39:743.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32666/abstract/91\">",
"      Marty FM, Cosimi LA, Baden LR. Breakthrough zygomycosis after voriconazole treatment in recipients of hematopoietic stem-cell transplants. N Engl J Med 2004; 350:950.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32666/abstract/92\">",
"      Kontoyiannis DP, Lionakis MS, Lewis RE, et al. Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases. J Infect Dis 2005; 191:1350.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32666/abstract/93\">",
"      Trifilio S, Singhal S, Williams S, et al. Breakthrough fungal infections after allogeneic hematopoietic stem cell transplantation in patients on prophylactic voriconazole. Bone Marrow Transplant 2007; 40:451.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32666/abstract/94\">",
"      Mattner F, Weissbrodt H, Strueber M. Two case reports: fatal Absidia corymbifera pulmonary tract infection in the first postoperative phase of a lung transplant patient receiving voriconazole prophylaxis, and transient bronchial Absidia corymbifera colonization in a lung transplant patient. Scand J Infect Dis 2004; 36:312.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32666/abstract/95\">",
"      Kontoyiannis DP, Wessel VC, Bodey GP, Rolston KV. Zygomycosis in the 1990s in a tertiary-care cancer center. Clin Infect Dis 2000; 30:851.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32666/abstract/96\">",
"      De Castro N, Neuville S, Sarfati C, et al. Occurrence of Pneumocystis jiroveci pneumonia after allogeneic stem cell transplantation: a 6-year retrospective study. Bone Marrow Transplant 2005; 36:879.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32666/abstract/97\">",
"      Chandrasekar PH. Real-time polymerase chain reaction for early diagnosis of toxoplasmosis in stem cell transplant recipients: ready for prime time? Clin Infect Dis 2005; 40:79.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32666/abstract/98\">",
"      Slavin MA, Meyers JD, Remington JS, Hackman RC. Toxoplasma gondii infection in marrow transplant recipients: a 20 year experience. Bone Marrow Transplant 1994; 13:549.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32666/abstract/99\">",
"      Foot AB, Garin YJ, Ribaud P, et al. Prophylaxis of toxoplasmosis infection with pyrimethamine/sulfadoxine (Fansidar) in bone marrow transplant recipients. Bone Marrow Transplant 1994; 14:241.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32666/abstract/100\">",
"      Martino R, Bretagne S, Einsele H, et al. Early detection of Toxoplasma infection by molecular monitoring of Toxoplasma gondii in peripheral blood samples after allogeneic stem cell transplantation. Clin Infect Dis 2005; 40:67.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32666/abstract/101\">",
"      Navari RM, Sullivan KM, Springmeyer SC, et al. Mycobacterial infections in marrow transplant patients. Transplantation 1983; 36:509.",
"     </a>",
"    </li>",
"    <li>",
"     Budak, T, Besisik, S, Akan, H, et al. The prevalence of tuberculosis in adult allogeneic stem cell transplant recipients in Turkey. In: 25th Annual Meeting European group for Blood and Marrow Transplantation and 15th Meeting of the Nurses group. March 10, 1999. Hamburg, Germany.",
"    </li>",
"    <li>",
"     Pamphilon, D, Adeodu, A, Steward, C, et al. Prophylaxis and prevention of CMV infection in BM allograft recipients: Leucodepleted platelets are equivalent to those from CMV seronegative donors. In: 25th Annual Meeting European group for Blood and Marrow Transplantation and 15th Meeting of the Nurses group. March 10, 1999. Hamburg, Germany.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32666/abstract/104\">",
"      Trillet-Lenoir V, Green J, Manegold C, et al. Recombinant granulocyte colony stimulating factor reduces the infectious complications of cytotoxic chemotherapy. Eur J Cancer 1993; 29A:319.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32666/abstract/105\">",
"      Anaissie EJ, Vartivarian S, Bodey GP, et al. Randomized comparison between antibiotics alone and antibiotics plus granulocyte-macrophage colony-stimulating factor (Escherichia coli-derived in cancer patients with fever and neutropenia. Am J Med 1996; 100:17.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32666/abstract/106\">",
"      Nemunaitis J, Rosenfeld CS, Ash R, et al. Phase III randomized, double-blind placebo-controlled trial of rhGM-CSF following allogeneic bone marrow transplantation. Bone Marrow Transplant 1995; 15:949.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32666/abstract/107\">",
"      Schmitz N, Linch DC, Dreger P, et al. Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients. Lancet 1996; 347:353.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32666/abstract/108\">",
"      Sung L, Nathan PC, Alibhai SM, et al. Meta-analysis: effect of prophylactic hematopoietic colony-stimulating factors on mortality and outcomes of infection. Ann Intern Med 2007; 147:400.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32666/abstract/109\">",
"      Roilides E, Blake C, Holmes A, et al. Granulocyte-macrophage colony-stimulating factor and interferon-gamma prevent dexamethasone-induced immunosuppression of antifungal monocyte activity against Aspergillus fumigatus hyphae. J Med Vet Mycol 1996; 34:63.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32666/abstract/110\">",
"      Gaviria JM, van Burik JA, Dale DC, et al. Comparison of interferon-gamma, granulocyte colony-stimulating factor, and granulocyte-macrophage colony-stimulating factor for priming leukocyte-mediated hyphal damage of opportunistic fungal pathogens. J Infect Dis 1999; 179:1038.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32666/abstract/111\">",
"      Dignani MC, Anaissie EJ, Hester JP, et al. Treatment of neutropenia-related fungal infections with granulocyte colony-stimulating factor-elicited white blood cell transfusions: a pilot study. Leukemia 1997; 11:1621.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32666/abstract/112\">",
"      Sullivan KM, Kopecky KJ, Jocom J, et al. Immunomodulatory and antimicrobial efficacy of intravenous immunoglobulin in bone marrow transplantation. N Engl J Med 1990; 323:705.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32666/abstract/113\">",
"      Sullivan KM, Storek J, Kopecky KJ, et al. A controlled trial of long-term administration of intravenous immunoglobulin to prevent late infection and chronic graft-vs.-host disease after marrow transplantation: clinical outcome and effect on subsequent immune recovery. Biol Blood Marrow Transplant 1996; 2:44.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32666/abstract/114\">",
"      Meyers JD, Leszczynski J, Zaia JA, et al. Prevention of cytomegalovirus infection by cytomegalovirus immune globulin after marrow transplantation. Ann Intern Med 1983; 98:442.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32666/abstract/115\">",
"      Ruutu T, Ljungman P, Brinch L, et al. No prevention of cytomegalovirus infection by anti-cytomegalovirus hyperimmune globulin in seronegative bone marrow transplant recipients. The Nordic BMT Group. Bone Marrow Transplant 1997; 19:233.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32666/abstract/116\">",
"      Gershon AA, Steinberg SP, Gelb L. Clinical reinfection with varicella-zoster virus. J Infect Dis 1984; 149:137.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/57/32666/abstract/117\">",
"      Varicella-zoster immune globulin for the prevention of chickenpox. Recommendations of the Immunization Practices Advisory Committee, Centers for Disease Control. Ann Intern Med 1984; 100:859.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 1397 Version 4.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-115.66.252.144-6F4C19BDB0-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_57_32666=[""].join("\n");
var outline_f31_57_32666=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      DEFINITION OF RISK",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      DONOR SELECTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      INFECTION CONTROL MEASURES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      ANTIMICROBIAL PROPHYLAXIS OR PREEMPTIVE THERAPY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Definitions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Antibacterial prophylaxis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - After engraftment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Antiviral prophylaxis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Herpes simplex virus",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Cytomegalovirus",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Preemptive therapy for CMV",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Varicella zoster virus",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Epstein-Barr virus",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Other viruses",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Antifungal prophylaxis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Fluconazole",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Itraconazole",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - Posaconazole",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      - Micafungin",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      - Amphotericin B",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      - Meta-analysis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      - Limitations to broad antifungal prophylaxis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      - Prophylaxis for candidiasis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Preemptive therapy for aspergillosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Prophylaxis for aspergillosis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      - Secondary prophylaxis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      - Breakthrough fungal infection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      Pneumocystis carinii (jirovecii) prophylaxis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      Toxoplasma gondii prophylaxis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      Anti-mycobacterial prophylaxis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H32\">",
"      OTHER APPROACHES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H33\">",
"      Blood product screening",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H34\">",
"      Immunomodulation with hematopoietic growth factors and cytokines",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H35\">",
"      - Use in the prevention of bacterial or fungal infections",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H36\">",
"      - Use as stimulating agents for granulocyte transfusions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H37\">",
"      Immunoglobulins",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H38\">",
"      - Use in the prophylaxis of CMV infections",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H39\">",
"      - Use in the prophylaxis of VZV infection",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H40\">",
"      - Other use",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H41\">",
"      Vaccination",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ID/1397\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/1397|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?8/10/8362\" title=\"figure 1\">",
"      Infections after allogeneic HCT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?4/7/4223\" title=\"figure 2\">",
"      Infections after autologous HCT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/1397|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?7/16/7437\" title=\"table 1A\">",
"      DDx of syndromes after BMT I",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?3/7/3197\" title=\"table 1B\">",
"      DDx of syndromes after BMT II",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?9/60/10183?source=related_link\">",
"      Acyclovir: An overview",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/55/14202?source=related_link\">",
"      Clinical manifestations and treatment of Epstein-Barr virus infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?3/52/3913?source=related_link\">",
"      Diagnosis of invasive aspergillosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/51/34616?source=related_link\">",
"      Epidemiology and clinical manifestations of invasive aspergillosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?19/32/19974?source=related_link\">",
"      Evaluation for infection before hematopoietic cell transplantation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?4/18/4393?source=related_link\">",
"      Granulocyte transfusions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/54/34664?source=related_link\">",
"      Hematopoietic support after hematopoietic cell transplantation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/57/25498?source=related_link\">",
"      Immunizations after hematopoietic cell transplantation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/5/24665?source=related_link\">",
"      Leukoreduction to prevent complications of blood transfusion",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/30/25066?source=related_link\">",
"      Overview of infections following hematopoietic cell transplantation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?43/13/44249?source=related_link\">",
"      Prevention of seasonal influenza in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/49/38682?source=related_link\">",
"      Sources of hematopoietic stem cells",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?9/4/9289?source=related_link\">",
"      Treatment and prevention of Pneumocystis pneumonia in non-HIV-infected patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/18/28970?source=related_link\">",
"      Treatment and prevention of invasive aspergillosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/50/23338?source=related_link\">",
"      Treatment and prevention of post-transplant lymphoproliferative disorders",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f31_57_32667="Cholinesterase inhibitors";
var content_f31_57_32667=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEURO%2F63284&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEURO%2F63284&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Cholinesterase inhibitors used for treatment of dementia: dose and administration",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1\">",
"       Drug",
"      </td>",
"      <td class=\"subtitle1\">",
"       Starting dose",
"      </td>",
"      <td class=\"subtitle1\">",
"       Maintenance dose",
"      </td>",
"      <td class=\"subtitle1\">",
"       Comments",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Donepezil pill or oral disintegrating tablet",
"      </td>",
"      <td>",
"       5 mg orally, once a day",
"      </td>",
"      <td>",
"       10 mg per day (increased after 4 to 6 weeks)",
"      </td>",
"      <td>",
"       &nbsp;",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Rivastigmine patch",
"      </td>",
"      <td>",
"       4.6 mg/24 hours",
"      </td>",
"      <td>",
"       9.5 mg/24 hours (increased after 4 weeks)",
"      </td>",
"      <td>",
"       Can cause rash; rotate sites. Fewer side effects than pill.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Rivastigmine pill or solution",
"      </td>",
"      <td>",
"       1.5 mg twice daily",
"      </td>",
"      <td>",
"       6 mg twice daily (increased in 2 to 4 week intervals by 1.5 mg twice daily increments)",
"      </td>",
"      <td>",
"       Give with meals",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       <p>",
"        Galantamine immediate release tablet or solution",
"       </p>",
"       <p>",
"        Galantamine extended release tablet",
"       </p>",
"      </td>",
"      <td>",
"       <p>",
"        4 mg twice daily",
"       </p>",
"       <p>",
"        8 mg once daily",
"       </p>",
"      </td>",
"      <td>",
"       <p>",
"        12 mg twice daily (increased in monthly intervals by 4 mg twice daily increments)",
"       </p>",
"       <p>",
"        24 mg once daily (increased in monthly intervals by 8 mg once daily increments)",
"       </p>",
"      </td>",
"      <td>",
"       Give with meals",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_57_32667=[""].join("\n");
var outline_f31_57_32667=null;
var title_f31_57_32668="Counseling women with pseudocyesis";
var content_f31_57_32668=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F56225&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F56225&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Factors relevant to pseudocyesis that can be a focus of counseling",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Contributory factors",
"       </td>",
"       <td class=\"subtitle1\">",
"        Focus of counseling",
"       </td>",
"       <td class=\"subtitle1\">",
"        Examples",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Strong desire for a baby",
"       </td>",
"       <td>",
"        Identify what fuels the wish; redirect energy toward other ways to achieve similar goals",
"       </td>",
"       <td>",
"        Helping a socially isolated woman focus on making new friends",
"        <sup>",
"         [1]",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Misconceptions about fertility",
"       </td>",
"       <td>",
"        Psychoeducation",
"       </td>",
"       <td>",
"        Teaching a woman that it is the man's sperm that determines a baby's sex, so she is not \"to blame\" for having only girl babies",
"        <sup>",
"         [2]",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Lack of awareness of emotions; use of denial as a primary coping mechanism",
"       </td>",
"       <td>",
"        Help patient recognize and articulate emotions",
"       </td>",
"       <td>",
"        Helping a woman voice anger at her husband for pressuring her to have a tubal ligation",
"        <sup>",
"         [3]",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Helplessness - eg, due to poverty and/or abuse",
"       </td>",
"       <td>",
"        Focus on aspects of her life that patient can control",
"       </td>",
"       <td>",
"        Helping a woman find resources to leave an abusive relationship",
"        <sup>",
"         [4]",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Low self esteem",
"       </td>",
"       <td>",
"        Help patient identify her strengths",
"       </td>",
"       <td>",
"        Helping a woman notice how she has social value without being pregnant",
"        <sup>",
"         [5]",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Losses",
"       </td>",
"       <td>",
"        Grief counseling",
"       </td>",
"       <td>",
"        Working through suppressed feelings about a past miscarriage",
"        <sup>",
"         [1]",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cognitive bias - \"jumping to conclusions\" and not questioning conclusions",
"       </td>",
"       <td>",
"        Cognitive reframing",
"       </td>",
"       <td>",
"        Helping a woman consider other explanations for physical sensations",
"        <sup>",
"         [2]",
"        </sup>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     References:",
"     <br>",
"      <ol>",
"       <li>",
"        Whelan, CI, Stewart, DE. Pseudocyesis--a review and report of six cases. Int J Psychiatry Med 1990; 20:97.",
"       </li>",
"       <li>",
"        Ahuja, N, Moorhead, S, Lloyd, AJ, et al. Antipsychotic-induced hyperprolactinemia and delusion of pregnancy. Psychosomatics 2008; 49:163.",
"       </li>",
"       <li>",
"        Bianchi-Demicheli, F, L&uuml;dicke, F, Chardonnens, D. Imaginary pregnancy 10 years after abortion and sterilization in a menopausal woman: a case report. Maturitas 2004; 48:479.",
"       </li>",
"       <li>",
"        Ibekwe, PC, Achor, JU. Psychosocial and cultural aspects of pseudocyesis. Indian J Psychiatry 2008; 50:112.",
"       </li>",
"       <li>",
"        O'Grady, JP, Rosenthal, M. Pseudocyesis: a modern perspective on an old disorder. Obstet Gynecol Survey 1988; 44:500.",
"       </li>",
"      </ol>",
"     </br>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_57_32668=[""].join("\n");
var outline_f31_57_32668=null;
var title_f31_57_32669="Stress MPI after stenting";
var content_f31_57_32669=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F79631&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F79631&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Stress MPI provides prognostic information after stenting",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 439px; height: 303px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    In 152 patients, stress myocardial perfusion imaging (MPI) was performed at a mean of five months after coronary artery stenting. The subsequent survival free of major cardiac events (death or myocardial infarction) was significantly better for those patients without evidence of ischemia by MPI.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from: Cottin, Y, Rezaizadeh, K, Touzery, C, et al. Am Heart J 2001; 141:999.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_57_32669=[""].join("\n");
var outline_f31_57_32669=null;
var title_f31_57_32670="Shikani optical stylet";
var content_f31_57_32670=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F55948&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F55948&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 508px\">",
"   <div class=\"ttl\">",
"    Shikani optical stylet",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 488px; height: 319px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAE/AegDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD6pooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiijI9aACijI9RRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUE4oAKD0pNw9aRmXacnigBcj6Gvl/4wfHrXNK8Wz6V4UEEFvZOY5ZJow7SODzj2r2z4mePtK8BaObzU5Fa5lBW3tVPzSH/AAr4P8S6q+ua/f6nJGI2u5mlKD+HJzigD66+DXxssvGQTTdf8mx13kKB8sc49snrXtIYDjpivzQsrl7O5SeIsk8TB43U4KsOhr7T/Z/+Jh8d6B9h1J1GuWKBZv8Apsv98D8gaAPXgc0UicLS0AFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAZprYPBPBpGzu4HavGvjV8Y7TwfbXGl6I6z+IGGM4ysHuexPtQB2XxH+Imi+AtPWfVn8ydyAltEfnPv7CuN+JPxy0bQvDVpcaGy32o6hEXgQdIh0y/49q+PtY1S91jUJb7U7iS5upTlpJGJP69BVNELMdvXuaANjWdav/E+qzX2sXMlzezMTuZiQo9FHYe1ZUy/Z5MNy/b2prP5fEZ+bu1Ej+YgLdR1PrQBEzFmLHqa6r4XeIbjwx470nUYHZEEyrMoON8ZPINdb8KfgvrHjm3a9nc6bpnISeVMmQ+y8HHvXrHgT9nOHR/ESX+vagt7awNujhRNu4jpnmgD6GtpRNBHKowsihx+IqSmQKEjVFwFUYAHYU+gAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKbvGSM80AVdTvbbTrWS6vZlihjG5mY+lfBPxg17T/ABL8QNT1PSYXit5HC/OMFivGf0r6D/aB1W7h8QWEVrOs0US+Y1sG74714VqWm23iGG6u0wmqZylsi/f9QfSgDgoot43Mdqeppk0gPyRjCj9afeSytMUkXYU42elQKrOcAZNADetfQP7Mnw20jxKs+vazMLhrOfYlkD0I5DN7V4bDCIxk8tXU/D3xxqHgTxCuo6YBKCNstu5wkg96APuLxP4l0bwfo7Xms3MNpaRriOMYBb/ZVe5rhfhr8atD8aarcac4/s683YtxMcCZfYnv7V8pePvGWq+OtdfUtWkwB8sUCn5IlznA9fxrBiikA8yJzG6HIYHBB9aAP0jjGAadXz98D/jdb6nFZeHfFTiHU1UQ290fuT4HG49m/Tivf0bI5I9eKAHUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUHgHFMdwiF2YKo6knAFAChic4xx615b8Tfiba6GJ9O0kibVCpUuPux/Q+tZHxN+Kxt5Z9L8PFSwykl16ewrwqR2mleWR2d2OWZupNAFl7yW4uJZ7uV5ZpTlnY5NZxtru2ma+0wSKD8khRSeDXVeC/DQ8R65aWU0xtbeXP74/xY6qD619PaD4R0fRtLjsba0jMYwWLDlz6mgD4z/4VT4q1/U7NtP00iG8yRPIwVV929K5fxN4X1Xwdrkum61b+VOnRgcq49VPev0Nd7extGd2jgt4xlmY7VUV8jftH/ELRvF95a6dottHMLJm3X5GGP8Asr7UAeKySEnC9+9JHHkgYz/Wp44CVBb8BV6K2hEJZid60AVo4Vj+eXIUdMetQ3ExkJxwP50SyMxxngVDIwUZNADJW2jgkN1BHavr39mb4kzeKtHk0LViz6npsSkTHnzIvujJ/vV8eKsk8oSNWd2OFVRkk+1fa37PXw0TwXoK6neljrGowqZVIwIk6hPrQB67nnFLSY+bNLQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFIxAHWgBCwZT6V4N8UfiBdXt5c6VpDbLSFjHJIhO6Qjr+Fdv8XPFbaFpQsLJlF7dqRkn/AFa9Ca+dYP7S1a9fT/Dtu1zcOSJbnGQD3xQBnyZMjFzjnJHrXceHfhnrOu6Jcaki/Z41QvCj8GXAz0rvfh58GLbTRFe6/LJc3JAYxE8A17LEiRxrGiqiKAqqBgAUAfJWn6+mhafIupIbc27Z8ojDxuDw0Z75PXFdj8PP2iLbUNWk0/xHaR2Nokf7m5UsxbaP4ge5rjf2svD99Z+LrPVvMhNhdoI4oY+GVlHzEj3yOa8Uih3uABuk7kdFoA9d+L3xk1LxgZ9J0oGz0Utg7SRJPg/xe3tXlKQBBufG707CnrGsQ+UZY9zQ7HjNADC2BzmmO7lMEnFOKkjI/KonJzQAzHFUZn3Mc9BV/Oc03QEtm8RWCah/x5mdRNk4+XPNAH0X+zb8I1eK18XeIY87v3llbMBgjs7A/jxX04oxVXSVhj0y0S22rAIU8sL0C7RjFW8igAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAopDnPPSuQj8VS2viWXTNWiWCJj+5fpkUAdhRUcQB+dG3KeRzmngc5oAWiiigAooooAKKKa2eo/HNAA5x9a4T4kfEGy8J2rRKVm1Jl+SMchfc1jfFL4kJpDDSdAbz9VlO3Kc7CeMD3qr8OPhzI8x13xoputSlbfHBL8wj75I9c0Ac/4U8Bar47ujrnjWeaK1m5iiDbWcdvoK9n0Dw7pHh+2W20qyihVRjcBlj9Sa1EG3aAAFHQAYAqWgArF8Xaunh7w5qWrSLvFrC0gX+8R0H54raqnq1jb6lp1xZXsQmtrhDHIh7g0Afnx4u8Xav4u1qTVNbuXklf7kYOFjXsAOnSpLCSCW2KwgIwHIPU12Pxq+FV14Hv2ubJWm0WVv3UoGdn+yf0ry63me3lDKSGFAG3c7YSSSAPeqbXUGcbqoXlzJcylnY89qh25FAGwrq6/uzk0NASeayopGjbIJBrVhmE0e7OGHUUARPGq9jVG5i5LD9KvStnpUJoA+gvgN8bRbJa+G/F8wW3RRFaXpHKAdFc9x719SRsGUFSDuGcjvX5ozR4O5cj6dq96+A/xql0eSDQPFtw8umtiO3unOTD7Me60AfW1FQwukqRyROHiYblZTkEVNQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABiuU+IHh0a5pwkhH+lwDcnuPSuroIzQB5H4M8WzaZKtjqDM9sDsJY8xsOMfSvWYZFmjWSNgyMMgjvXmvxL8NNG51jTYc4B+0Ivf/arH8F+LZdIdIZ2MunufXJjP1oA9loqva3KXUKzQOrwvyrjnipWc5GPWgB9FFUtQv4NOspLu+nSG3j5Z26D2oAszMEQszBVHJYngV4x8R/iHc6jfL4d8IB5rmY7Hlj6/h6VQ8VeK9W+I2oNoXhCKT7Gp/ez/AHRj1J7fSvS/h74HsPCOn4hAmv5ADNcHkk/7PoKAMj4X/DuHw3C19qwS71qfDO7gN5Xstei4GaFULnHeloAMUUUUAFFFMaQL97gc89higCprGnWmq6dPY6hAk9rMpV43XIIr5A+MHwZ1LwzeyXuiwyXukyNlSgy0WT0Ir6u07xZoepapJp9nqUEt2hxsBxk+g9a3V6njFAHxV8JfgzqnirVUm1mCay0eI5kdhhn/ANkA/wA6+mLr4UeDLjQjp39hWsIKbRNGiiUH13Y613/Wm7F9KAPhD4v/AA1vvAOrKjkz6bOSbe4xwR/dPvXnqMUPXFfpFrujWGu6ZNYapbpPbSjBVgDj3Hoa+LvjP8K77wRqbz2sTz6HMcwzjny+fuv7+/egDzqN/MXj79IapqSjccVaRw4680ABNQyxjqOlTYppoA9p+AnxjuPDd3b6D4jnebRpWCRTOSTbk9P+A9OO1fXsEyTxxSwOJIpFDKy8gg981+aciZ6CvYfgT8X7jwdfxaVr07y6BK2NzZZrc+o9vagD7Roqnpmo22qWMF7p08dxaTLujlQ5DCrlABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUARyxrIpV1DIwwykdRXh3jXQJPDusu6Iw0q4Ysp9GPavdD6965rx++nt4duItSuVt45BhWIBJPtQB5p4Y8ZS6NOLcyK1vIeFc/cHrXS2/xF36ypMO3S920yHr/AL2K8hsLeGO/l3sxDN+7L/xCt0qQMH7uMAY7UAe5a34o0rR9FOqXl0gtSu5COS/sBXi93P4g+LWreTZLJaeHkbDTDhVx/M1SbTLbWr/TrfWLqSLT0fMgBJBFe/6RZWdhp8EOmRpHaqo2BBwR6+9AFTwp4Z07wzpaWemRBAB88mPmc+pNbSLtByc04dOKKACiiigAoopCwxmgAzziuZ8f6vZ6X4avhd3a28k0TJD/AHmYjtUHjnxzpPhG0LXkwa8K/urdeWJ9/QV8w+KfFOoeJNVe81CQksTsjB+VB2FAFDSr+Sz1FJY3eK+jfMZBPzN6k19P/DDxxb+JLAWlzPH/AGxAMSxjuPUV8sRWF3qdyIbGCSa7YfKqDnivRfgno+q2fjK0nSymRkYpdNJxtBGKAPp0E+lLSDGTS0AFUtV0u01bT5rLUYUuLWZSro4yDn09DV2igD4n+NvwlvfB2pS32lwyXHh+Q7lmHPkkn7jf415GCUNfpTfWFvqFpPa3sST20ylXjcZBBr47+N3wevfCV5PqmjxPcaFIxb5eWgz2Pt15oA8jRw4HrSHpz1qvyjehqZXDdetAB25qORM9KlNNY4xQB6j8Dvitd+B9YistUnll8PSnEqfeMJ7Mv49hX2fo2r2WtabBqGlXCXVnMMpLGcg1+bu3J5r0n4MfFK98AasILlnn0K4YefD1Mf8AtL7+1AH3QKKyfDfiHS/Emkxajot2l1aSDIZeo9iOxrVRgwyOlAC0UUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUABrxX4wWN+msLd3LtJp7DEajop9K9ocgAsxAAHU9q8Y+JnxCS+lk8O6DZfb7h28tnAJwfbH86APN2mUyhWBLN90f3a2dNuRct5cikOOMZrP8AEOh6h4S1SH+2IiVuYwwlTlVbuDitDwxod3rmrQrYbgjY3SY4UetAG3p1nLqF6lpapvlbj2A9TXtXh/Tn0vSYbWSUyunOT/Kqvhzw9a6FbqsIDzEfvJSOSa3RQAi5wM8GloooAKKKQ4xyaAFrzn4l/Ea38KwyW1kFudTI+7niP61s/EPxZD4V0hnPz3kwKwoOufXFfMniVgyT3up3L/brljIkCDcxz646fjQBjazqV3rF/PeX0zy3ErFix5/Km6ZaSXNx5UCsX4Lkc7V7n8Oa7H4f/DvVPFMiSsjWmnj78rjn8PWp9a8Nal8PtdKAvNYyndHdBT+Tex/rQB7d8MfCOkaBpEF3YSLd3NwgZrkjnkZwK7mNFGSqKM9SBjNeTfC7xGkL/Y3AW1uGJUKeI3PXHsTXrcZBHy9KAFAx9KWiigAooooAKgubdLqGWC5iWWCQbWRhkMPSp6KAPj744/Be58NPc65oO640h3MkkQX5rfJ/UV4WQUOD2r9L7mFLiN4ZkWSJ1wyMMhh6Gvk/44/BWXRnuNd8Mo02mu5eW1Vfmg+mOooA8FVwwwaD1qIgqcU8Nng0ASR/exTZBlj60sY+ekbrQB3Hwm+JWo/DvV3kgQ3OnXBAuLZmwCB3HvzX214L8UaX4u0KHVNGnEkLj5l/ijb+63vX51kZrrvhn8QdW+H2s/a9NPm2shAuLVz8kg/xHOKAP0EBz0orlfhz410zx1oCappTbc/LNbsfnifuD/j3rqqACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKr3txDaQtPcyLFEgyzscCqeva1ZaFZvdajOsa4O1SeW9hXit1qOvfFbWDZ6cWtNEiO2SVQdo/HoW9qALXinxvrPjLWJfDvg6E+RuKSTjIyPUnoBXefD34f6f4ShM+77Tqki/vbhwOD3C+grY8HeFdN8K6atrp0eXwPMnb78h9Sf6Vv4HpQBmeINEsdesDZ6jHvjPIPdT7Umg6JY6FaCDT4ginq2OW+tauBRQAUUUUAFFFI3HOcUAKao6zqNrpOmzXt9II4Il3Ek9faqPinxHp/hvTDd6jNtzxHEPvyN6Ad65PRtM1Dxsy6r4pSS208MDa6cpIV16hpM9T7UAeeai2v+O/EX23T7IyjO23eVSIoV7EZ4J6Gut8MfBuytLoX2t3T3d6/wA0gPr6A+lerWsENpEkFrDHDEvARFAA/KrGB6UAV7O2is7WKC3jEcMYwEHaoNZ0y21fTprK+iWWCVSrA9s9xV+igDyDw58ML/SdbKNfKdISTevTewzwtetwKFUKo+UAAfhUhAJ6CjpQAUUUUAFFFFABRRRQAVHOFaMo6hlcFSD0IqSggHqM0AfKnx2+Cq6ZDceIfCkbvZgl7i0AyYueq+3PTtXzsylDX6YTojwujorowIZWGQwPY18wfHb4KpaW1x4h8KRO0Qy9zZLzs9WX9eKAPnGJueaVvvUwKVcg9jg0uc0AGaQilpyI0kiJGpeRyFVVGSSegoA6X4c+Ldc8H+IoLjw67PLM4V7TkrPnjBA6n0r7+0iea60yzubmDyJ5oEkli/uMVBK/geK8M/Z9+D8WiW0HiPxLAW1iT57a3fpApHBI/vfyxXvynJPNADqKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKQnqB1oAU1y/jjxhZeE9P826YPcMuY4geT7/AErD+I/xFtfD8X2PTWW41KTICrzsP4d65fwP4DvfEd9/b/jYyyq5DwWspzn3YUAZmh6FrHxU1M6trM8ttokbYSMn7464UenvXuOjaXY6RYJaabbxwW6DAVBjPufU1Zgt4YLdYYI0iiUYVEGAB9KkUYAFAAAB0FLRRQAUUUUAFFFM3nPA4oAGLZ649K5bxv4vg8NpDbxxtdapc8QWsfJb3PtWX4z8ZTm4/sPwki3utScOycpbjuWPrWj4K8GxaKrXmpynUNZm+aW5l+YqfRc9BQBl+FfCFzf3g13xptutRY7oLZ+Uth6AetehbRjGAB6UBcEn1paAEwPSloooAKKKKACiiigAooooAKKKKACiiigAooooACARg0xo0KkFQVIwQe4p9FAHzl8dfgtDdRXPiDwlAqXK/NPZRrgSerKPX2r5bnieGVkYEMpIIPY1+l+0fWvDPjX8FIvE8o1PwtHb2uplsTx42pIP73A60AfIlvG880cMCNJNIQqIvJYmvrX4CfBuPw9bprnim2in1aUBoLeRci2GOpB/i/lW98Gvg7p3gi1+26nHFfa5KAS7qGWDrwmR+teuYyKAEUA5/WlAAPFCrtJOetLQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRQTiqupX1tp9nJc3sywwIMs7UATzSpDGZJXVI15LMcAD615D8QPiFcXlx/Yvg1Zbq7Y7XkhGT+Hp9ay/E3inWPHmr/2H4XhkWy3bZJQDgD+8x9PavRfAPgew8JWzGD/SL+QDzrhxkn2HoKAMD4a/DhNKI1TXwl1qr4dFcZEP/wBevTtuRzzQBgk9zS0AFFFFABRRRQAUUHiqmp6jaaZYzXl/OlvbRLueRzgAUATTTxwRNJM6xxIMs7HAUe5rzbXfEt/4uvzoXg4uLRjtudUUHYg7hT61Vln1b4k3rW9vHNp/hNW+ec5DXQ9B7f416Ro2k2ej6fHZ6dbpBAg4VQPmPqfegCh4R8K6d4XsfI06L94/M0zcvIfUmt5QQOaFzjkYNLQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUhB55paKAEK5BHr1oUbVAHQUtFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFGaKwPFvinTvDFkZr+QGVh+6hH3pD6CgDR1jUrTSLGW91CdYbeNclmP8q8ovl1n4mX6C2V7Tw6jf65v4x7DvV3TvD+s+O7+LVvFJa00lGDwWA6uOxb2r1Kzt4bWBILaJIokGFRRgCgDN8N6DY+H9PW002HYo+9IR8zn3PWtYZ39MLinUUAFFFFABRRRQAUZFIxxXK+NPGdj4aVIdjXmpTHbDaRH52Pb8KANXxL4h03w5p7Xeq3CxIPur/E59FHc1wFhouteO9Vi1PxNC9locTb7fTyfml9C/t0ODV/w54Mu9R1Zde8ZzC5vT88FmP9XbjsCOhP4V6GuOgHA/IUAMggjhhWKGNYokG1UUYAH0qaiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAoooPSgApM013VELO21VGSScCvLPE3jvUdY1WTw/4Mh8243FJLvsnrigDa8ceP7fQZlsNNhOo6s/Cwxn7h96zvDHgOa71GPxB4vuTd6gxEqW5HyQ55wfpWz4G8EWvhwNdXTfbNWmO6a6ccgnqB7V2YUAdKABelLQBjpRQAUUUUAFFFFABTGzu9qV22jJIAHJJ6YrzrXvFmo67qraB4JAdx8t1qJ+7b9vl9TQBd8W+Nms79NG8O239o61LxtU/LD7sak8GeC49JupNW1mf+0NduPmkmYcJn+FR7VqeD/Cll4as2WHM17L81zdP9+Z+5NdCFA7UAICA2CeTTqMDOe9FABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABQeAaKD06ZoAqyXsEV1HbyzRpNKPkQkZb6VYJOeBkd680+IXgnVNQ1SLWtF1GYXMBysPp9DT/BXj5nlGmeJv3F+p2iQjAb/AHvSgD0qimK4KgqQykcNng04HIoAWiiigAooooAKKKKACikzzim7+cY59KAHMcCqmp6jbaZaPc3syxRKMkk1g+MfGlh4dQQsftF+/CQR8nPv6Vymk+GtX8Z3I1HxfLJFYA5hsh8u4dfm6UAVbzUdc+JN3La6Gz6foEbbZLlhhpfXHQ16H4X8N6b4c09bbToAhwPMl/jlPck1pWNhbWNsltZwpBboMLGgwBVgLz1oANgxjtThwKKKACiiigAoopGOBmgBar3d1FZ28s91KkUEY3M7HAAqrr2t2Gg6dJe6pOkMK9Mnlj6D1rzqystT+I999t1jzrHwvGR9nsuVa5936H+dADrrU9W+ImoPaeH5pLHw3Edlxd4w859F74I4yPWvQfD2g6foGnLZ6XAIYc7mI6u3qx7mrVhYW2nWkdrYQR29tGMLHGuABVkAgcnNACgYooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigBMenFcx4s8HWGvxByiwXqAlJo1wSff1rqKKAPIbHXtY8EXxsdcSS508kBZDk7R04PpXqGkapZ6taC40+dJo+h2nJB9DS6lp9tqNs8F7bpNE3UMK831b4e6hpc7XvhS+lt5M58sHH4YoA9TDDJ9qXcPWvKY/HPiXRESHXdEebbw0sanJ9/StOL4raOcCe0vYXxyGQcfrQB6JQTiuEX4oeHDjNw4+q9KZJ8U/D4/wBWZ5P9xaAO93D1pc8V5dd/FdJJBHpOjXlw54G5Ov5VVl1Hx/4idUtLI6TbvwZCCCB+tAHpesavYaRbNPqNzHDGBn5mwT9K84u/FmueL7k2XhC3e3ts4e9kGOPY81oaL8NI/tYu/El5Jqcv/PJmJjzXf2tvHaQiK1hjiiXhVUYAFAHKeFfAllpDfar5jqOpty09x820+wrslXFKOnNFABRRRQAUUUUAFGaMimkgkDg0AKSBXP8AjLxVY+F7ATXRMlzJ8sFunLyt6AVneMfGC6W66do0f2/XZ/lit4/m2e7Y6Cq/g3wZLZ3bax4in/tHWZud0nKwD0WgDO8O+GdQ8T3ia542+dc7rTTj/q4h6sPX616OsSoipGqoq8AKMAfQU4g9BTqACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKQjJpaKAGSRrIrLIoZT2IrPl0PS5uZLCAk+qVp0UAYbeFdFLZ/s+H8FqRPDejRYKabb5/3a2KKAK1taW9ohW1gji9Aq4qwM45paiufM8mQQY83Hy56ZoAlB454ornNG115blrHVovs1+CdueFcdsV0S55zQAtFFFABRRRQAUU3HOOc+tc9rvi3S9KbynmNzdHhYIBuYn0OOlAHQSsiKXkYKi8lmOAK4LxD4ou9WnfRfCCPNdt8st8B+7gHc59evSmtpniHxZKr6tJ/Zmjnn7MjfvJB/tEf1rs9G0yy0q1Fvp8CQxjrgYJ9z60AYngrwhaeGbZmybjUZiWnuX5ZieoB9K6deOBnjrmn0UAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAGZrekW2rQ7ZspIv3JUOGX8a5/7Tr3hwFZ7dtVsv4Wiz5iD39a7OjFAHLWHjfSJwVnkktJR1S4G0itNPEmjOMjU7X8ZBVi70mwuzm4tYXPqUGazZfB+iSElrJcn0YigCaXxTocZw2qWufaQVj3Xj/Tg7RabbXeoSg4xAmQfxrUt/COiQEFLFM/7XP861raxtbUAW9vDHj+6gFAHFzL4p8RoPmj0axfqrAmUj9MVs+HvCWmaL+9iQz3TctPP8zZ9RnpXRkA9aMCgAxxzRiiigAooooAKKKKACiiigAoPSiigBsbFs5GKdRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAf/Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: King BR, Hagberg CA. Management of the difficult airway. In: Textbook of Pediatric Emergency Medicine Procedures, 2nd edition, King C, Henretig FM (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2008. Copyright &copy; 2008 Lippincott Williams &amp; Wilkins.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_57_32670=[""].join("\n");
var outline_f31_57_32670=null;
var title_f31_57_32671="Algorithm for treatment of metastatic neuroendocrine tumors";
var content_f31_57_32671=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F79461&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F79461&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 574px\">",
"   <div class=\"ttl\">",
"    Algorithm for treatment of metastatic neuroendocrine tumors",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 554px; height: 479px; background-image: url(data:image/gif;base64,R0lGODlhKgLfAcQAAP///0BAQMDAwICAgAAAAPDw8NDQ0ODg4KCgoDAwMGBgYHBwcFBQUCAgILCwsJCQkBAQEAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAACH5BAAAAAAALAAAAAAqAt8BAAX/ICCOZGmeaKqubOu+cCzPdG3feK7vfO//wKBwSCwaj8ikcslsOp/QqHRKrVqv2Kx2y+16v+CweEwum8/otHrNbrvf8Lh8Tq/b7/i8fs/v+/+AgYKDhIWGh4iJiouMjY6PkFYIAZSVlpeYmZqbnJ2en6ChopqRpaZjAwoCq6ytrq+wsbKztLW2t7i5rwSnvb5aAwO/N7zDxsdNwcgzxcvOz0DK0C7N09bXM9LYKdXb3t8m2uAk3ePm2OIABawGIwYBCELv8TEOlO1UCwEs5ef+z+kEEBhIoEG7AwMECEGoEMYBAgkGHKAxgEBDFgKFoSCwDwACjSr6/RtpLCBHAAIg/0AowBAlA0oPRBRQECCYwgEIHgRQUECdPgX4DNBkgKBlAX01Szh4GROAAo70RHy0t2BmAHwHaAI9EICAgnhIgYrQGWBBVo7CJgVg4MBjQYkfRRzQx7aESJJ4T5ns+PRBRgCpBnSNl4DAgqfCBiZo4BVAAggDHh94GFEBg78NIC9oQMIBAQYLDDsuuIBE1waMIZwGcABCRJUGGCco3WDAAgicny6ILKBwg32gBzCeS0D1O14FVKbqOOJu3ueP9oqomJCAsAIPGBSurgCldQAnC3A0INrzA/INFjxY912lAokkGBDo+dg7SBFd7QPI/8CrYIsVNSSAPhDwIh8DCenHmv9gjCl00n689EfPRORAZ6Fe93nHFwEI/PXYA/1VJ8xfD3L011/2FJjAXwYwkBqFEOLHy1+mzfhdfhW9FwxCFgHgGVuFqaNAYQQ48FdrCSDwlIMd4djjCc5dKKUhJq1YUQL6FTSgdeI1sGViHZ2EmwDyGSCAAkaq9Bc8AnSFDwAh/qjgCPmtyQt5CRi5gAHUCUCdA4w55Vdofn1m5Gdt9qglV3dCJAACDNg15aSMmDQQBDzph8BAXaVVYKfghbmPAb7FcwCRCZj5nXwFRSXCbZ/1RCOdNgqTn4+oTsYYAwX4FugABUJQGoQQOFVcYTcNdJwIDhCZYZSURttHOjN0SGb/kZBAK+22eFArw1NvRaItt+TO4S0445arrhvnfpPuuvCm0W4U88hQ7xbvxqsvGfNCMesLLcXw7xD57mvwF+f66QBNbbGmVTtxeTTiAAZ06CNTI6jVFE46ZWqVfNf9hA92MDHkQFEJTsUAA/hoXMJTSeE0XTxTlWVVUDRVhRLFFkN58M9snFuRagNN5hqwxd7qZIED/BhaaU/LF5NijHVX2GHfPRYZBBN1tcBtAn1qZwO+ARA1AU2J4Ns+Je5zWmqrIQkslkN/5zPQeJ8hdI+hCdDfe10lKiNg2AIgH33F4hbMSeGN11hG5JVmHnndsSbQsHaqzYviFTGnYNsxZt5f/1uh8Vn4Rnmnzm+GIwRIuJ/+7ag0L67HGONbwcTT9onW8S7iCDRmfnttuZNAI+h13kh7jwHWjrrq0CPM+nTMW4Snni1+BuvrY1knJ8iPgikCR8l5GZowY5YJgEoONBu88oODH7EIAtVVINZu1xojeZdlxj030QsgF/aWLIU0SzEHiM1nguQ8WPFKSMESX6g88qnvkKpVIsieiewmvPzMJIIl6EqxEKCS0ORPP7dCgGza4by7CfCFVugXNgoGwxoKQYbXoKENd9gDHFpDhzwMIg58OA0gCvGI2ZgeupDIRCIQERpGbKIUVfDEZ0RxilgsgXBGwcUuevGLYAwjJa6Yxf8yHkAXaEyjLhLgFzW68Y2wKKMc/RCAi8zxjuWqIx73SC498vGPlPIjIAdpIUES8pAkMSQiF2kORTLykSlYBxwnSclKwpGNlsykJjfZCkhS6TdiDKUoR0nKUprylF0koyeDpsRV1kCVrpRXK2MpA1jS0gxVvOXzdDmtWfKyBbb8ZRhyKczmFHMPxDxmMI/ZhWQWc5nM3IIzhQnNaF4hGJSYZiz9RJ0EWTMOBSIIlr6ZAs8QhEPkhAO4BjKsdJpAPOeEkTvXsCmC2HGetBoIZ/DJhocQhJ/hIEjlAKoGInmOoAIZSMMImobQoI2hJAhnTyCKBnO+CaLyGSdFzyCeYm3/FE52+6gZdiJS8txTpGKQmUj3idIyGECeFF3oHs3EyZra9KY4zSkaYeqFM+r0p0CdBU+3EYAEoPKoSE2qUpfaidqgApRMjapULeHURp7UldpkQlYHsdVIOBKrvsRCVwMx1kd8dZVlPUJa/bBWRpzVk211YlijM1dnvBWScR1CXvWwV0Tc9ZF9jUZdGxFYQ/y1CWQxyw2uegIDTNQEjpXKUG1QzSQU1geXvdhOGLuCZ1Uhs4M47BJSUYAC5IQYLjirH4vSg8oiAbQ7uOwAGDCRAWVDUlSAbSBEq4QAyBRXCcjU1wLgJe1EyjFFLc2mygKYBEREHZRogAMM4Jp9LMCo/wEoAHWNarZ2lIW4jwUAqYoaD6EYV23JHZ+QnNuwB2C3Hdet6mcHm1v61kA84QVuphCgjwbEZLwN6JoIhpRC55bGALtp0kVvaF9j8DYJDsDUeUTQgJ4MICbwwBV92jHRVIEngwq2TQb305CJqofE+HHQRE48gokmByUJ2LA61NaOCF2HM6RKcW9GHMMGR6GwbTJBhQETk1SoI2ltYcmHHzCsO/GlQxDwC34WHATdAuLBSTgAfxvQoY4EWY9BRrFgAgABB01HIzZpgALWg2IfRddWDdFjMcRhlTo16SaUKPOH/VhHadSxAA1A0GSfYOUh+lgGYQael/chjQilhx688P8j7UBZm0Rb9tC+wPIS7JFjl6A4zHXMToo/DKdhXVgdS+mOHmNjYTiPes73YUBTZnRnUaPYQA27ip8FtJlrYtoJhcUvCTpNJsBopBhaTtKeG0K7dqLkoGr99Sk0bYQFJPk9APBSAYjy6VpHSgBeWt8BWBLgAwTYSHCKFFG0W2GuCGPdtz5zfGKyqWenWNTgNjOk1oHjdnupYuL16HxRIe0XLIC2KKGNALYdj0bDaSKyXvK3eWFuhRjASJ67ihEKTUfOOuFMlJgQTeixJ/EOq+T6sE077DGilVlcKz1pUaQmsebyrqy7+5GKq7bt21GdHL41KXlHaE4hlq/oKGuh8o//Cz5aprsAUmVRSFYy7BF67GMpSck5YHqewYch2DRK/wHH+0BtcLTF3Pn1NcGRMXY+lP0bQwn7wFPqdLLW3aweB+zdo832vTfi7XtsO0X83stzvLVZLIlHAWBSg+tgxVU4yLsUBJndJGgXs4SXqwq4+YBBA4xCq7jBeCXPGsiLPfOKeGuMS1/qG4yoI1rmgWt34McDHBcJltaB4JNIRVWQMO0xkEbobVAXF8Rer6hPxFkj9nXUaFwqB+fyevMkXqMGOOcKUA0CELx4OmkXu+GdCXtf5VyccKQ0PTfAeCvfrOD2JL7XoUSexqts8ybg9lIxqof5S9ymuJfMDdE009cW/wgmGCSAAM61D2JhNgJgf19BXArBXy4SD9kHD+9wD+JlGcE1CeEGfyiwezIwL7tWfZTwfosRf0XFYfIHKL9RMfHQfsLVX/cEg9pVXSTwNS4CMQ+gAHuiXP3Ff0N2XSVoNpCiE96XAiCIB2e1gEGWDkaWHNhxY/uRZBNBa/TjNm1hD9nWE0pCAg8ghbZWY82xAAs3ZF04ZBe2Y+JlOE0RWUcGYzLWYswSKU9YLJ3mR+P0herAGSkhZc0Rc3DSHa0Bh47xgnTYHVAYZpfhab1BH4aohmGXhDAggiMyZGaoCuPUDotobmyYQdKgDGiIYYZYAqHYZnQSDzsmHNPVhIhIAP8rFhMmhmF1ZHs0g3/hkHx+xVjM0YQZsmt85jePpl5hFmSQYjhpIn8ZF2dtYkfNUAwpgYzDmF2BBh/VUGdWaIri9RLc5XAjaFttVke5ZzgRoRCAVgDKAGoKwYs6FibGhI7PBmiC9oG4KFhU9BsE0A7PWFTSGI8cMUakJm/GFo3dZjyLho1tRjsaoY6kpgz2QFyuZm93JYl2oFqKZmxapBGpUnwal2y6Y28eaRB8qFEloJHvIFPNSD8iSWzHNSCcMR8jEHEf5o4jAAH4yGjHZpEotoAkGY7i9QBcIyjX544KmSphthIiUCxC6WW9dgIS6QKUaDbdoYbG02su+Yetg2b/FDNOxQZmnqOSBqlHLyZ8NqlexsZqFilI0sVS8mh4jFVy9uaEUckZ+wZuD9eJd8IZ69ARwoGRMXF8UsErdDkJpRUPXNMTzcBGrKdtRAFw1OUUpXEAS0Fv12hINIl0OHmX5KYQzDGXfAhtA1BaBsEajeGRXAkYcSleeIltRpaUjClwF7l2SKgRARATiKllrQmVpRUTPMgaDrCD6gCKC8dtpUkCihkPipRhRiaWl3lmrOZuprgppveaVoUCZ5JBygV5Y6YAFEJ0miWb0+FbX8calecTa/Fb3OkR5elmttJidHF2I0eeLPObO+FYL6GF4emWIEYU14kfzBJ0FZM26Kmd/yZnAmSxUKE5oDj3ddlJIYLhAOZYEzH3cyaHdPHJlPN4eiqAAPSwbY7VnhSKD2QBi4IBFFahZabyngnqbA5DdfiJHy/xmVVnnTGqdRoaoA8AFm8yiJ11oYXwVs8Xm6eAcDbAk7eoeXS3BoC3oyzQlHTwVi0CfBkTnY0gdy/gTStQo8gHmw1FpcQHpSTApHOQpHcEpkp6DGQaB2I6R2cKpGbKo4SQpjSweLN5lUtgSBJ5eazHAgj4Wm7KA96CeLEnpwBqA6y1BG4Yp9RXpNO5BEwmnUlgp33aAmHml50lpRh6pCawerHXqDtQqL1FeirQKxbKlkZwgRrnfG8yW/03gP/4wWnDVVz3Nx3lhx/9ZYJDaKcv4V9OgQ9kKBRDUjkIOButehUeKKceRn9atoNQ41wUqH1fZ6oQ019NIaobF6m6xzrMRxst2GIrSH80Y3Xk51RCV6viSQkqCn/dhx9HIYPntR+CEWPbdXXOFYMQeF5yKl0zo6jjAKctsIjFBpdvqIeANj5kuHgvuHqp8g5TBh6vOGNmg2F2VIeByBpIuXrg+WTgQYbNMmKbyBk0qQ4IIV0GoIfZdkYF6a+H+IYiIKRGOkysw4RjOW8Z5GLF4nCQeGsNWxeWdrPcVowZhniOUWMTIWJ+VIo/i7B8Miw4o6/gwK/8YExOeJO/+I/D2Wf/WLmQwtCQTgWp6lWO56iXwUBpiSET01iFlWARnuNn2FVmAnmSDjcdoGpoWkonFZkO1UgTOHKT8AgfciZvzug5e1tbbqOZ6XhnpPZlhXuFA0li4LZmj+WZ1nplcXsDRrk+OEmnH0aSVJu4JMappwZrZqkMXEtqaxaUHaEeIlYhwEOVjyWVOOlbBKm4lVuzNwm31Tq3/Km4dvtYMImQZJlwnNG3Fvm3JsCSFAYoo+aOxbAUKOaVVUuOqUa3jtq0k2sDqtkdUatenPm7z2tuulKFzNluSTG6yDaajei9FSdebVEMt3kYuZltbdGA0tAsEzFdsaEOQXa9y7myXtpDkSu3/yXglgo5ArsJmRFXb8VYb7cpvMoQcQboDuXlUdCZvIbrigxnOAjQE8W5uHWEbmGoopdLvUbwoDCKpVGau+fJHCV3n/jocihMMztxozh3wlqXbfgAbi6cgfOpdR86Fow3dVVhwlinMw36dSTMheAqnnyHqcZTOV9nwjIxovTJdU7BdT0sdDonJAgCuHSBFQK3whLqFVQncytKcu3AwkKxExOlCkz7DU4rB4lGpFWwiLfLxGBnqCvmSzi0TArbxt7wxnFgpeGpBfzFp7ibQQ+UBG2SdSqQyCsAbTfAoaO6qLq0pmvZpqTKS5Y8ySXxvx33S5vsx70QymwAyFJEyl/qyf/sospuV72AhMqY28mGpyPBUMu2fMu4nMu6vMu83Mu+/MvAHMzCPMzEXMzGnMuMDAaCcczM3MzO/My6nMzf8BHQXM3WXM3ZdM3avM3E7MpRwE3cHM7i7MzePE+w3FLonMrpvM4uy87u3Eys/M7yTEXxPM/2PL33nM/JUM/6vC91NlVT5XwAPdAE/Qlc2s9Z0BtBtdAM3dAOjUYrgtBjIMfCZMoSTQQU/UsWfdFCkNG8tNEcDQQerUsgHdI+MNK3VNImzQMoTUsqvdI60NKx9NIwHXmQfEw0XdM0wCr2xEzwRBBqqdNS0B/nZE1EMhADJdRSQB4EYYvC5FADYalKzQT/4fRQ0WROA9G/U60E63TQsSROW00F9eSazNQVohHWUuBPSc1MFXE6aA0FjCHVusTUbz0FoeF5vKQadS0FG5tOCLLXUXAU7rR9gB0FeM1LWo3QZn1OjN3Yjv3YkB3Zkj3ZlF3ZlV3Oe7DYlr3ZnN3Znv3Zkc3P3JLTSIrZekDabXDO/4DaacDaI2XabCXa2+LaZ0DbZGDbaKDa/oDbtw3bSujbfKDbmYx3xG0Kwk3JjsDbYaDcZXDc+2pHfumpDgF6wK3OMCDdL4CnplHddQDICLEjS21U3B3Cg2RIiVZ2wjfe5K2nh30C4cjcXwDICg0oXk0Exeensi0t5s0cqwZ+/2YTfRCjf+2AqjWKrO6gAL86rOrn373hkOJVCWesgQ/Ygd5FrgiYgh4hrU6hfdtd3DsQZqLLaetXWtFFgP79quS4gmbDrEoxrzXIXfi9SOatGnmmEJe4H6iIJRPFvJ+IPhwGI404hRlbhlzYHUbZwOn4bQg7inLWsDuesi/23uotB/LdJLpTsJeYugNe5Dh+MZ3YkxpxfSNgtFPu3CJckTpG49wladmojzhpE5AM4mOLEmpeR2D7j5OZuAwsDC3i5jYLbfDtBfKtGsJ6uHXeuOuRj2ueuNWgjwCI5oiLeTJuR+e9CiKJYi/2sQppE5euuA97uCIp5+szUUhpuJEOa//rU5PLKeUeHtMH5YyXXgCp5roDWZVCDllaGSmmbOZuTOn8rRC1aZwNZ+Qdug++aY7CgK8NCDwx5r3/GOypvm3CoL9JGW8WWZn6sJz3G16B3gVVjluO0ZcI4MGRAu2lWcDtkwD1e1EbvOv5HS2GNMglR6FtsRYQ+uD6KSQBYKIrqjP0E2h0zBz0no01J58wysIDisUx+g75jqV6Cbt0MuVoqt6DnLvwOV0wd/EpKp9iMcThNXVmLOmIRG1wKtOTJ/Fw0O3tPPKu3KI1UPGCjvJvoPLK/O6BJPMpj/NtQPPSM+lepfOlDPRwwOt/LPSxS6nxbfStXb3Vq00XMVdBhvT/Mc7yirwPUu/tSo8GmpYv2tQMUG/1cm0DRE9URs8Vbv7ECUh+9ad/5WV9ExGsIBwEPJ8FigT3Gf4qGnp+BbgP+gfCqqqrK15/CB5c6CWsy4V+an8fZs9daM9dxhrgGB6sp8vi1n1IOa2z+xBkLtkOJBtgNCvkLNHHX2EEc48F8Y6xs2mEhi5lHbZgEtv5Z2SxSUZjeJ5uPLay8Zv5bAOIHeuwzLv5cBLm8jT22JDTxBtk2pEgjl5m1ggnwbhFDl4EpX8Fdiq2eziexPudAHiBpeFwy78Kdz5menaSX3X8wDGOoeKPfc5dya+ZaxuxNj8pxq+4YTayXAPxKztrcoGA/x8BAgswkqV5oukZCKr7wrE80y9bDmJZJEkxEkaCwOjBGN1wAyAg4CgNR4uHEdkKMp0obDQKMDwgB8KPBDEAvGCxFjVY1uLyOb1uv+NpybyL8QAMEEUNFBQ0GDgkHAA4GPgBIAQ9LPodNLQg8tm0aHZ62u0BWGI+BSA8EAGIFXhVCVyavDElLjYK+FgeuMKuAgQhBBQilDwGphERGhosKBT+nRUsIBce0jKikch+bnN3e3+XhHYXKDAgiCwDoLY5MAQsFLo7ELUHwBkoBChgf4uD/38Sh0+fgXNShs0bkE6KvQX8RiAY1mREPXivGDDgJC0HmoQTIQVg8IQEOXPoRP+sG7nuj4GQBlNSdAdPCcCaNm/ibMIpJ886/noChfGzppegNbQZTap0qRWmTlfsfMp0KMCFUlUgvap1ayeqXHN6/VozrFicWcuiTeuCrFpvbNsGjAo359m5dsW+vaspr947fPvyqQt4sNK/hOcYPqxHrmJughtDHss4cp7ElNdOvpznsebOXQmADi16NOnSpk+jTq16NWvUmT3XCNB6Nu3atm+vhgN7t+eivH/3tAx8OPE8vosjd/s6OfPmdY47j+53ufTq1k9Av649hvDt3ndn/y4+HPXx5n+HP/+9u/r2fdO7v84+Pn218OtHn48fsIE3/v8DGKCAAxJYoIEHIpj/oAINJNiggw8O+JBmB0BYoYUGNqDAhRsiONJ+/wTCoYgjFpghiSeiSKA94DGYoosvwjhAPh8CxFlf+qVlo2L3qccjjZvp1hiOaOl4mI/mHfmjHUXaNWRZTA6WpHhSKjkHlHA5KdaV76VCI5VVxrGlWll+JeZdX26HJpgzmIkWmVy1OZea1825Jgxx4lWeYni2VWd1ftqJVZCKvbkVn/Z1+SGggZpA2mEGjJYoZQ2MtghlsokmYXsKjCYRo6CIdsRhEIimg2YLiNbAqanuF4loln5axwCi/XEYp6Hp2ZcDoimg2a6h9YpfAazGagekoWmql6ugwTZsaB5SJpqn9SUQ/5qpxdJBKgGqKjYGaJJeVi1oZVyGKQGw1ocqaNBiKwcDoAWrGKUE1OrZrAQkYC9o+SoaGrntyuHqtISpm2xkAoB2LWXHKlzftwDX4S26hO0KwW+g5doXqezWJ9ugENfQAL+NDSvqbu+eTMaPDxCQMcgnKNAwYQkM3FkVsAGjpAEWvzyHAxwTNsDEnYGxG4VVxttzDYVQ9u9uTmsGtbBKU1211eIBE4DWW3Pdtddfgx222GNv7ak0ZKOdttprs83P2WzDHbfcYsuMQtZz48123f+0lLfff8+991wyClC44YcjnrjiizPeuOOFa0hCAA88Xrnll2OOeQI7TZ6555+D3v84KjIQHrrpmI/O0y2ns9466KkH/bGWuhXq1B61K3XkoeAsSkfviO4pe5m0u9wk58X3CW4Ku3/zuxzOowW9UcybRbxntyMPfAzUdyM9Dd5/BX5P3NuEFO5LYa+Z7sIvJX4M7msFf/VwmZ8ZFoCw78JCakaER/qXrY8r8nPBAJ9SwJpsyQACGBofCkc6620hG3AQwAAkcoADIIAQAChABh/wAwRs7gAFwAYFEfCv/gyAEwYY4QEUoAABfDCFI1ihARRIAhii4H+UCWAKHPAGg6lghTG4YAn6hx3lAWROBygcED+RPRQcsEb520ECNFTFME0Rfw+UnP0MFzkEZGQBIhj/QAIc8IB8gUEAoxsAgwpHBBCqsV7qcMDqmpAAU2hNaBoaQinuiIAGLMISKdChJu6nRdUh8QSP0YcA5uEyh8TAiCMQTBSPSIcQMSBpcUGCcRI5uCwWwVRoEOIIhZCGGC5QFJbK4BN0UcFJgvKQOkkBAfyzogbQEWGHTAAaMDirYwiBCIBMAQVXZApYiuISaiTCMQEhggUIj5B8MOQFD4ANVmzwAUIzJQ41wUMTPCBpBWhhSHqJAAp+wR1/QMAiBjCPYBUgRD9wIDlXZElEXhIOmxOAO5qRBgfkgxPzEAkgKCTCfMAha0uwROTgMFCgvc+T9IslCB9yAy8QQGuOSOGK/2ThQgEsoJHnbGgs60dLCfriP4dkAQjPGQQvRMGQJElASCOXBFm8wj/DSEIBINBTqc2yKZ4w5A+5BcYCmMIaGQ1AE58nUZSugF3W/IKqBAABBgjtEAX4ww0IMAxzAKChvZLF5sIqu0qaYE7aOIQBFhFOQATAmqpKxDiHkVGhlRWapwSAOXhAOV8wAhc1kwFav3ElMmYUDRdNxbmSicw3CLIEYJgRlEwaQWTCYoOH9GkSXpqKKGSWXF6QxU0X6tMR/GAP+dAkebj4CaIuoawszYgAItdYT3yztSZAQD48G8rWYkEWPFMF/gzAL0o+tXvJXZ499JFNBtzxkEEgKAmwYP+AFs2IQgFgUFCnC9EZFNYbZkKAxRbLBGBq8Q2+KYcZkVFSCJ7gfrK4rhjzxcYQQSIBA0BZT90ZhUTIqF48YIZ+g5rTgjDIhUH9wm1zeLzX0oS3ggyRegHrxOUKRgFyBAAzFuFbWc4yuEu4XxDUmwrk9kStL7RUAjw4CDgEIRRc2KcA2opLLXZ2wXMIbzegxI+ezhKjI4isLCB72g1ywb1bFCp2SEBEIXBCvbCyISdYUYhrpnIHCySiEIdc5RrPULSelGYeYDsCCEwBJCSxMG4xfNZhpqElrfzwK2YYYmQSlJ/4+ymHz7rcbag1SCrLmTZKHCw0YKGn2FAgv2w6EkP/29mpwZPBH6FJs/ye7bxhZcACClzk5uKD01oDsQssKwfygWI5ZMZDLdWrjQUcGaGPkGkD3dzDO4ZEru/4MCDueISuIrNvTNUiCDHi5xT/WZFB+qM+lAxYctxxxCQwbgAKrABfLyERRAgCtO0ZBx47JpYbLBy5aljKNEj2AGl+8hLLUONSPvlO8I1DvINCnVXf4XDVRO1DlmipJ8Igt1IBN7iRPelPxEwaQF3SvC/1YADaeisETzZhCv4JVJPEgdswdb6Xg0Ge4LviEY8fxTth8ZycvBMYB1HDZZW/F8PAiLsLeZRGfpWJDyflmlg5ODieAgp5cIMKVMhWg/6GDJaB/0ISicIFWWE4UWhTIh8d5yq3+QVdBH0TrjWswbcnbnyCPWCDJWDuSg6nr9dhf2aPRctNIGcQpoFBDmjAAgC6BDKaMV+38KEg3Euh/VrMASNdQh7/3gR3ylYkkdM6k6XQVDnQepAq6FLkCWhzGFTeGzi3EtopznOdByaLLcBhBjnx93+/UggV5GAIz01B0/uSgWzfugr2uDovmFcbvFTASBQB8w3ycobhdDZk+QXQID+VkH4d/SlRqEKs/2CrMhwhBbHB7Q5Gf+gtGAOYfbhN7qPB9KmnvgyhcHkC1pKdEmEnJNrBgHhOTggYibJBCbv2Tp5goOYMRK3quQT4axBc7f8DBqHTQmVQ/KVTG0iOPWBQIA2DL5mCIzDAIgDgPAmAJKFX7GCeRu2RE1iC4IkAGIFUCG4OFdyXGwFCRmBVr53CU/ncCmgIZOHe6DkbCyQBC/zeI2xaex2SiQUT8gnFww2ZifiCRj0AHSWe3QFAi7VD3B3hMAVBGo1OTs0dK6QfhzVSA1jhK71UGRkDFWqh+S3ZELWMAqXCDbzDVm2OIVwQIOVCEVpdwN0fHhxHO4yTFr4CDA1TWUWOWHFYryCCVa3gS10CGx6AIiBVVEydeeWhIRDCW/nhAKDZtIAekGBeICkTKlwXP+BS4QQBnKEXaEWfqhSavNFeCizeuJ0hDW7/VjTUCh4q2Vud1++9AZBBggiYF+PpWHfBSjERHitCgId4QZphgS99GLChlg/BAomFVe8t0SqKodfRQJI1RS6ygDZN0h9kHjHNYb5JSia9gTKtonEh03BZzJFl4DEu0xt420qx4gwCkzmSWgYORpFwQYu8EjDUUkr5B5uF4rZVl3SZYuOhAA9YkRk2xSAwyIoc4kYA0w8RADQtQTlk2oF9WqctQi5ixil2F2rRVG39IjDxEwT0HTL9As3oEjxaVwNQTlkx4w2ioI4J3AtQ4yxZIwXBgSxsIxR1ox0cR+eQ2wyOlrQxgSEVhTqWTpYhExDCY0wFZF1UIh7Y45AdGdMg/xkAhBZWftlnEUHwHaJAvsALooACZV+YCZ0qKWUaWAq8idDhCAENeZkqxaVZnttGEmSOoRdpsWIZ7FMqEFSMcYI6Wpg2ICNgpRlWsgI03tD5uYDKkCMPtMBNkmMTIFoNbF42iMo4zSCf6VWe/ZpEICQTCGUYfgEO6ABB5UxTEoFnzmNU3sFUQkSC7QODZBJV1VdgBVh/0RE96FcZgWWptZ2QCOEkvYOFDdi1hSRo1RcroNmMABYI7Zdg6sMDXNd+wcJ0AlZDrgg8LuYYbg9N8VUCQFdksuIskVGB+WNEdV0JdFq1PWNTFNsKCtsobc1uBiQ8glC1QcshMtUrNBt6mf/XfLZmTzpFkUQFK2DZQ2jcuK0lDJ2blQ3Zvw3kLkYGmdUQuqHWli0CKZEQJwzBhZrSFzDfuXVZKrVbiS7CTmQZif7LTDrFZfKGazLcRHFkhQ4n/pWddw4cgfoOj2qPBraFWG5QAKoewP3DguoWhd5BXRqFizIFjIKHjyoFzxlWcCrAMHTB5jxeOOxcFgkGzQGGk7aPlH4bmZaFjLpcQRJpGpTfkKVemOzW0BSNG7TdAaRCKU0dSWgfalHBD4DfDmjT9kkoupFeCgVS1bVS1C2lCYCpHFDnHMTTwu0YYz6pmX6PpYYPpo6P7FypSGopSXRibFwBo05GpypbjQLCSET/QeHdkNxpoSFEBB5eIQkw4RGUYhEyFVYNwd1N5AuFlOCB5DwuWJbwVh0UqzdR6piuZ4xqKk/UhZ3yW1i9ELnA0SKUHkVAlptukxCdizs1hfSt5cjQBEEigbs5W3fqhEFwmF2dQDBCFRY0FpHxamRN2/AJa6PWgA9wUwF4n4QWKufI3qTqqAE1qxzmXMHOTyyoKjMxYDa0UQc+wa9q4QcaRFelkG+yAFIhgDVg4amS60c85KDMoDboJHYwAEmCZU0WGUeVAHutkezgK3iZylItQxb+AM1CLLYiK+ngRs/aBsKin88K7dDiBtCWz8cEww+eBdNlIhHwKxvV2CG4FhY0/+FsQY5DfYxYvp/SiuwqNmEzpqdmLSFOnlcxcsvKHkBVUuOX3uiSeMhtPe0yYmLhpA5S7SzKGW1v5K29IG13Lq0g4CMCXFdLtoA+hiQ1sgCFlR86zd7HPsDSnesP2qQLnaGGlQDdddo4QUB0ahpFetrdgRpFjhrbouol7cRKEq6F5dTRSc7d4gSaJk+V1MXWhmxaEUHalkE8wUHGohZgWtgD4OIFdkkZmJHHKikPRGu9neUXlAGICsHELOgSYWhUtNW6WUq7vSVbOljpzsERBqQ7WhjuohZqmQwd7q3tKgnsBunHPC7Xoi8kyGZ1MsAlyG+vdFXMKMIsyVqt7IPxDv+FjABFwiVtqnGvHODD98rvMpLAH8lIsJyC696E+qaFBOfIxyDvWSpvXSKol41Q9IEZ86rlTnSZvw2Z8gjpXvGE01VG24LCoIoCDAnRgX7wEkpqmYadopyvZggGAAcFZNJpARNGzIKXvs5BKuLo6+bwDiUxZTxGN/XEVP3wx17c8tTAz8iBEM9AW0GqkXLjDe8HBRMJ2k1pcA6VppkxlxZk/ooqEHOJF+MHGD+JGCfFCasAK0Fd6l1QBl1vBXGBm0YCtn5fGYrCAGRdbcUBFsMFj8FxpsquHE8PGaOir4pUsJJRC35BGf0xYBmX4GGBxG6h4DoB3I2AuMoAIscu3tL/iLo8C41QqXhB8gnQq/BRFoyFlUTAay2fV9yOqlkVTll17GKwsV4o8hIrxq/4Cys7clDQ8T2NgMs6m+9aGDRHIUvWERbog39YSpuWMgsbCTEvslY4y778yL0QbTm3xiubgPheZe0ClqnesjuDLxakYhlAEjAjgTnjMz57MzETirVczVQUT4gwleg+M1XlwC1XJ6oY9PxGpoYZJBlhAylzBxf3CD8fBjlT9D/vBfJgb5xpL4Zik4dmKIaeqLtZCllChBifj3R8s1Ycy05qtE2sdCdcVw1vb7u0tFaQikXHdJKKhRYfckYjCU8TxrtsWE+DnFBzxUw7R05fBctsKVL3/4NSbwVTN4dTS0XaSrVRXHOMeDWEZBa2YLVUJPNW80EGfXVaO0jArslYm/Vbw7XAxvVc0zVkRJG55HNe6/Ve8zVplHVdA/ZdU/XLtDJga7RgG7bxJvZiqydAWLWdFDZjUw1iS7awVvZl0+NUX3ZkYzbEULZkc3Zn4/Tezof3RbXmuYDgWMUNaYLyvuZfi3ZMf/YcLEBGAMMuHwVsg2z+CQ50SCkGSqVux/bVzDbkadkVCo3QkIM9bSxGpBYDkpNE/IcIyRNFhMQTGCD/kYACpGg/RV8guIMonNPdiUI+MMD+RSBGUHc2FEI+WEThuh9bS+NwY3ZxH7JIXK8g39Uhtv+AXhVnFUxdIYJV4ZBXC91dr9DVxxGiHlIgv2jxW+lVal6VtE3VdcWdHj5ir5TVLSwhQqBQE8CDLOYTfdc3aXPxVs2vvjKjQcsIMwWmFrWE/HlkC8gjdYkmNBoRikfXaXUB5UFEbwEoKxbrlU4mMmkk55H4Zds3HdjW994emOUYTnFlM9NyFkSFYBJxiyWm6pYkE3QYYKnmme0MPeplZmNRklf2ktNAvYCVyhjnGdjZDTRhDpzZDxAyJJgMa/JwZc5gC1XXB3VlC8xDOjbBnAV5XnJXT1Gg4R35qQk3mr+Mms/AglRbToLn/VBbgVWbRonCHSFCD/gTvmiUgHabtI3/rIcw24wYVyZ1uSY3wK4duheMAfHiGqOX54hD+mJLunIAhER3w7H23KPnOsDsejcwNb/WBChW6bAndrHHdWgz+484O1xDe7TjsGRstrBb+6dM+1tX+7bXR7enRXRDRBodHLjDtbijhYDvVBudO7qbtbr/9Gf92mCPMbynu4nvyJQ/NgJpO75XibyLxWndeb9LEcDHu74XM6inlr3P8b8jvJcoPGhDfMR/8cQz9rdb/JRg/GJr/MZ7h8D39MeDvHaIvB3Uswww6WqnQMr7hKFUfMm7R3GfD1+sNo/oh0yZye7UBcnL/J9gPEP9H0JBhPvBX63wU0awKeuSe5DN3yTN/wM8BJR4D2lIpIL+rcB+bS0/6cMPOII9YT1IcAqjMqDg/lUg+BPX+1PhNVI+IIJzbRDRt596N0HDQtXPV81sL9/Y9hmIqyGD50Lgu5EIsLtOBD4UftUEWngURDg9vJ8lOM2KVMGD9wo0/IEdQj7my9QitpFeDTrlSysMBYI1QcBXDUNeEV6I90qe3j3eKw3NYwJ2uXiQYyMg1ErOxHga1Hvt37mI3bgqzNNqxuAlZM1OvbiOC1NI/QA4Qi116fzucsLmvgG3GUF0kWyVF9UbzEjuZW3Mu/54wH4a0JhilWfi5uQS1PQ/6sT1DyYtOyUwAaUTC1UQaHkUoDhnUQ654f8lVHUWCAiiACRPIQTAMABrCxAuKySjAQRk+rp+/wsKh8Si8YhMKpfMpvMJjUqn1GqUZ03qggEHoADBAXBbrM6QcAUMhYQYACmsHjkBWo2TAWU8G8ChMsDgUnDAReIwSCCHoEJSIiBIeLDQUqDnM7Cg9hhANxbDGLi5NzMAJka2MyrEkvUKGys7S1tre2uFhVsX5JCgghaQ0FKmwjuQMLwCERCw6ZugILeFrBxj6sIHnMCgYLzwm2D4I9yMg9AQ4A3AkEwKLnxQ0DyA6XLwa7D11c4NgK5OBb41rq71CKasGICBb4DseggxosSJFCsO0YVrn8WNHKkU7AgypMiRJGP/YbylsaTKkR9XunwJM+bEk7ZSyry5qyXOnTx7+rxobJfNn0Sn6CyKNKlSizRrDV0K1cjRqFSrWr0SNOOjq1yxdf0KNqyLprSeik069azatT3JzlLHIq7cuXTr2r2LN6/evXz7+v3bNwAMtoQL33QrCwHgxYwbz1XQwLHkyX23Gr6MeSTizE02c/4MOnTnrKKdeC6NOrXo06qDsG4NO/bZ17Fpy76NO6rt1rtz+/7Ns3dq4cCLGy9JvHTy48ybU1weGrrz6dRpSf98vbr27VKyZ/bOPbz4I+Avlx+PPv35wuvTu9/enm389/Sbz1d7v77+3/nF9t8PYG2kHfdfgAai/1bgVwkeyCBnC3L1YIMSEhahVRVOiGFYF1K1YYYeWjigcR1+SOJSI5oYYokq4naiUi2uCCNOLyI1Y4w2ulQjUTneyKNIO/r0Y49CMpUicEEOieRDCwjDTADjFPcAk814kWSVailAQJYEQMAcAlpm+aSVYnblwJeDHHfAlw2MyWZXl2j5yXENaKlAm3ZalYCWYRa3gJYI3AkoVPUQsGZzZWYpR6CKFiVAlnU292Yai076U5ZUNpcnKZRuihMDi0xXz6WcjvrSA5I61yipqr5kgKbOnblqrCQlOh2tst5KRDO67sprr77+Cmywwg5LbLHGHotsssouG6yruAZIwAjSTv9LbbXWXottttpuy2233n4LbrjiYhvlswzaY253RaabHrrsPnHku1e5Ky8T8dZLFb34JnHvvkvp668R/QaMFMBUoWCZFAjsadjABBNlsKCRLdBAQ0qkZJZ86z7sXMRKAeJDIQsN8OcXBkTySCQnjCFHAQ+Y+ohij7BhgCE1g+Uwxz15nBQDJftQgwMDOBKZAw0U4IsAL9fRBgJGk6DAACl4Uc6fguG8sc7H8YyUTQpQKY4ZSjPwpA4IPKrDAQ2IUG4AP9+sYNZaF8d1UT4fwonYBSADAdWRwKCDAJGxYHXCWM/NXd1ENRIyJZ8crbcLIJuNtgAHxEEILy7A3VXOiMv/pDhRFGtSMT5LtiB2lMgU3sYCFJOAzgAK1KnR1XF/rl3oRKHQkOWEpCLHAb6zPFYBbBBix+a0cg6h3Ljjpru/nj/vUvT7Tk+9Stbji332JG1fb/feiwS+vOKPD1L5756PPkfqs8t++xa9n2788lNEv7n23y8R14oNwDDiHWEenqCFHsDxKPU4j3+h4RoaViaEjPngAc6KhQzuQJ/9MfAhdduHMwJwNANA4Bdj+EUA5LAABPisAekwAALcoQZAGAAa0gCA60BouHCQQgYKYAYC4HFC8Whwg7jo4CMIYIgF0GEfR/sH7dLmCn24QAF/IsACBFCAJg5giX9KhBAS5YZr/2AhUUoU4gKJmBl3NcJteDOIK8rQJBLuwxUDSAcIW6AHLPBAIWv809ACAAESaENyzYiMGdF4GyNmAxtlOBUnsKGJIOgBgwIYhEJ+8IAzbWGQBtDiYOBzRkQaRpFubIHP5GCChRQOG2ojwQwNAoC1FeBul5zgIAQnSADwoJOFsB13hijKWXBtSWvIgQsQ8CcDMGAQBVgSA7ywADEgc3PeUAAZfHAAb5QsmmOo4Om4CQxSNEIBD/gZKIMJm/w9C5johIU6ccXOdmbhnbeKpzyrQE9Z2fOeU8hnrPbJzyj4c1UADegTBqqqghq0CQgllUIXuoSGjuqhEE2CRDlF0Yoe4f+im8qoRovAUUp59KNDcKAIbEWF49kLCtz8ZShJmi8loEMBAWzCPlp6BA9CQYIHxc5LYQoVUg4AEHVy4T3ooMwuzCAADKhZA6L2D0NUkgEA/Ac9FvLUFsBgnOMYqjqOeVXNjYUB6mjZ0FJIyKaqcmh0aBTJVsBUMVTVPz8FqlJISYA/+exyLngATcUxj7GNwQFteAAJ0gZYP2CRHQgobC5ViIJC5ZWxupQDLS1zM7/asAWMS0QhICfLBhwgTXbI5GCzYbjm2ZUwamyGOTWnB1fcTbSqGxrJEoAAMXhQaaTYwgGGZsh9yIABncgDK4FLDMu4rB0qwBwPusGCtYnNIC//zC176rraouAVGymQouxGINXRaU4HBUlbA7zwxiOON5cvUBt6k/sDE6BABXlUgSdGMN9HYkIA4tVYdteyXSCk40+CS5QBjjc5KukAZJCowRSJQSUZUPALkjWFgwEA1ZR8inF+AJkkviA8Y2xSDgg2xlw1hN3/+mSYIzQuEB5QqH+EwwG+EAYOaswLBK4Nw7+g6h9IKIMCKCAZEcbGkJkKXx8AZB1oWOY3whHiRyJjATUOYwxSe5WRZjekRkiUaCmSqLP5Rsur5XIR0oHbigAkiLkhs13NrCg3AxXOgZIzTOlMhJPVFAqfrEWfM4FiFZ+loVaGw97sWEw0VKIdumxS/zGX0FJ1kgVdm8RbipFzaUHjpKET/sMgWpLFN+CALJYb6uZo8AUTCPK3fzLe5saykAe8FQVAo5WrR6uYcSDxrcTbNZXYQFocsBpolZVRpjUNuiwAos9qm6IfFYBfMbsmRQSQWgK88AAH1MByWY3BFW0AhjEs4g4OQIAAoPrlZgMtELgtl7e3zYtqB60ObjX3tYeWDXMYG9lgoV+asvTaMGLOtiz4LQzi0uhmOEsPXtSlbWGLDTcsgIo/3JxfWVGJH/CgIHqILXwZbkn2fs0F4ojBnldiZ5LSzwBwCgIFG94SzeoyVZMeywkTcMUMq7cHKXSSAqiM4WeWCwxE13ggYP/QcUayd4/s3S0s983vruSvT2zGJgTu5hAKv2GQJe3rFU2cZI97ehPNkEN9p/hVo5eilPH2ettt+Dizt+XYUa9eRri01LgYwheLTsOkf57YiSvjrGyPAQ5MNUUGEHNzSJz22sW+ScAbYgvqeIDpbIfnKaT8oxc9wBuEh18fnCxRri6p8EJmudFubtT3GIcYSq9Lmtn8i8IeR8paTzzLbUWlwxueLuded65kXqAowTKC6B78kgwfCsbPQvOVg/zkj2T5bNq8Rqk/JutXFPti0j5EuW8l7y+0oQYfgMWEwIMDvNYrbSRCeo3AUyjAnjxEKL36YbEc8Ru0odt+msAEsn7/WecDEvR+RRB/8OI8+oIF9/cK+Rd90hcSkoZSWOAKL2RjC9EMJNQqY6ArOOAKQDQNy1QxX5CBHghfL4RzffULgfQDwfBl1QA4S2IDIIRU4fAnPeQ2+qBvLqh+BOAMCHGDPrSBP0SDQWCBYUSEDVCDwkBgwNCBGKhwJQRCe6J/AZU/eQIBYZJ+fpAoXvRMuuQIKkBcuvRpluACZaRUDjaGzZZeUoRhuSUpGOMFheCGxdR4E/cFXEJ6XIIFY1hJOTCHhqAHewiGsyc7eRgEXfhpdRJuhPhcOzAIX7hHgeh4EBgV9NMoWfJJAsAMEPAJSQVks8cDmCADrgAIdwRxPtgM/6WYXHVUSAgnVgAAY2hVEK4gdtcgZKtYiLAkYQ2AVgaRiwHAdRuHdEEAike3SME4SKRoEDwwi+tXhfxEP2CQJZbBA74gB2FQiGfHA5gDBy/ASz2wBeH2KZnQiq5SXgmjfu1GCltUeMP1CVznjXi3jlXkAgwQj7tIjIv0A9q4j9eAj4vUjYnCJWenSmmmdpYYVFnwWwlDgYMQBs0khnSAbzwAVYfIArx0AFfDRoc4cQXgMuLIba7kABq5YxNkCPioNqP1ZbcIj/9wQWsiZFpVJ5bHDnSQhbNEB14yBjL5j+gSkUtSCgHJkxZJkzcJV7KYknEyewr5L7awgWeYW0xVcf9C5jObsIF7IxiM8CfjVE425A2n0FfNsJN/wk0GUE03Jhg45Wm2M1WdcEwlowKz1AUm1gVaKZaJYDvLRpcMNjQluQnTZEwtSJWBKZf8UJfd9AW21TIKQFUqoJd/Fo33BH4ecjMZ939O+ZQBkwK+VASTKU+VmSSg2U6iiSSkiU6mOSSoGUyqKSSsKUoXxTsX8XyywIAT8Wc08oCaWRESdTrewJXs9xAV4prqwptJ0VCMMwN1MjtYRDhz9VsrYzy0hk3qN1cuszJw43kjszInITRzVWq/dgBLsxCjJWy8VgCKAUHRKYjDdkxScw8Fdxi7eZz9o2yeSVn3wCX08Fvt5oT/5eZ3DUBCmeCfFIZMRyNz5KQPALqLPnBFRmN21kY1xPVzK+AOQYNvBmBY5dJJ5bYJVgRvUTM17lVxMgGbiORvfkIOlsGKXsFDUrNtNYBSHPcP79BYcZBFMykCNnASSFNH7OVF48glh4hhYGMI1slD5uRxraQ0azCCUFeflWIFLJclTPmF+gkENAoXBUcTNFqLLUBxtBM1XJoVnWRYfnB2wgUEu1VdqaJhFjY4b9UI1TafUQoxWUB1tqKcK1AnX7pIUIU8A0KjDTdywYADgPoFGJGOBjFhW3AHBVFGsRRYfwoDctde3giShFCc6EefdroLvikYwKlLkWEANNoGUeMG411ajDkwO0ExoKeKDCdTppHBADtGAJKXA4JxbUBweZw1DJ6yEDiHh2IXO7PTSYKQQDBxomgkm8mDTSSger+3OYs1f7gnrWPQENE6rS1jMcIznSa3FV2wWOWpcU9yMtfqrI8QrbOZqOeHI53qqbewqfPTfqsBr/FaC/NaEQmjUtCHrzyhrzGyrEQUsDAysBtUsCtysAyUsCqysPwTLeMisRNLsRVrsReLseLibv96E8zisR8LsiErsiNLsh9bQRyLsimrsivLsi3rsi8LszErszNLszVrszeLszmrszvLsz0LVCEAADs=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     VEGF: vascular endothelial growth factor.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_57_32671=[""].join("\n");
var outline_f31_57_32671=null;
